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Summary 
 
The Host presents different innate immune components to fight 
bacterial infections, most of which are evolutionary conserved strategies. 
Conversely, Bacteria present numerous mechanisms of virulence and 
evasion, transversal to different bacterial species, that confer resistance or 
subvert the activity of the Host components. This thesis presents a study 
on how the Host perceives the Bacteria and reacts to them and how the 
Bacteria protect themselves from those responses. 
Peptidoglycan (PGN) is a ubiquitous cell surface bacterial polymer. 
It is composed of glycan chains cross-linked through peptide bridges. The 
residue at the third position of the peptide moiety shows the highest 
variability among the different PGNs. Nevertheless, most bacteria possess 
either a lysine (Lys) or a meso-diaminopimelic acid (DAP) residue. 
The Host components that act on the PGN, range from enzymes 
that degrade it to receptors that upon recognition initiate downstream 
signalling cascades leading to the production of antimicrobial peptides. 
The Peptidoglycan Recognition Proteins (PGRPs) are evolutionary 
conserved innate immune receptors in Invertebrates and Vertebrates, 
including Humans. In Drosophila melanogaster, PGN is the main bacterial 
component that triggers an immune response and it is recognised by the 
PGRPs. According to the current model of bacterial recognition, the PGRPs 
possess discriminatory ability between Lys- and DAP- type PGN. PGRP-SA, 
in vivo, binds exclusively to Lys-type bacteria, whereas PGRP-LC 
specifically binds to DAP-type bacteria.   
Previous work from the Host Labs1 has shown that bacteria 
                                                          
1 Filipe Lab, Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia 
Química e Biológica António Xavier, Universidade Nova de Lisboa. 
Ligoxygakis Lab, Laboratory of Cell Biology, Development and Genetics, Department of 
Biochemistry, University of Oxford. 
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present components at the cell surface that impair detection of the PGN 
and thus compromise host survival [1], [2]2. The wall teichoic acids (WTA) 
are phosphate-rich polymers of the Gram-positive cell wall that exert 
stereo hindrance by shielding the PGN from PGRP-SA [1]. Atl is an 
autolysin that cleaves PGN in order to sustain cell growth and division. In 
the absence of this enzyme, the bacteria accumulate cell surface exposed 
PGN which is recognised by PGRP-SA and allows the survival of the Fly [2]. 
From the Bacteria side, I aimed to understand: 1) whether WTA are 
a transversal bacterial evasion mechanism that impair PGN recognition by 
Host receptors; 2) whether other autolysins could impair the binding of 
PGN by PGRP-SA and contribute to evasion. From the Host side, I aimed to 
ascertain the discriminatory ability of PGRP-SA and PGRP-LC towards the 
Lys and DAP residues. Why are two major immune receptors limited in 
bacterial recognition due to the discrimination of two residues? As the 
work evolved, the data suggested that PGRP-SA could engage in cellular 
responses. Thus, the final goal of my work was to evaluate the role of PGRP-
SA in phagocytosis. 
As an overall, the work here presented asks for a re-evaluation of 
the current model of bacterial recognition and confirms the importance of 
cellular responses as a first line of defence, followed by the prolonged and 
protective humoral responses. In addition, I show that recognition of PGN 
is paramount for the triggering of efficient responses by both the cellular 
and humoral responses. 
I show that PGRP-SA has access to PGN fragments that are 
                                                          
2 [1] M. L. Atilano, J. Yates, M. Glittenberg, S. R. Filipe, and P. Ligoxygakis, “Wall teichoic 
acids of staphylococcus aureus limit recognition by the drosophila peptidoglycan 
recognition protein-SA to promote pathogenicity,” PLoS Pathog., vol. 7, no. 12, 2011. 
   [2] M. L. Atilano, P. M. Pereira, F. Vaz, M. J. Catalão, P. Reed, I. R. Grilo, R. G. Sobral, P. 
Ligoxygakis, M. G. Pinho, and S. R. Filipe, “Bacterial autolysins trim cell surface 
peptidoglycan to prevent detection by the drosophila innate immune system,” Elife, 
vol. 2014, no. 3, pp. 1–23, 2014. 
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temporarily surface exposed during the bacterial cell division. Thus 
autolysins do play a role in the impairment for PGN detection. If their 
activity is compromised, there is accumulation of PGN at the cell surface. 
Particularly, Atl and Sle1 have a great impact in cell division. Besides Atl, 
Sle1 also contributes to impair PGN detection. In the absence of Sle1, there 
is the accumulation of newly synthesised PGN fragments at the septum 
which are recognised by PGRP-SA. However, the amount of PGN that is 
recognised is fundamental for the triggering of a potent immune response. 
Therefore, paradoxically, Sle1 does not seem to contribute for virulence 
regarding PGN recognition. I propose that it is the sum of the autolysins 
activity that can properly impair the detection of PGN during cell division, 
albeit the Atl protein presents a more preponderant role 
 I show that PGRP-SA and PGRP-LC are promiscuous for the Lys 
and DAP residues of the PGN and both participate in the immune 
responses upon infection. When the PGN is detected, both PGRPs act as 
opsonins and engage in the phagocytic and clearance processes. In 
particular, PGRP-SA has optimal binding ability and presents lytic activity 
at low pH, indicating that it may act as an enzyme inside the 
phagolysosomes. After phagocytosis, the macrophages seem to present 
two ways of clearance: phagocytosis-exocytosis or phagocytosis-
apoptosis. Through induction of apoptosis, the macrophages may be able 
to incorporate the internalised bacteria in the apoptotic bodies which will 
be phagocytosed. The bacterial destruction can then be achieved through 
a new phagocytosis process. This strategy of phagocytosis-apoptosis is 
likely to occur until complete bacterial clearance.  
Concomitantly, the clearance is dependent on the degradation of 
the PGN, which is compromised by the WTA. Therefore, the WTA are a dual 
strategy of immune evasion. At a first level, they impair the primary 
recognition by both PGRPs which is crucial to trigger the phagocytic 
processes (and also the induction of antimicrobial peptides). At a second 
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level, they impair the processes of clearance by impairing the activity of 
these PGRPs (and perhaps by other Host components).  
I propose that it is the accessibility of the PGRPs through the cell 
wall that determines the PGN recognition and not the discrimination 
between the DAP and Lys residues. Furthermore, I propose that the WTA 
of the Gram-positive bacteria and the outer membrane of the Gram-
negative bacteria, are conserved bacterial immune evasion strategies 
towards the recognition and activity of PGN host receptors.  In addition, I 
propose that the macrophages present two pathways of clearance: 
phagocytosis-exocytosis and phagocytosis-apoptosis. The activation of 
either pathway is in turn dependent on the bacterial type and the factors 
that they possess that interfere with an efficient phagocytosis-clearance 
process. 
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O Hospedeiro apresenta inúmeras estratégias de resposta inata 
contra a Bactéria. Estas estratégias estão presentes em diferentes 
Hospedeiros por serem conservadas ao longo da evolução das espécies. A 
Bactéria, por seu turno, apresenta diferentes mecanismos de virulência e 
de evasão que permitem a sobrevivência e o estabelecimento de uma 
infeção no Hospedeiro. Estas estratégias são transversais a diversas 
espécies de bactérias. A presente tese de doutoramento descreve um 
estudo sobre o modo como o Hospedeiro perceciona e reage à Bactéria e o 
modo com que esta se protege de tais respostas. 
 O peptidoglicano (PGN) é um polímero ubiquitário da superfície 
das bactérias. É composto por cadeias polissacarídeas que se interligam 
por pontes peptídicas. A terceira posição da cadeia peptídica alberga o 
aminoácido mais variável dentro dos vários tipos de PGNs. Ainda assim, na 
maioria dos casos, encontra-se ou uma Lisina (Lys) ou um ácido 
diaminopimélico (DAP). 
O PGN é detetado por componentes do Hospedeiro que iniciam 
respostas imunitárias. Estes componentes compreendem quer enzimas 
que degradam o PGN, quer recetores que o reconhecem e ativam cascatas 
imunitárias que conduzem à expressão de péptidos antimicrobianos. As 
“Peptidoglycan Recognition Proteins” (PGRPs) são recetores 
evolutivamente conservados do Sistema Imunitário Inato de 
Invertebrados e Vertebrados, inclusive o Homem.  
O PGN é o principal componente bacteriano que inicia respostas 
imunitárias na mosca Drosophila melanogaster. Segundo o modelo de 
reconhecimento do PGN em D. melanogaster, as PGRPs possuem 
especificidade para os aminoácidos Lys ou DAP. A PGRP-SA, in vivo, liga-se 
exclusivamente à Lys e a PGRP-LC ao DAP.   
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Os Grupos de Investigação que participaram no presente trabalho1, 
verificaram anteriormente que as bactérias apresentam componentes à 
sua superfície que impedem o reconhecimento do PGN com consequências 
na sobrevivência da mosca [1], [2]2. Os ácidos teicóicos da parede das 
bactérias Gram-positivas (WTA – “Wall teichoic acids”) são polímeros de 
fosfato que impedem o reconhecimento do PGN pela PGRP-SA por 
comporem uma camada que impede o acesso da proteína ao ligando [1]. A 
“major autolysin” Atl, cliva o PGN para promover a duplicação e a divisão 
da célula. Na ausência do Atl, a bactéria acumula à sua superfície 
fragmentos de PGN que são reconhecidos pela PGRP-SA o que resulta na 
sobrevivência da Mosca. 
Pelo lado da bactéria, o meu trabalho de doutoramento teve dois 
objetivos: 1) avaliar se o efeito dos WTA é um mecanismo bacteriano 
conservado que permitem a evasão do reconhecimento do PGN; 2) se 
outras autolisinas impede o reconhecimento do PGN pela PGRP-SA como 
mecanismos de evasão. Concomitantemente, procurei averiguar a 
capacidade discriminatória da PGRP-SA e da PGRP-LC ao PGN. Por que 
motivo estes recetores centrais à resposta antibacteriana, encontram-se 
limitados na deteção devido à especificidade a uma molécula? Com o 
avançar do trabalho, os resultados obtidos levantaram a hipótese de que a 
PGRP-SA participa em respostas celulares. Com efeito, o trabalho culminou 
com o objetivo de avaliar a função da PGRP-SA no processo de fagocitose. 
                                                          
1 Filipe Lab, Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia 
Química e Biológica António Xavier, Universidade Nova de Lisboa. 
   Lygoxygakis Lab, Laboratory of Cell Biology, Development and Genetics, Department of 
Biochemistry, University of Oxford. 
2 [1] M. L. Atilano, J. Yates, M. Glittenberg, S. R. Filipe, and P. Ligoxygakis, “Wall teichoic 
acids of staphylococcus aureus limit recognition by the drosophila peptidoglycan 
recognition protein-SA to promote pathogenicity,” PLoS Pathog., vol. 7, no. 12, 2011. 
   [2] M. L. Atilano, P. M. Pereira, F. Vaz, M. J. Catalão, P. Reed, I. R. Grilo, R. G. Sobral, P. 
Ligoxygakis, M. G. Pinho, and S. R. Filipe, “Bacterial autolysins trim cell surface 
peptidoglycan to prevent detection by the drosophila innate immune system,” Elife, 
vol. 2014, no. 3, pp. 1–23, 2014. 
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 As conclusões do trabalho constante nesta tese pedem que a 
comunidade científica reconsidere o modelo atual de reconhecimento das 
bactérias e intensifica a importância das respostas imediatas celulares 
como primeira linha de defesa, seguidas pelas respostas prolongadas e 
protetoras humorais. O trabalho aqui presente demonstra ainda que o 
reconhecimento do PGN é crucial para a ativação de respostas imunitárias 
celulares e humorais eficientes contra as bactérias. 
O meu trabalho demonstra que a PGRP-SA reconhece fragmentos 
de PGN que são temporariamente expostos à superfície durante a divisão 
das células. Por conseguinte, as autolisinas assumem um papel importante 
na protecção do reconhecimento desta molécula. Quando a actividade das 
autolisinas é comprometida de tal modo que a célula não consegue 
controlar a exposição do PGN durante a divisão, fragmentos de PGN 
recentemente sintetizados não são prontamente incorporados no 
polímero da macromolécula e por isso acumulam-se à superfície. 
Particularmente, a ausência do Atl e do Sle1 têm um forte impacto na 
divisão da bactéria. Com efeito, para além do Atl, também o Sle1 assume 
um papel importante contra o reconhecimento pela PGRP-SA. Na ausência 
do Sle1, há acumulação de fragmentos de PGN recentemente sintetizados 
na região septal que são reconhecidos pela PGRP-SA. Porém, a quantidade 
de PGN que é reconhecida revela-se crucial para a ativação de uma 
resposta eficiente. Por conseguinte, paradoxalmente, o Sle1 não contribui 
para a virulência da bactéria através da evasão ao reconhecimento do PGN. 
Por fim, eu proponho um modelo que se baseia no todo das atividades das 
autolisinas que eficientemente conseguem impedir que uma grande 
quantidade de PGN esteja acessível ao reconhecimento, sendo que o Atl 
assume um papel preponderante. 
Eu demonstro que a PGRP-SA e a PGRP-LC reconhecem quer a Lys 
quer o DAP do PGN e que ambas participam nas respostas imunitárias 
contra os dois tipos de bactérias. Aquando da deteção do PGN, ambas as 
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PGRPs atuam como opsoninas e participam nos processos de fagocitose e 
degradação da bactéria. A PGRP-SA demonstrou ser uma potencial enzima 
lítica que atua em condições acídicas, indicando que deverá exercer 
atividade no fagolisosoma. Após a fagocitose, os resultados sugerem que 
os macrófagos seguem uma de duas estratégias para a degradação da 
bactéria: fagocitose-exocitose ou fagocitose-apoptose. Através da indução 
da apoptose, os macrófagos potencialmente podem conter  as bactérias 
dentro dos corpos apoptóticos que serão por seu turno fagocitados. As 
bactérias serão eliminadas ao sofrerem uma nova fagocitose. É provável 
que este processo de fagocitose-apoptose se repita até se atingir a 
destruição total das bactérias.  
Por outro lado, a degradação do PGN é essencial para a destruição 
da bactéria e os WTA comprometem e dificultam a clivagem do PGN. Assim 
sendo, os WTA atuam a dois níveis contra as defesas do Hospedeiro. 
Primariamente, eles impedem o reconhecimento pela PGRP-SA e PGRP-LC 
e, por conseguinte, a ativação do processo de fagocitose (e a indução da 
expressão de péptidos antimicrobianos). Quando o Hospedeiro ultrapassa 
esta barreira de reconhecimento, os WTA atuam contra a segunda linha de 
resposta que é a destruição da bactéria após fagocitose, ao impedirem a 
ação da PGRP-SA e PGRP-LC (e provavelmente de outros componentes). 
Em suma, eu proponho um modelo de reconhecimento segundo o 
qual é a acessibilidade das PGRPs através da parece celular que determina 
o reconhecimento do PGN. Eu proponho que os WTA das bactérias Gram-
positivas e a “outer membrane” das bactérias Gram-negativas são 
estratégias bacterianas conservadas de evasão ao Sistema Imunitário. Por 
fim, proponho que possivelmente  os macrófagos apresentam duas vias de 
degradação de microrganismos: fagocitose-exocitose e fagocitose-
apoptose. A ativação de uma das vias está por sua vez dependente do tipo 
de bactéria e de fatores que possuem que dificultam a eficiente destruição 
por parte dos macrófagos. 
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Thesis at a glance 
Chapter I. The Bacteria and the Host 
 Are autolysins redundant in impairing access to surface exposed 
peptidoglycan by PGRP-SA? 
 Are PGRP-SA and PGRP-LC specific towards Lys and DAP residues of 
the peptidoglycan? 
 Are WTA a transversal Gram-positive mechanism to shield different 
peptidoglycans from different PGRPs? 
 Is PGRP-SA involved in phagocytosis? 
Chapter II. Recognition of peptidoglycan determines efficient 
antibacterial responses 
 PGRP-SA recognises PGN that is temporarily exposed at the cell 
surface during cell division, which can be impaired by the temporal 
and spatial activity of the autolysins. 
 Sle1 appears to be crucial for cleavage of septal PGN to allow septum 
re-shaping upon splitting of the cells. 
 Recognition of peptidoglycan is key for efficient antibacterial 
responses. 
Chapter III. PGRP-SA and PGRP-LC recognise both Lys and DAP 
residues of the peptidoglycan in vivo 
 In vitro assays showed promiscuity of the PGRPs towards Lys and 
DAP residues. 
 In vivo assays showed that the recognition of both PGN types by both 
PGRPs is paramount for host survival. 
 WTA impair recognition of both peptidoglycan types by both PGRPs. 
Chapter IV. PGRP-SA is involved in bacterial clearance 
 PGRP-SA and PGRP-LC participate in phagocytosis and clearance. 
 PGRP-SA has lytic activity towards different peptidoglycans. 
 Apoptosis is a mechanism to promote clearance. 
Chapter V. Bacteria present mechanisms to evade cellular and 
humoral responses mediated through peptidoglycan recognition by 
PGRP-SA and PGRP-LC  
 The access through the cell wall to the peptidoglycan determines the 
detection by PGRPs. 
 PGRP-SA and PGRP-LC play dual roles in phagocytosis and humoral 
responses. 
 Bacteria possess conserved mechanisms that impair accessibility to 
the PGN. 
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CHAPTER I 
The Bacteria and the Host 
 
The event of the first cell was paramount in shaping all the 
subsequent steps of Evolution of Life. The first cell was the first individual 
and self-sufficient structure that presented defined boundaries, raising the 
concepts of intra- and extracellular environment. Thus, it constituted the 
primordial individualized entity that clearly presented a “self” and 
therefore a “non-self” – the surrounding environment and other cells that 
were grown from it, identical but not the same individuality.  
Colonial organisms evolved to multicellularity, which can be 
described as whole organisms that in their own self are composed of many 
non-self-individualities. Evolution of multicellularity culminated in 
organisms composed of interconnected systems and finally the idea of self 
and non-self was fully stablished and thus shaped the evolution of the 
Immune System (IS).  
As an integrated system in an organism, like the other systems, the 
IS guarantees and maintains homeostasis, i.e. it helps to maintain a state of 
equilibrium in the organism. Particularly, the IS plays the role of protecting 
the organism against danger [1]. As the scientific knowledge grew, we 
became aware of the two branches of the IS – the Innate and the Adaptive. 
Whereas only the Vertebrates possess an Adaptive Immune System, the 
most basic mechanisms of an Innate Immune System (IIS) are found to 
some extent in almost all life forms across the Eukarya Domain. The IIS is 
a constant vigilant of danger signal and is the first line of defence in an 
organism. 
The surveillance and detection of invading microorganisms relies 
on an evolutionary conserved system of receptors that are constitutively 
expressed, non-clonal and independent of immunological memory. They 
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are collectively known as Pattern-recognition receptors (PRR) and 
recognise specific structures in the microorganisms, i.e. they detect danger 
through discrimination of non-self [2]. Whether the detection of danger is 
followed by an immune response is dependent on the confirmation of the 
danger signalling, which is in turn dependent on how the microorganism 
is perceived. It is within these interactions that two concepts became 
implemented: a “Host organism”1 and a “pathogenic organism”2. 
These evolutionary conserved PRR detect conserved microbial 
structures that are specific of a class of microbe and absent in the Host. 
These microbial structures are designated as Pathogen Associated 
Molecular Patterns (PAMP) [2], however nowadays they are also 
commonly referred to as Microbe Associated Molecular Patterns (MAMP), 
since these structures are not specific of pathogenic microorganisms [3], 
[4]. As PAMP are not present in the Host and are conserved in a class of 
microbes, it is the logical that they are crucial for the microbial life. Hence, 
the pathogens present various mechanisms to avoid the detection of their 
PAMP by PRR. The Host-pathogen interaction can be viewed as a 
battlefield that in extreme cases, upon failure of efficient recognition and 
response, can culminate with either the survival of the Host or of the 
pathogen. 
As the definition of boundaries in a cell, the cell surface, was of 
extreme importance to evolution of Life, again we find that it is at the 
surface of the cells that most immune responses begin. Upon breaching of 
the Host surface, many of the first encounters of a PRR and a pathogen 
happen mainly at the level of the microbial cell surface. Thus, many PRR 
are specific for PAMP that are components of the outer surface of the 
pathogens – viruses, bacteria, fungi and parasites. 
                                                          
1 An organism that harbours another organism to which provides nutrients and shelter. 
2 An organism that can cause disease in a Host. 
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 The basic mechanisms underlying Innate Immunity are 
conserved among Plants, Invertebrates and Vertebrates, including 
Humans [5]. Moreover, the virulence determinants and strategies that 
bacteria employ against Host defences are also conserved among a group 
of pathogens, such as Bacteria [6], [7]. Therefore, it is possible to study 
fundamental questions in one organism and extrapolate to others. Hence, 
the concept of model organisms became a foundation for studying 
processes and mechanisms both in Microbiology and Immunology.  
The work presented in this thesis describes a study on Host-
Bacteria interactions. As an overall, the work aimed to understand how a 
certain type of PRRs – the Peptidoglycan Recognition Proteins (PGRPs) – 
recognise a ubiquitous bacterial component, the peptidoglycan, and how 
Bacteria can prevent this recognition. The study of the bacterial factors 
that evade the IS was focused in the bacteria Staphylococcus aureus and 
Bacillus subtilis and the in vivo studies of the PGRPs recognition were 
conducted in the fruit fly Drosophila melanogaster. In this chapter, I 
address the current knowledge on the structure and biology of the 
bacterial surface, particularly the peptidoglycan, and a brief state of the art 
of the Drosophila immune responses. Finally, I present the goal of my PhD 
project and an overview of the contents of each chapter of the thesis. 
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The Bacterial Cell Wall 
 
 Bacteria present several molecules that “coat” and cover the 
outer surface of the cytoplasmic membrane. The arrangement of these 
“coating” molecules forms the cell wall or cell envelope. The cell wall (CW) 
is a complex and dynamic structure that protects the cell and helps in the 
adaptation to different environmental conditions. In broad and simple 
terms, the CW components can be divided in three types: 1) a ubiquitous 
bacterial component, the peptidoglycan; 2) components that are 
characteristic of either Gram-positives, Gram-negatives or of Gram-
positive Corynebacteria; 3) components that may be present in both Gram-
types but are often species- or strain-specific (capsular polysaccharides 
and S-layers).  
 The CW comprises many bacterial components that are in 
contact with the external environment which are determinant for 
infection. It comprises PAMP, virulence factors and components that 
function in immune evasion strategies. Indeed, most current models of 
bacterial recognition are based on how certain CW factors confer 
resistance to Host responses. Thus, the knowledge of the CW composition 
is crucial to understand how bacteria interact with the Host. In addition, 
peptidoglycan is a major PAMP and PRRs that specifically recognise it can 
be found from Plants to Humans. Moreover, along with PRR, the Host also 
produces lytic enzymes capable of degrading the peptidoglycan such as 
Lysozymes and produces antimicrobial peptides3 (AMPs). The PRR, the 
lysozyme proteins and the AMPs are the most conserved immune 
strategies found in almost all Animals.   
                                                          
3 Innate Immunity cationic peptides. They are expressed in response to pathogen detection and 
control the microbial growth by participating in killing and clearance. 
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  Most cell biology studies on bacteria rely on microscopy 
techniques that use specific staining methods. Any staining method is 
inherently dependent in either or both chemical and physical properties of 
the bacterial CW. The most widely used staining is the Gram stain, which 
was first described by Carl Friedlander in 1883 for detecting Streptococcus 
pneumoniae in autopsy of lung tissues [8]4. It was his colleague, Christian 
Gram, who published it in 1884 and soon it started being gradually 
stablished as a routine stain in Hospital settings (Roux 1886) [8]5. The 
original procedure was subsequently improved and published as we know 
it today by Hucker in 1921 [9], [10].  It has been known for years that this 
differential stain which discriminates Gram-positive from Gram-negative 
bacteria, is a function of cell surface characteristics. However, only in the 
past decades have we achieved some understanding behind its mechanism 
[11], [12].  
 The first step of the Gram-stain is with the crystal violet, a basic 
positively charged dye that stains all bacterial surfaces (i.e. it stains 
negatively charged cells). The next step is an iodine-iodide mixture which 
serves as a mordant, so it forms a complex with the primary dye thereby 
fixing the dye to the cells. Through the use of a solvent, usually ethanol, 
some cell types lose the dye-mordant complex and the purple colour given 
by the crystal violet. Hence, any cell that retains the dye is designated 
Gram-positive and any cell that loses it is designated Gram-negative. For 
practical visualization, the final step includes a counterstaining with 
safranin that stains Gram-negative bacteria in red. It was long presumed 
that the CW of Gram-positive bacteria has physical properties regarding 
thickness and porosity that are able to retard the efflux of the dye-mordant 
complex and confer higher resistance to the solvents. Indeed, it is known 
                                                          
4 Original reference: C. Friedlander, “Die Mikrokokken der Pneumonie,” Fortschr. Med., vol. 1, 
pp. 715-733, 1883. 
5 Original reference: G. Roux, “Sur un procede technique de diagnose des gonococci,” Arch. Gen. 
Med. Vol. 2, 1886. 
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today that these bacteria, in contrast to the Gram-negatives, possess a thick 
peptidoglycan layer, a macromolecule that covers the entire cell surface 
nearby the cytoplasmic membrane and that it accounts for most of the 
physical properties of the cells. 
 In this thesis, the description of the Gram-negative CW and 
peptidoglycan takes as a reference Escherichia coli, because it is the main 
bacterial model organism thus the most well studied, including in vivo Host 
responses. Regarding the Gram-positives, two model organisms are here 
referred which were used for the work presented in this thesis: Bacillus 
subtilis and Staphylococcus aureus. B. subtilis is the major Gram-positive 
model organism and the S. aureus` CW has been extensively studied 
because its pathogenicity is highly associated with the surface 
components.  
 The structure of the Gram-negative CW is relatively uniform 
among the bacterial species, whereas the Gram-positive bacteria show two 
types: the typical and what is commonly referred to as “Gram-positive CW” 
and the CWs of Corynebacterineae, that although also capable to retain the 
Gram dye, they have a distinct wall structure from the classical Gram-
positive bacteria. 
 
Cell Wall architecture – layered vs. mesh-like structure 
 
 The Gram-negative CW is structurally well defined by three 
distinct layers (Fig. 1): the external layer called the outer membrane (OM), 
the middle layer harbouring the peptidoglycan (PGN) and finally the 
cytoplasmic or inner membrane (IM). The thin PGN layer is enclosed by 
the OM and IM, such that it forms an outside cellular compartment, the 
periplasm. The OM and the periplasm are not found in the Gram-positive 
CW. 
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 In contrast, the Gram-positive CW presents itself as a 3D mesh-
like structure (Fig. 1). A very thick layer of PGN is decorated by wall 
components that apart from proteins, they are characteristic and exclusive 
to Gram-positives, such as the teichoic acids – wall teichoic acids (WTA) 
and Lipoteichoic acids (LTA). Since these walls do not possess an external 
membrane covering the PGN, there is no cellular compartment like a 
periplasm. It is presumed that the thickness of the PGN compensates for 
the lack of a protective OM [13]. Indeed, in Gram-positives the PGN 
accounts for 30-70% of total CW whereas it accounts for only 10% in 
Gram-negative bacteria [14]. In the same line of thought, it can also be 
presumed a protective role for the teichoic acids as they can represent over 
60% of CW mass, they extend beyond the PGN layer thus concealing it and 
are great contributors for the wall structure and function in various 
processes [15].  
 
Peptidoglycan – the common feature of every cell wall 
 
 The word “peptidoglycan” describes the chemical composition of 
the molecule. Historically, it has received many names and nowadays it is 
also commonly referred to as “murein”, that derives from the Latin murus 
meaning “wall” and was introduced in analogy to “protein” by Weidel and 
Petzer [16].  The PGN may be understood as somewhat equivalent to the 
Insects exoskeleton, since it is a rigid structure responsible for cell shape 
and integrity. However, it is simultaneously a flexible and dynamic 
structure as it is involved in growth and cell division, can reversibly 
expand in response to pressure changes and serves as a scaffold for 
anchoring CW components [17], [18].  
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Figure 1. Schematic representation of the Gram-negative and Gram-positive 
bacterial CWs. OM – Outer Membrane. CM – Cytoplasmic membrane / IM – Inner 
Membrane. LPS – Lipopolysaccharide. OMP – Outer Membrane Protein. PGN – 
Peptidoglycan – composed of GlcNAc (N-acetylglucosamine) and MurNAc (N-
acetylmuramic acid) that form linear glycan strands linked through the stem peptides. 
WTA – Wall Teichoic Acids. LTA – Lipoteichoic Acids. ManNAc – N-acetylmannosamine. 
Glycerol-P – (two) Glycerol-Phosphates. The WTA repeating units are one of two 
types: glycerol or ribitol. 
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 The PGN is exclusive and ubiquitous to Bacteria, albeit there are 
exceptions. PGN and its biosynthetic genes have not been detected in some 
bacteria: Mycoplasma spp., and Orientia tsutsugamushi [19]. The PGN has 
been detected in non-bacterial organisms, the glaucophytes algae, as a 
component of the photosynthetic organelles [20] and, its biosynthetic 
genes (but not PGN) have been found in two Plants and are presumed to 
participate in chloroplast division – Arabidopsis thaliana and 
Physcomitrella patens [21].  
 The PGN macromolecule is formed by linear glycan strands of 
repeating disaccharide units of N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc), linked to a peptide chain, the stem peptides, 
which cross-link one linear strand to another (Fig. 1).  Hence, it is a large 
polymer that forms layers around the entire cell surface. The chemical 
structure of the PGN, described in the “Peptidoglycan composition and 
Host recognition” section, is quite similar in both Gram-positives and 
Gram-negatives. However, regarding the architecture there are two main 
differences between the CW types: the thickness of the layers and the 
presence/absence of certain wall-covalently linked polymers. The Gram-
negative PGN is only a few nanometres thick, which can comprise only one 
to a few layers and the Gram-positive PGN is 30–100 nm thick because it 
is composed of many layers (Fig. 1) [22]. In addition, Gram-positives 
typically present surface polymers covalently attached to the PGN, such as 
the wall teichoic acids (WTA), that are absent in the Gram-negatives (Fig. 
1). Although the thickness varies among these two bacterial types, the 
pores have similar average sizes [23]. It is estimated that globular, 
uncharged proteins with molecular weights of 22–24 kDa can penetrate 
the isolated, relaxed PGN [24]. Interestingly, the length of the strands does 
not correlate with the thickness. S. aureus that presents a very thick layer 
has short strands with an average length of about 18 disaccharide units 
[25], [26]. Both in Bacilli and E. coli, the average length varies within 
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strains and growth conditions [27] but it is estimated to be 50-250 
disaccharide units in Bacilli [26], [28], [29] and up to 30 disaccharide units 
in E. coli [30]. 
 
Components of the Gram-negative cell wall 
 
The Outer Membrane – LPS and OMPs 
 The OM is essential for the survival of E. coli and its only known 
function is to serve as a protective barrier. Like other biological 
membranes, the OM is a lipid bilayer but in contrast, it is asymmetrical: the 
inner leaflet is composed by phospholipids and the outer leaflet is 
composed by proteins, glycolipids and mainly of lipopolysaccharide (LPS) 
[31]. Both LPS and proteins participate in the selective permeability of the 
OM [32]. LPS forms an effective barrier for hydrophobic molecules, the 
protein porins limit diffusion of hydrophilic molecules >700 Daltons [32] 
whilst other type of proteins – the outer membrane proteins (OMPs) – 
allow the passive diffusion of small molecules such as disaccharides and 
amino acids. The OM is linked to the PGN as if it was stapled, through a 
lipoprotein called Lpp, or murein lipoprotein, or Braun’s lipoprotein, and 
it is the most abundant protein in E. coli [33]. 
 LPS is the molecule responsible for the endotoxic shock 
associated with septicemia by Gram-negative bacteria thus it is also known 
as “endotoxin” [34].  It is composed of a lipid portion, the lipid A, which is 
anchored at the outer leaflet of the OM. The lipid A is linked to a 
polysaccharide core that connects to the outer surface polysaccharide 
chain, the O-polysaccharide or O-antigen, which carries the antigenic 
specificity and its composition varies among bacteria (Fig. 1) [34].  
 OM proteins can be divided into lipoproteins and β-barrel 
proteins. Whereas the latter are transmembrane proteins, lipoproteins are 
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not and seem to be embed in the inner leaflet by the lipid moiety. There 
are about 100 OM lipoproteins in E. coli, still the functions of most of them 
are unknown [35]. Nearly all of the integral transmembrane proteins 
assume a β-barrel conformation and are designated Outer Membrane 
Proteins (OMPs). Some OMPs, such as OmpA from E. coli, can be non-
covalently linked to the PGN. 
 
The Periplasm 
 The periplasm can sequester potentially harmful compounds 
thus it has been proposed as an evolutionary precursor of the lysosomes 
in eukaryotic cells [36]. It is densely packed with proteins such as enzymes 
involved in CW biosynthesis and periplasmic binding proteins that 
function in chemotaxis and transport of sugars and amino acids [37]. 
 
Components of the Gram-positive cell wall 
 
The teichoic acids – WTA and LTA 
 The teichoic acids (TA) are long anionic polymers that are 
divided into Wall Teichoic Acids (WTA) and Lipoteichoic Acids (LTA). 
Although neither of them are essential, it is not possible to delete genes 
from both pathways because they are synthetic lethal and their presence 
appears to be crucial for proper CW architecture and integrity [38], [39].  
 The major distinguishing feature between LTA and WTA,  is that 
the WTA are covalently attached to the PGN, whereas the LTA are 
anchored to the cytoplasmic membrane (Fig. 1 and Fig. 3) [18]. The WTA 
are attached via a phosphodiester linkage to the hydroxyl group at position 
6 of MurNAc and they have been propose to extend perpendicularly 
through the PGN mesh  [40], [41], into what has been characterized as a 
“fluffy” layer [18], [42], [43]. Generally, WTA are composed of a conserved 
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linkage unit to which is appended a chain of either polyribitol phosphates 
(polyRboP) like in S. aureus and some B. subtilis strains, or polyglycerol 
phosphates (polyGroP) as in most B. subtilis spp.. The RboP or GroP repeats 
are in turn commonly tailored with D-alanyl esters and glycosyl moieties. 
The nature and extent of these tailoring significantly affect the properties 
and functions of WTA as they introduce positive charges along the polymer 
backbone [18]. Accordingly, S. aureus strains lacking D-alanine esters are 
more susceptible to the cationic AMPs and to Host lytic enzymes [44]–[46]. 
 The TA present several functions, some of which may be species-
specific. They have been described as a “continuum of anionic charge” 
which seems to be of vital for the cell [18]. Because they are anionic they 
play major roles in cation homeostasis which in turn influence the rigidity 
and porosity of the CW. Indeed, the presence of covalently attached 
glycopolymers is a hallmark of the Gram-positive CW. Gram-positives 
lacking WTA like Micrococcus luteus present other polymers such as 
teichuronic acids (repeating units of the disaccharide N-
acetylgalactosamine - D-glucuronic acid). Similarly, when unable to 
produce WTA, bacteria can compensate by producing other polymers 
instead. For instance, under phosphate limiting conditions Bacillus spp. 
can produce teichuronic acids [47].  
 
Surface Proteins 
 The surface of the Gram-positive bacteria is decorated with a 
variety of proteins, some of which are analogous to proteins found in the 
periplasm [17]. They can be inserted in the CM, covalently attached or 
tightly associated with the PGN, or even bound to the TA [48]. Most of these 
proteins play major roles as virulence factors. In S. aureus the presence of 
surface proteins is highly dependent on environmental changes and 
growth conditions [49] and they have great impact in pathogenicity. 
Furthermore, S. aureus relies both in TA and in surface proteins, generally 
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called adhesins, to successfully stablish colonization on Host tissues [50]–
[52]. In addition, many proteins have been implicated in iron acquisition, 
which is necessary for pathogenesis since it is a requisite for the function 
of many bacterial enzymes [53]–[55]. 
 
The Gram-positive cell wall of Corynebacterineae 
 
The Family Corynebacterineae includes the major pathogens 
Mycobacterium tuberculosis and Mycobacterium leprae and the complexity 
of their walls substantially contributes to virulence. Similar to the typical 
Gram-positive wall, the PGN is composed of several layers and contains 
covalently attached glycopolymers, the arabinogalactan, which is 
covalently attached to mycolic acids [22]6. Both components are unique to 
these bacteria and the mycolic acids are responsible for their acid-fast 
resistance. Similar to the Gram-negative bacteria, they possess an OM, but 
in contrast it appears to be symmetrical. Moreover, the porin proteins 
seem to be structurally different from the typical OM porins of the Gram-
negatives. In sum, these walls comprise features of both Gram-positive and 
Gram-negative bacteria. Accordingly, a genome-based phylogeny places 
them in between the two types [56]. 
 
 
 
 
                                                          
6 Original reference: D. E. Minnikin. Lipids: Complex lipids, their chemistry, biosynthesis and 
roles, p. 95–184. In Ratledge C., Stanford J. (ed.). The biology of the mycobacteria, vol 1. 
Physiology, identification and classification. Academic Press, Inc., New York, NY. 1982. 
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Peptidoglycan composition and Host recognition 
 
As the name intuitively suggests, PGN is a macromolecule 
composed of sugars and peptides where linear glycan strands are 
connected to one another, i.e. they are cross-linked by short peptide 
bridges, the stem peptides [57] (Fig. 2 and Fig. 3). The glycan strands are 
composed of repeating units of disaccharides made of GlcNAc residue 
linked to MurNAc residue through β-(1,4) glycosidic bonds. The MurNAc 
sugar is exclusively found in the Bacteria Domain (apart from the 
glaucophytes algae), whereas GlcNAc composes the chitin present in the 
Fungi CW and in the exoskeleton of Insects and Crustaceans. Regarding the 
stem peptides, they are pentapeptide chains that are covalently linked 
through the N-terminus to the lactyl group in the position 3 of the MurNAc 
residues (Fig. 2 and Fig. 3). The pentapeptide chain contains alternating L- 
and D- amino acids, being the latter a typical feature of PGN. Whereas the 
glycan backbone is highly conserved among bacteria, the peptide moiety 
shows a great degree of variability in composition [14]. Apart from the 
third position, the amino acids in all other positions of the pentapeptide 
are quite conserved among Gram-positive and Gram-negative bacteria. 
The amino acid at the third position is most commonly either L-Lysine 
(Lys) or meso-diaminopimelic acid (DAP) [14]. Generally, the Gram-
negative bacteria like E. coli and the rod shape Gram-positives like Bacilli 
and Listeria spp. and the Gram-positive mycobacteria present a DAP-type 
PGN. In contrast, most of the other Gram-positive bacteria present a Lys-
type PGN (Fig. 2). As for the stem peptides, typically, Gram-positive 
bacteria present several types of peptide bridges that link one stem 
peptide to another, in contrast to the Gram-negatives which have a direct 
cross-link. Thus, the composition and structure of PGN is quite uniform 
among Gram-negatives, but shows great variability among the Gram-
positives [14]. Accordingly to being the most conserved PGN moiety, 
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Gram-positives and Gram-negatives present the same type of sugar 
modifications after the PGN biosynthesis. The differences rely on 
modifications in the Gram-positives due to the attachment of 
glycopolymers and the typical presence of an anhydrous form of the 
MurNAc in the Gram-negatives (Fig. 3). 
The differences in the PGN composition at the pentapeptide bridge 
between the Gram- positives and –negatives have been accounted for 
determining different innate immune responses. In addition, bacteria 
present modifications of the PGN backbone that render them resistant to 
Host immune strategies. Therefore, understanding the impact of the PGN 
composition on the interaction with the Host is crucial to unravel bacterial 
immune evasion mechanisms and how PRR perceive and recognise the 
PGN. The triggering of immune responses by PGN-derived compounds was 
discovered more than 30 years ago and the muramyl-dipeptide (MDP) was 
the first minimal inflammatory PGN fragment to be identified (Fig. 2) [58]. 
However, the study of the PGN molecular structure has been a challenging 
topic, particularly when it comes to the Gram-positive CW due to the multi-
layered PGN decorated with wall polymers coupled with inter-species 
variabilities, such as the ones found in the Bacillus Genus. 
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Figure 2. Schematic representation of PGN monomeric species and polymeric PGN. 
The basic unit of the PGN is the disaccharide-pentapeptide. The Gram-positive 
bacteria typically present at the third position of the pentapeptide a Lys vs. a DAP 
residue present in Gram-negatives and some Gram-positives. TCT – tracheal cytotoxin 
– is a muropeptide produced by Gram-negative bacteria. Some bacteria such as 
Bordetella pertussis do not retain it at the CW upon growth and division, thus they 
release it to the medium and trigger potent immune responses. MDP – muramyl 
dipeptide – is the minimal PGN-component to be identified as immunostimulatory. 
Regarding the polymeric composition of PGN, S. aureus presents an indirect cross-
linking, connecting the glycan strands through peptide side chains, typical of Gram-
positives. In contrast, Gram-negative bacteria and some DAP-type Gram-positives, 
show a direct cross-linking between the pentapeptides. 
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The modifications in the glycan strands 
 
 To date, there are no bacterial species known that in their 
mature PGN possess unmodified sugar chains [59]. As a matter of fact, the 
attachment of components to the PGN happens mostly via the sugars. The 
sugar backbone is structurally modified during synthesis or after insertion 
into the CW. These secondary modifications happen either by enzymes 
that directly modify the sugar residues or by the attachment of polymers. 
There are two types of sugar modifications found both in Gram-positives 
and Gram-negatives: N-deacetylation and O-acetylation (Fig. 3). 
Deacetylation happens in both sugars, whereas O-acetylation has only 
been identified in MurNAc residues. A third type of sugar modification is 
N-glycolylation where there is a glycolyl group instead of the acetyl group 
at the amino group on the second position of MurNAc (Fig. 3). This is a 
hallmark of most bacteria containing mycolic acids. Regarding Gram-
negative bacteria, they present a 1,6-anhydro ring at the terminal MurNAc 
residue of the strand that is the result of the cleavage by specific bacterial 
PGN hydrolases during the processes of turnover and cell division (Fig. 3). 
As for Gram-positive bacteria, specific modifications happen through 
linkage of WTA (Fig. 3), capsular polysaccharides (and arabinogalactans) 
that bind via phosphodiester bonds either to MurNAc or GlcNAc. Although 
these PGN alterations have been known for a long time, their role in 
bacterial biology remains to be fully understood. It is thought that they 
control cell division, PGN turnover and, as it will be here briefly discussed, 
they are also involved in the pathogenicity of the bacteria.  
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Figure 3.  Modifications in the PGN glycan strands. The top panel shows modifications 
at the sugar level in the different bacterial types. The bottom panel shows the 
modifications of the Gram-positive PGN by the attachment of the WTA. S. aureus has 
RboP WTA similar to some B. subtilis strains. Most B. subtilis strains and 
Staphylococcus epidermidis possess GroP WTA. Note the difference between the 
terminal MurNAc residue on the PGN chain represented at the top with the PGN chain 
at the bottom. Gram-negative bacteria possess a number of lytic transglycosylases 
that cleave between the MurNAc and GlcNAc residues (same bond as the 
muramidases) and originate 1,6 – anhydroMurNAc (see Chapter II). In contrast, these 
termini are rarely found in the Gram-positive PGN, thus the MurNAc terminal residues 
present a reducing end. N-deacetylation can also occur in the MurNAc residue in both 
Gram-positive and Gram-negative bacteria (not depicted).  
 
 The deacetylation introduces positive charges into the CW, thus 
it potentially affects the binding of proteins and other components to the 
PGN. An increase in the positive charge is more likely to increase the 
resistance of the bacteria to the activity of the cationic AMPs. In addition, 
the deacetylation affects bacterial clearance through the activity of 
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Lysozymes and through phagocytosis. Lysozyme is a muramidase, i.e. it 
cleaves the β-(1,4) glycosidic bond between MurNAc and GlcNAc and it is 
ubiquitous in Bacteriophages, Bacteria, Fungi and Mammals.  
Deacetylation of GlcNAc or MurNAc strongly decreases the activity of 
lysozymes [60]–[64] and a Listeria monocytogenes mutant lacking 
deacetylated residues was very sensitive and rapidly killed by 
macrophages [65]. 
 O-Acetylation of the PGN is more frequent than N-deacetylation 
and occurs in many important pathogens. In fact, most of the known 
muramidases have decreased or no activity against O-acetylated PGN, 
particularly the Host Lysozymes [59]. To date only the N,O-
diacetylmuramidase of Chalaropsis [66] and mutanolysin from 
Streptomyces globisporus [67] are known to cleave O-acetylated PGN. 
There is a strong correlation between pathogenicity, lysozyme resistance 
and the occurrence of O-linked acetate in the PGN of staphylococcal species 
[68]. Immune strategies are generally keen in killing and lysing the 
bacteria, followed by clearance of bacterial debris. However, even when 
there is efficient killing, it has been observed the persistence of PGN with 
a high degree of O-acetylation [69]–[71]. 
 In Gram-positive bacteria, WTA contribute to virulence in 
several ways. At a first level, as they protrude through the PGN layers to 
the outer surface they impair the direct recognition by Host receptors. 
Work from the Host Labs7, has shown that they exert stereo-hindrance in 
Gram-positive pathogens, including S. aureus, from a PGRP (PGRP-SA) in 
D. melanogaster [72]. Moreover, it is known that the WTA affect O-
acetylation which in turn confers resistance to Lysozymes [73]. Also, the 
tailoring of the WTA, for instance with D-Ala as in S. aureus [45] together 
                                                          
7 Filipe Lab, Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia 
Química e Biológica António Xavier, Universidade Nova de Lisboa. 
Lygoxygakis Lab, Laboratory of Cell Biology, Development and Genetics, Department of 
Biochemistry, University of Oxford. 
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with the deacetylation of the PGN, are two ways of introducing positive 
charges that can protect the bacteria against the activity of the AMPs. 
 Additionally, the Host Labs identified another CW factor that can 
dampen the recognition and compromise efficient immune responses. We 
identified the activity of the major autolysin protein Atl8 in S. aureus [74]. 
The loss of virulence is attributed to the recognition by PGRP-SA of PGN 
fragments exposed at the surface of the cells. We observed a similar effect 
for the Streptococcus pneumoniae major autolysin LytA. Autolytic PGN 
hydrolases are ubiquitous in Bacteria, thus it can be inferred that perhaps 
other autolysins from other bacterial species may impair detection of PGN 
by other PGRPs or by other PGN receptors. 
 In Gram-negative, the glycan strands do not terminate with a 
reducing MurNAc residue but with a non-reducing 1,6-anhydroMurNAc 
(Fig. 3) [30], [75], [76]. This is due to the activity of the lytic 
transglycosylases (Fig. 4). They are PGN hydrolases that cleave at the same 
site as muramidases but form a 1,6-anhydro ring at the MurNAc and are 
particularly abundant in Gram- negative species. Interestingly, the lytic 
transglycosylases cannot cleave the glycan strands at O-acetylated 
MurNAc residues, thus it has been proposed that O-acetylation and de-O-
acetylation regulate the activities of the lytic transglycosylases [77]–[79]. 
 In sum, the activity of PGN hydrolases/autolysins, the presence 
of WTA and the N- and O- dea-/acetylations, modify the glycan backbones 
and contribute to bacterial virulence [61]–[64], [72], [73], [80]–[84]. 
Similar to Lysozymes, PGRPs are found in almost all animals, possess 
affinity to PGN and their recognition is affected by modifications like the 
WTA and autolysins. However, the effect of N-deacetylation, N-
                                                          
8 Autolysins are enzymes that degrade a component belonging to the cell or tissue where they 
are produced. Autolysins or PGN hydrolases cleave the PGN in order to sustain cell growth – 
PGN present at the cell surface –  and to split the daughter cells – PGN present at the septum – 
prior to separation of the daughter cells. These enzymes are the topic of study of Chapter II. 
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glycolylation and O-acetylation on the PGRPs recognition has not yet been 
addressed. 
 
Variability in the peptide moiety 
 
 The peptide moiety of the PGN is highly variable among Bacteria. 
However, unlike the modifications of the glycans, the impact of the natural 
variability and modifications of the amino acids on the Host recognition is 
not so well understood. Paradoxically, current models of Host-bacterial 
recognition are almost exclusively based in the amino acid composition of 
the PGN. 
 
Variability in the stem peptides 
 The variations of the stem peptides can be divided into two 
categories: those due to the specificity of the Mur ligases, the enzymes 
responsible for their biosynthesis and incorporation into the nascent PGN 
chain, and those occurring afterwards upon insertion of the amino acids 
[85], [86]. The first amino acid is usually L-Alanine and in rare cases, 
Glycine or L-Serine (Fig. 2). At the second position there is always the 
incorporation of D-Glutamic acid and any modification that may happen 
occurs at a later step (Fig. 2). The greatest variations regarding both 
incorporation and post-modifications happen at the position 3 where it is 
generally found a diamino acid (Fig. 2). The most prevalent is DAP which 
is present in probably all Gram-negatives and many Gram-positives 
(Bacilli, Clostridia, Lactobacilli, Corynebacteriales, Rickettsiae) and in the 
glaucophytes algae [14]. The diamino acid Lys is the second most common 
and it is found in most all other species of Gram-positive bacteria [14]. Less 
commonly, it can be found other diamino acids, such as L-Ornithine or 
meso-lanthionine and also monoamino acids (L-Homoserine, L-Alanine or 
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L-Glutamic acid) [13]. The two last amino acids of positions 4 and 5 are 
added as a dipeptide, in most cases D-Alanine-D-Alanine, and the last D-
Alanine residue is lost in the mature PGN (Fig. 2). 
 Variations of the incorporated amino acids, mainly at the second 
and third positions, can happen by amidation, hydroxylation, acetylation, 
attachment of amino acids or other groups, and attachment of proteins. In 
fact, the stem peptide is an anchoring point for proteins in both bacterial 
types [17]. In E. coli, Lpp is the only known protein covalently attached to 
PGN (at the DAP residue) [87], [88], whereas the Gram-positive bacteria 
contain many surface proteins that are involved in pathogenicity. One of 
the most common post-modifications at the third position is the amidation 
of DAP (Fig. 4). This modification happens in B. subtilis and Bacillus 
licheniformis and not in E. coli or Bacillus megaterium – all of which are 
bacteria commonly used in the Drosophila literature as bacterial 
organisms to study Host immune responses. 
 Current models of PGN recognition by Innate Immune receptors 
are based on their discriminatory ability between DAP- vs. Lys- PGN. As 
evolutionary conserved receptors, it is intuitive to consider that PGRPs 
recognition may rely to great extent on the binding to the conserved sugar 
moiety, still they have been reported to possess such discriminatory ability 
at the peptide level. It is postulated, particularly in Drosophila immunity, 
that PGRPs can discriminate Gram-positives vs. Gram-negatives and Bacilli 
through the residue at the third position [89], [90] and therefore they 
differentially activate distinctive immune pathways [91]. Indeed, B. subtilis 
and E. coli present a similar PGN composition, albeit they mainly differ in 
the percentage of muropeptide species and the amidated DAP in B. subtilis 
[92]. Importantly, the amidation of DAP has been pointed out as the reason 
for literature reports detecting Drosophila PGRP-SA binding to PGN of E. 
coli and B. megaterium but not to B. subtilis [89][90]. 
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Figure 4. Differences between the amino acids L-Lys, DAP and amiDAP. It is 
presented the basic structural PGN units with Lys, DAP and amiDAP. The difference 
between the Lys and the DAP amino acids is the presence of a carboxyl group in the 
latter (depicted in pink). Unlike E. coli, B. subtilis suffers a post-incorporation 
modification of the DAP residue, whereby the extra carboxyl group not present in Lys, 
that is not engaged in the peptide bond with D-Ala, is amidated (depicted in blue). 
 
Variability in the peptide cross-linking bridges 
 The bond between two stem peptides from different glycan 
chains is designated by cross-linking. The nature and the degree of cross-
linking show the highest variations in the types of PGNs. It is the 
differences at the level of the peptides that allow the taxonomic 
distinctions sometimes to the species level. As such, although there are 
many differences among Gram-positive organisms, the most notable 
differences are found at the level of the cross-linking [13], [59].  
 Most commonly, the cross-linking happens between the amino 
acid at position 3 of one stem peptide and the D-Ala at position 4 in another 
stem peptide from another glycan strand (Fig. 2). The link between these 
amino acids can either be direct or indirect when the linkage happens 
through an interpeptide bridge (Fig. 2). Most Gram-negative bacteria show 
direct cross-linking like E. coli, although B. subtilis also shows direct cross-
linking (Fig. 2). In the indirect cross-linking the peptide bond between Lys 
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and D-Ala occurs via a peptide chain, thus these are called “branched stem 
peptides”. The composition of the peptides in the branch shows substantial 
variation and these branched stem peptides serve as attachment sites for 
covalently-associated proteins, such as protein A from S. aureus which 
plays different roles in the pathogenicity of the bacterium [93].   
 There is also considerable variation in the degree of cross-
linkage, i.e. the number of cross-links between the strands in one PGN 
macromolecule. In terms of muropeptide content, the soluble fragments 
released upon muramidase digestion, it translates into a low cross-linking 
like in E. coli, where the PGN units appear mostly as monomers or dimers, 
accounting for 20% of total cross-linking [57]. In contrast, in S. aureus most 
PGN units are present as oligomers with a degree of cross-linking over 
93% [94]. The degree of cross-linking is also associated with the 
susceptibility of PGN to lytic enzymes. In S. aureus the high cross-linking 
aids to the O-acetylated MurNAc and the presence of WTA on the 
resistance to Lysozyme [73].  However, we did not observe a correlation 
between the cross-linking and the binding of Drosophila PGRPs (data 
shown in Chapter III). 
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The Drosophila melanogaster Immune System 
 
 In order to study Human-pathogen interactions, several animal 
models have been developed. Due to logistical, ethical and financial 
reasons, the use of mammals is difficult and time consuming. Therefore, 
non-mammalian models of infection for Human pathogens have been 
developed. The conservation of signalling pathways for the activation of 
antimicrobial responses suggests that some innate immune components 
share an ancient origin in metazoan evolution, making non-vertebrate 
animal models suitable for infection studies [95]. Moreover, virulence 
factors for disease in one host, also contribute to disease in non-natural 
hosts [96]. 
 The fruit fly Drosophila melanogaster has shown to be a highly 
adequate invertebrate model to understand mammalian biology [95], [97], 
[98]: the organs systems are analogous to that of Vertebrates and the 
signalling pathways and transcriptional regulators that control 
development, metabolism and immunity share evolutionarily conserved 
components [99]. In addition, there is a wide array of genetic tools coupled 
with the sequenced genome [100], [101]. Regarding Host-pathogens 
interactions and fundamental innate immune mechanisms, flies have 
proven to be one of the most suitable organisms to date. They are naturally 
infected by bacteria, fungi and viruses and can be experimentally infected 
with human pathogens [72], [74], [102]–[104]. Moreover, the mechanism 
of bacterial recognition and one of the outcomes of it which is the 
expression of AMPs, is similar and probably common to all animals 
including Humans [95]. The discovery of the AMPs induction upon 
infection [105] helped to put D. melanogaster as a model organism for the 
study of conserved innate immune mechanisms. Besides the genes 
encoding for the AMPs being conserved sequences both in insects and 
mammals, their regulation is under the control of the conserved nuclear 
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factor kappa-light-chain-enhancer of activated B cells (NF-κB) signalling 
cascades. The D. melanogaster conserved NF-κB pathways are the TOLL 
and IMD (Immune Deficiency) pathways (Late Immune Responses section 
and Fig. 6) [106].  
Early-Constitutive and Late-Induced Responses 
 
D. melanogaster possesses multiple innate defence mechanisms, 
many of which similar to mammals [107]–[110]. The systemic responses  
are divided into constitutive responses and induced responses [111]. Upon 
an infection, these responses can be temporally classified as 
immediate/early responses and late responses, respectively. The 
constitutive early responses are always present and rely on cellular 
responses through the haemocytes, the insect blood cells [112]. These 
responses are paramount for clearance of the pathogens and they are 
followed by the induced late responses which are protective responses 
that rely mainly on the antimicrobial activity of the AMPs [113].  
Early Immune Responses 
 The boundaries of an organism are vital for its integrity and 
survival. The epithelia are the first barrier in an organism against invading 
pathogens. A breach on the cuticle initiates a series of reactions against 
infection – production of Reactive Oxygen Species, coagulation, 
melanization and local inducible AMPs by the IMD pathway. In addition, 
there is constitutive expression of AMPs in specific tissues.  
 The cellular responses play major roles in phagocytosis and 
encapsulation of microorganisms and are crucial for clearance of the 
pathogen [114]. These responses act immediately upon injury and are 
maintained for as long as it is necessary until clearance of the pathogen.  
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Local expression of AMPs 
 This synthesis of AMPs is referred to as the local immune 
response as opposed to the systemic response. They can either be 
constitutive or inducible. The AMPs constitutively expressed in a defined 
tissue are not upregulated during microbial infection, i.e. they are not 
regulated by the NF-kB pathways. However, the inducible local AMPs` gene 
expression is triggered upon natural infection with DAP-type bacteria, 
mediated through PGRPs and regulated by the IMD pathway. To date, no 
implication of the TOLL pathway in the local immune response has been 
demonstrated and there is no evidence that AMPs are induced in the 
epithelia in response to neither Lys-type bacteria or fungi [95]. 
 
Production of Reactive Oxygen Species  
 Both in Mammals and Drosophila, natural infections with 
bacteria induce rapid synthesis of Reactive Oxygen Species (ROS). Similar 
to the IMD pathway, ROS responses are crucial in gut immunity.  
 
Coagulation 
 Upon breach of the cuticle there is a rapid reaction to control the 
bleeding and initiate wound healing called coagulation. In this process 
there is immobilization of the bacteria at the local wound, thus preventing 
the spreading into the haemolymph [95], the Drosophila equivalent to the 
Vertebrate blood. Since Insects possess an open circulatory system, the 
trapping of the bacteria is crucial against septic infections and it also helps 
in the killing by ROS and phagocytosis.  
 
Melanization 
 Melanization is observed at the site of injury and also at the surface 
of the pathogen. It is the de novo synthesis and deposition of melanin, seen 
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by blackening of the wound site and it is regulated by the 
prophenoloxidase cascade [115]. Particularly, melanization helps in the 
encapsulation of pathogens that are too large to be phagocytosed [116]. It 
is thought to play important roles in arthropod defence reactions such as 
wound healing, encapsulation, sequestration of microorganisms and 
production of toxic intermediates that are toxic to the microorganisms 
[117], [118].  
 
Cellular responses 
 Phagocytosis is paramount to eliminate apoptotic bodies, bacteria 
and fungal spores. The Drosophila haemocytes are the functional 
equivalents of the human blood cells. There are three types of functional 
haemocytes – plasmatocytes, crystal cells and lamellocytes. Plasmatocytes 
are monocyte-like cells involved in phagocytosis of apoptotic bodies and 
pathogens. Crystal cells are required for melanization and thus participate 
in the engulfment of parasites whose size is too large to follow a canonical 
phagocytosis route. These two types of haemocytes circulate in the 
haemolymph and/or can be found sessile. Lamellocytes participate in the 
encapsulation of foreign bodies that are too large to be phagocytosed and 
are only differentiated in response to specific immune challenges, such as 
wasp parasitism.  
 
Late Immune Responses 
 The late responses are systemic humoral responses via humoral 
molecules, including the AMPs. These systemic responses happen through 
production of AMPs by the fat body, a functional equivalent to the 
mammalian liver. These inducible AMPs are controlled by the immune 
pathways TOLL and IMD and are activated by the recognition of pathogens 
by the PRRs, in particular by PGRPs. In contrast, the local constitutively 
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expressed AMPs in specific tissues are controlled by transcription factors 
independent of these pathways.  
 The AMP responses are a hallmark of Insect Immunity [95]. The 
nature of the AMP immune responses and its temporal expression upon 
infection, has been well characterised in Tenebrio molitor and Bombus 
terrestris [114], [119]–[122]. In Tenebrio molitor, the late induced AMPs 
start to increase after 99.5% clearance of the bacteria [114]. It is estimated 
that induced AMPs take at least 1-3h to originate and 12-48h to reach peak 
levels [119]. This induced response can persist for weeks [119], [121]. The 
induced systemic AMPs are late responses because their primary role is to 
protect against the bacteria that persist within their body, rather than to 
clear the infection [114]. This expression is prolonged in order to prevent 
the enrichment of resistant bacteria, as it has been shown that bacteria 
which survived the early/constitutive responses were more resistant to 
AMPs [114]. As a consequence, the induced AMPs are also believed to 
protect against reincidence [120], [122]. It is presumed that the role of 
AMPs is conserved among Insects. However, in D. melanogaster it seems 
that haemocytes rather than the AMPs are responsible for protection 
against secondary infection [123]. Priming of adult flies with heat-killed 
Streptococcus pneumoniae cells, conferred resistance to infection in an 
AMP-independent manner [123]. Furthermore, the resistance remained 
for the life-time of the Fly and it was specific for S. pneumoniae infection.  
 
The Drosophila immune cascades – TOLL and IMD 
In Drosophila, there are two main immune pathways that control 
the inducible expression of the AMPs, which are evolutionarily conserved 
NF-κB signalling pathways– the TOLL and the Immune Deficiency (IMD) 
pathways (Fig. 5). The TOLL signalling is similar to the MYD889-dependent 
                                                          
9 Myeloid differentiation primary response protein 88. 
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Toll-like receptor (TLR) pathway in mammals and share conserved 
membrane receptors with a TIR domain10 (Fig. 5) [124], [125]. The IMD 
signalling is similar to both the tumour necrosis factor (TNF) pathway and 
the TRIF11-dependent TLR pathways (Fig. 5).  
The NF-κB family of transcription factors (TFs) is found in the 
cytoplasm of virtually all cell types in most Animals. Proteins of this family 
share a 300 amino acid Rel homology domain (RHD) at the N-terminus, 
which mediate dimerization, binding to DNA and interaction with a 
regulatory family of inhibitor proteins, IkB. The NF-κB TFs regulate the 
expression of hundreds of genes that are associated with diverse cellular 
processes including innate (and adaptive) immune responses. The NF-κB 
signalling cascade is probably the most frequently targeted intracellular 
pathway by anti-immune modulators that are encoded by a wide spectrum 
of pathogens. This is an indication of the relevance of this pathway in 
immunity and evolutionary conservation mechanisms.  
The NF-kB signalling pathways happen through three main steps 
that take place in different subcellular localisations (Fig. 5). First there is 
the activation of a transmembrane receptor upon recognition (directly or 
indirectly) of the PAMP on the extracellular environment. Second, the 
activation of the transmembrane receptor triggers the formation of 
cytoplasmic signalling complexes through conserved adaptor molecules 
[126]. These adaptor proteins contain death domains (DD) that are 
homotypic protein interaction modules, thus they stablish protein-protein 
interactions. In non-stimulated conditions, the NF-κB dimers are 
sequestered in the cytoplasm by the IkBs through their ankyrin repeats12 
that mask the nuclear localization signals of NF-κB. Upon activation of the 
                                                          
10 Toll/interleukin-1 receptor (TIR) homology domain. 
11 TIR domain-containing adaptor protein inducing IFNβ. 
12 Ankyrin repeats are tandemly repeated modules of ca. 33 amino acids and represent one of 
the most common protein-protein interaction motifs found in nature.  
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signalling cascades, IkB is phosphorylated by the IκB kinase (IKK) thus it 
is degraded and the NF-κB dimers are activated to translocate into the 
nucleus. Finally at the nucleus, the TFs bind to the promoter regions of the 
responsive genes containing the NF-κB sequences.  
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Figure 5. Summary of the similarities across the NF-κB signalling pathways. The 
pathways share a conserved molecular mechanism whereby a set of adaptor 
molecules transduce the signal upon activation of the transmembrane receptors and 
trigger the downstream signalling events. The TOLL and TLR pathways share a 
conserved membrane receptor containing cytoplasmic TIR domains. In the TOLL 
pathway, an IKK complex has not been yet identified as in IMD, however it is known 
that the IkB Cactus undergoes phosphorylation and degradation similarly to the other 
cascades. Drosophila has three NF- B TFs: Dorsal and Dif that regulate TOLL-responses 
and Relish that regulates IMD-responses. 
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Final remarks and thesis overview 
 
My PhD project aimed to understand Host-Bacteria interactions 
through the recognition of PGN. For that I followed two different 
approaches – one from the side of the Host and another from the side of 
the Bacteria. Through the Host side, I aimed to study how PGRPs can 
distinguish different types of PGN. Through the Bacteria side, whether the 
presence of WTA could impair recognition from different PGRPs and 
whether the activity of different autolysins can prevent the recognition of 
cell surface exposed PGN fragments. The rationale behind this dual 
strategy was that data collected from both sides would be complementary 
and thus help to achieve a wider understanding of these complex 
interactions. 
I aimed to study the role of autolysins in the S. aureus virulence. I 
enquired whether the dramatic impact of the absence of the major 
autolysin Atl [74], would extend to the other autolysins from S. aureus. I 
studied the binding of PGRP-SA to different autolysins mutants and their 
virulence in D. melanogaster. 
To understand the PGRPs-PGN interactions, I started by studying 
the reason behind the reported PGRP-SA specificity to Lys-type PGN, using 
Staphylococcus aureus as a model pathogen [89], [90]. Because I aimed to 
study in vitro the biological relevance of the binding of PGRP-SA to the PGN, 
I tried that my in vitro assays would be as close as possible to in vivo 
conditions. This made me start the work by optimizing experimental 
procedures. As I was finishing my optimizations and testing several 
controls, I made a striking discovery that shaped the following steps of my 
PhD work. I detected binding of PGRP-SA to the B. subtilis amiDAP PGN. 
This binding had never been previously detected [89], [90]. This 
observation suggested that PGRP-SA is promiscuous towards the amino 
acid of the third position of the stem peptide, which if true, it should 
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possess a biological role in the Host upon infection. Furthermore, if PGRP-
SA proved to be important for a response towards different bacterial PGN 
types, then PGRP-LC as also a major immune receptor, should also be 
promiscuous for the PGN-types. Consequently, I aimed to ascertain the 
binding specificities of PGRP-SA and PGRP-LC towards the Lys and DAP 
amino acids. In parallel, I aimed to understand whether the WTA in the 
Gram-positive CW could impair recognition of different PGN types by both 
PGRPs. Thus, I contacted Eric Brown and asked for the Bacillus subtilis Δ 
tagO mutant (unable to produce WTA) with the respective wild-type strain 
and I used them as model organisms of DAP-type Gram-positive bacteria. 
In parallel, as the work evolved, the data suggested that PGRP-SA was 
likely to be involved in cellular responses. The final goal of my PhD project, 
was to study the role of PGRP-SA in phagocytosis by both Lys- and DAP- 
type PGN bacteria. 
After describing the variability in PGN composition, I aimed in this 
introduction to demonstrate how variable the peptide moiety is and open 
the readers` mind to the fact that conserved immune receptors may 
perhaps target more conserved regions of the PGN. Accordingly, I also 
called the attention that although being the most conserved regions among 
PGNs, the glycans present modifications that effectively protect the 
bacteria against Host strategies. Moreover, I intended to be clear for the 
reader that independently of the CW type, PGN is the common 
denominator of bacteria. Hence it is logical that it is a target for Host 
receptors and intuitive to realise that Bacteria may present common 
strategies to avoid its recognition, such as the WTA and the autolysins. 
Briefly, in Chapter II, I present novel data regarding the recognition 
of PGN by PGRP-SA and how autolysins play simultaneously a role in cell 
division and evasion to the Host responses. In Chapter III, I present data 
that invalidate the specificity of PGRPs towards the PGN peptide moiety as 
the reason to the reported differential activation between the TOLL and 
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the IMD pathways [125]. Moreover, I show that the WTA can impair PGN 
recognition by both PGRP-SA and PGRP-LC and that these two PGRPs are 
important for an efficient response upon infection of Lys- and DAP- type 
PGN bacteria. Chapter IV presents work which shows that both PGRP-SA 
and PGRP-LC engage in cellular responses through phagocytosis and 
clearance of the bacteria. Finally, Chapter V – conclusion of the thesis – 
presents an integration of all of these data on the comprehension of the 
interaction between the Bacteria and the Host. 
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Summary 
 
 The work presented in this Chapter is a follow-up upon the 
discovery of the role of the major autolysin Atl in the Staphylococcus aureus 
virulence [1]. Atl impairs the accumulation of cell surface exposed 
peptidoglycan (PGN) which can be recognised by the Drosophila 
melanogaster PGRP-SA. The recognition of this PGN results in a drastic loss 
of virulence and survival of the Fly. I aimed to ascertain whether the role 
of Atl was exclusive or if the absence of other autolysins can also result in 
the accumulation of PGN that can be detected by PGRP-SA. 
 I present data that show that during bacterial cell division, PGN 
present at the septum is accessible to PGRP-SA. In the absence of Sle1 there 
is accumulation of newly synthesised PGN at the septum that cannot be 
incorporated into the PGN mesh. This is due to the stiffness of the septal 
PGN which is not resolved by the specific activity of Sle1. PGRP-SA can 
recognise these fresh PGN fragments, however the levels of PGN 
accumulation are not sufficient to aid in an efficient immune response. I 
propose that PGRP-SA recognition plays with the probability of finding a 
dividing cell at a certain moment that presents exposed accumulated PGN 
in a particular subcellular region – the septum. In turn, the interplay 
between the activity of the autolysins and the incorporation of new PGN 
material into the polymer mesh, determines the level of PGN that is 
accumulated at the septum. Concomitantly, the amount of PGN that can be 
detected is determinant for the triggering of efficient immune responses. 
 Overall, the results show that detection of PGN is paramount for 
the triggering of efficient immune responses. Recognition of a certain 
amount of PGN at the cell surface, can efficiently combat an infection from 
a major pathogen such as S. aureus. This in turn suggests that the virulence 
factors can only effectively play their roles for as long as the bacteria can 
protect their PGN recognition.  
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Introduction 
 
 As unicellular organisms, bacteria depend exclusively on 
themselves to survive and propagate. A single tiny cell has to manage by 
its own to get nutrients, to keep its internal homeostasis, to protect itself 
from environmental conditions and replicate. A key factor for bacterial 
survival and replication is the maintenance of the cell wall (CW) and 
peptidoglycan (PGN) integrity. When a bacterial cell divides, there is the 
coordination of several processes which involve the duplication of the 
bacterial components and culminates with the separation of the two 
daughter cells. For cell growth and separation to occur, old PGN needs to 
be degraded. This is mediated by the activity of PGN hydrolases, commonly 
referred to as autolysins [2]. Maintenance of the cellular integrity is 
achieved through a coordinated process of synthesis and degradation of 
PGN in order to avoid cell lysis.  The last stage of PGN synthesis is catalysed 
by the Penicillin Binding Proteins (PBPs) and the cleavage of old PGN by 
the autolysins opens up space for the insertion of new material. Thus, 
regulation of the autolytic activity is of uttermost importance, in which 
autolysins act in a temporal and spatial well-orchestrated manner.  
 The PGN hydrolases compose a vast and diverse group of 
enzymes that cleave the PGN sacculi or PGN soluble fragments. They are 
classified into two main types– the glycosidases and the amidases (Fig. 1) 
[3]. To the bacterial PGN hydrolases involved in the bacterial cell division, 
I will refer to them as autolysins, to distinguish from PGN hydrolases 
produced by other organisms which can cleave another organism` PGN, 
e.g. mutanolysin from Streptomyces globisporus and lysostaphin from 
Staphylococcus simulans that can cleave Staphylococcus aureus PGN, and 
they do not participate in cell growth and division.  
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Figure 1. Representation of the PGN hydrolytic activities in an S. aureus PGN model. 
The glycosidases cleave the glycan backbone and there are three types: lytic 
transglycosylases (A), glucosaminidases (B) and muramidases (C). Lytic 
transglycosylases (A) and muramidases (C) are also collectively known as N-acetyl-β-
D-muramidases and they cleave between the MurNAc and GlcNAc residues. They are 
differentiated by their reaction products. Muramidases (C) generate terminal 
reducing MurNAc residues and lytic transglycosylases (A) generate a 1,6-anhydro ring 
(Fig. 3, Chapter I). The N-acetylglucosaminidases (B) hydrolyse GlcNAc residues from 
adjacent sugar residues. The amidases cleave the peptide moiety and are divided into 
N-acetylmuramyl-L-alanine amidases (D and F) and endopeptidases (E). N-
acetylmuramyl-L-alanine amidases hydrolyse the amide bond between MurNAc and 
L-alanine separating the glycan strands from the peptides. Endopeptidases cleave the 
bonds in the stem peptides and peptide bridges. In particular, carboxypeptidases 
cleave the C-terminal amino acid (D-alanine) of the peptide chain (not depicted in the 
figure). 
 For every type of bond present in the PGN, there is a PGN 
hydrolase able to cleave it [2]. However, a bacterium may not possess all 
autolysins` types. Autolysins comprise different PGN hydrolytic domains 
which confer a certain lytic activity, which is often specific or optimal for 
the PGN of the bacteria that produce it [1], [4]. However, it is often difficult 
to assign a distinct specific function to an autolysin, mainly because many 
bacteria possess a high number of autolysins which appear to have 
redundant roles [5].  
 As autolysins are responsible for PGN cleavage, which in turn is 
associated with several physiological processes, these enzymes present 
numerous roles. They are central for CW/PGN growth, PGN turnover and 
recycling, separation of the daughter cells, autolysis, remodelling of the 
sacculus to determine cell shape, assembly of cell surface organelles, 
sporulation and germination, resuscitation of dormant cells, biofilm 
formation and bacterial lysis in species competition [6]–[14].  In addition, 
autolytic activity can result in the release of PGN turnover fragments into 
the surrounding medium [8]. These turnover products can act as signalling 
molecules [10] and/or be detected by PGN Host receptors, such as the 
detection of muramyl-dipeptide (MDP) by Nod2 [15] and tracheal 
cytotoxin (TCT) by PGRP-LC [16]. 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
69 
 
Autolysins in Staphylococcus aureus 
 
 The Host Labs have discovered that when the major autolysin Atl 
of Staphylococcus aureus is absent, PGRP-SA from Drosophila melanogaster 
can recognise the accumulated PGN fragments at the cell surface [1]. This 
recognition renders the atl mutant significantly less virulent and highly 
susceptible to the Host responses. After participating in this study, I aimed 
to understand if other S. aureus autolysins could also contribute to impair 
bacterial detection and dampen the immune responses by accumulation of 
high amounts of PGN fragments that are accessible to PGRP-SA.  
 I searched the genome of NCTC 8325 S. aureus strain for genes 
encoding for proteins containing a PGN-Binding/Lytic Domain (PGN-BLD) 
which is associated with an autolytic activity. I excluded the 
bacteriophages genes and identified 19 bacterial genes which codify for 
proteins that are or might be autolysins (Fig. 2). These 19 proteins fall into 
five hydrolytic activities (Fig. 3). 
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Figure 2. Chromosomal distribution of the bacterial PGN-BLD proteins associated 
with autolytic activity in NCTC 8325. 19 bacterial genes were identified and found to 
be distributed throughout the staphylococcal genome. The genes encoding proteins 
which have not been named in previous reports are designated by their locus number. 
The names depicted in green are the genes that I deleted from the NCTC 8325-4 
background (expect the atl mutant). 
 
 
Figure 3. Cleavage sites of the S. aureus autolysins. The S. aureus PGN is degraded at 
the glycan backbone by N-acetylglucosaminidases and lytic transglycosylases. The 
peptide moiety suffers cleavage from the glycans through the N-acetylmuramyl-L-
alanine amidases and the peptides are cleaved by endopeptidases at the cross-bridge 
either between two glycine residues or between the glycine and the D-alanine.  
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 The presence of a great number of PGN-BLD proteins with a 
possible function in hydrolysis, led us to enquire whether a certain activity 
given by a specific domain could have an effect in the virulence of the 
bacteria. Thus, I constructed six single null mutants of the genes depicted 
in green in Fig. 2 in the NCTC 8325-4 background (reference strain from R. 
Novick).   
 The domains associated with glycosidase activity are3: LYZ24 – 
mannosyl-glycoprotein endo-β-N-acetylglucosaminidase-like domain 
(IPR002901), SLT – transglycosylases SLT domain 1 (IPR008258) and TGL 
– transglycosylases-like domain (IPR010618). The domains associated 
with amidase/endopeptidase activity are: CHAP – cysteine, histidine 
dependent amidohydrolase/peptidase domain (IPR007921), PGRP – 
peptidoglycan recognition protein family domain, metazoa/bacteria 
(IPR006619), M23 – peptidase M23 domain (IPR016047) and MurNAcLAA 
– N-acetylmuramoyl-L-alanine amidase, catalytic domain (IPR002508). 
The LysM (Lysin motif) domain (IPR018392) and the SH3b (SH3 (Src 
homology 3) -like domain, bacterial type) domain (IPR003646) are usually 
present in autolysins with other domains and their main function appears 
to serve as binding and adherence domain [2], [17], [18]. The distribution 
of these domains in the 19 S. aureus autolysins is represented in Fig. 4.  
 
                                                          
3 EMBL-EBI interpro database. 
4 Lysozyme subfamily 2, SMART accession number: SM00047. 
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Figure 4. Representation of the PGN-BLD domains from each of the 19 proteins 
identified. The genes to be deleted were selected based on the proteins` proposed 
function according to the activity domain. At least one protein of the more prevalent 
domains – LYZ2, CHAP and M23 – was selected to enquire if one specific domain could 
be more associated with the impairment of PGN detection. The proteins represented 
on the top panel are the ones of which the genes were deleted to construct single null 
mutants. 
  
Overview of the deleted gene products. 
The major autolysin Atl. 
Atl is a 137 kDa enzyme with a PGRP and LYZ2 domains which renders the 
protein with both activities of N-acetylmuramyl-L-alanine amidase and N-
acetylglucosaminidase, respectively (Fig. 3 and 4) [9], [19].  The protein 
undergoes proteolytic processing and generates two extracellular forms: a 
62 kDa amidase (AM) and a 51 kDa glucosaminidase (GL) [20]. Both 
enzymes participate in the splitting of the daughter cells. Each processed 
form presents binding repeats – R1, R2 (AM) and R3 (GL) – which seem to 
be involved in targeting to the septum region [21]. It has been proposed 
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that the presence of WTA mediate the binding of AM and GL through an 
exclusion strategy mechanism [22]. Atl seems to be involved in different 
processes that aid in the establishment of infection. Atl can mediate 
bacterial internalization by non-professional phagocytes [23] and AM can  
bind to host matrix proteins such as vitronectin [9]. In addition, in the 
absence of Atl, accumulated cell surface PGN is recognised by PGRP-SA, 
resulting in a dramatic loss of virulence in a D. melanogaster model [1].  
 
The amidases. 
 The CHAP domain can be found in phages, bacteria and 
eukaryotes and is associated with two types of PGN cleavage: N-
acetylmuramyl-L-alanine amidase and D-alanyl-glycyl endopeptidase (Fig. 
3) [24]–[27]. Bacterial cell surface binding domains frequently 
encountered in the CHAP superfamily of proteins are LysM, CW- binding 1 
for choline binding (ChBD) and SH3 [26]. The LysM domain is one of the 
most common attachment modules in bacterial cell surface proteins [17], 
[26]. The ChBD (choline-binding domain) is responsible for the 
noncovalent anchoring of the choline binding proteins to the choline 
moieties of both teichoic and lipoteichoic acids, such as Streptococcus 
pneumoniae hydrolases LytA, LytB and LytC [28]–[32]. The SH3 domain 
was first identified in eukaryotes [18]. The bacterial SH3 domain, SH3b, is 
thought be involved not only in PGN binding but also in the binding to Host 
receptors [18].  
 LytN is a ~42kDa protein presenting an YSIRK/GS-type signal 
peptide, a LysM domain and a CHAP domain (Fig. 4). LytN possesses N-
acetylmuramol-L-alanine amidase and D-alanyl-glycine endopeptidase 
activities (Fig. 3). The CHAP domain contributes to both lytic activities 
[33]. The LysM domain is responsible for binding to the PGN [34]. The 
YSIRK/GS-type signal peptides direct the deposition of secreted proteins 
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into the cell division site [34]–[36].  LytN appears to be distributed all over 
the cell surface, including the cell division site [33].  
The autolysin Sle1 or Aaa is an ~32 kDa N-acetylmuramyl-L-
alanine amidase composed of 3 LysM domains which have binding 
properties to the PGN and a CHAP domain that confers the lytic activity 
(Fig. 3 and 4) [34], [37]. This autolysin is found at the cell surface and it 
participates, together with Atl in cell splitting [37]. Similar to Atl, it appears 
to have a role in pathogenesis as both domains mediate the adherence to 
the extracellular matrix proteins fibrinogen, fibronectin, and vitronectin 
[38], [39].   
02855 is a ~17 kDa uncharacterized protein with a CHAP domain, 
thus it is predicted to be an autolysin with amidase activity. 
LytM is an ~34.4 kDa glycylglycine endopeptidase with significant 
homology to lysostaphin (Fig. 3) [40], [41]. It has been found both at the 
CW and in the extracellular medium [42], [43]. At the CW, LytM is 
distributed over the cell surface, and thus it has been proposed be involved 
in CW plasticity rather than cell division [41], corroborating recent 
findings by Monteiro and colleagues [44] (see Discussion). Nevertheless, 
the levels of lytM are highest during the early exponential phase and 
almost undetectable in the stationary phase [45], which indicates that this 
enzyme participates in cell growth processes. It possesses an M23 domain, 
belonging to the lysostaphin-type metallopeptidases [46], [47] (Fig. 4). 
However, unlike lysostaphin from S. simulans, LytM does not lyse S. aureus 
cells, rather it cleaves the pentaglycine bridges altering CW thickness 
without compromising its integrity [41], [44], [47]–[49].  
 
The glycosidases. 
02580 is a 24.4 kDa uncharacterized protein which possesses a 
LYZ2 domain like Atl, hence it is expected to have an N-
acetylglucosaminidase activity.  
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The immunodominant secretory antigen A (IsaA) is a 29 kDa 
extracellular protein first identified as an immunodominant protein 
candidate for the development of antibody based vaccines [49] and its 
immunogenicity was corroborated later on [50]. IsaA is a soluble lytic 
transglycosylase present both at the cell surface and in the supernatant of 
medium cultures [51]. The SLT domain belongs to a superfamily of 
glycosidases ubiquitous in phages, bacteria and eukaryotes [52]–[54]. In 
bacteria, the lytic transglycosylase activity is commonly found in 
autolysins of Gram-negative bacteria. The IsaA SLT motif shows a high 
similarity to the soluble lytic transglycosylase Slt70 of Escherichia coli 
[55]–[57]. The lytic activity was detected by a Zymography assay and it is 
non-covalently bound to the CW [58].  In particular, it was found to locate 
at the septum region and it is presumed to be involved in the cell splitting 
[51]. In accordance, IsaA was detected in the supernatant of exponentially 
growing cells and its concentration increased until the early stationary 
phase [59]. As for the cell surface, IsaA was predominantly found in 
growing bacteria and the levels decreased proportionately with cell 
proliferation, i.e. the reach of stationary phase [59].  
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Results 
 
Muramidase treatment only allowed detection of processed 
forms of Atl. 
Zymogram assays of SDS crude CW extracts showed five major lytic 
bands (Fig. 5), typical for the major autolysin Atl [60]. Atl activity can be 
detected both in Micrococcus luteus cells and in S. aureus cells, which 
indicates that the AM and GL activities are not specific for the S. aureus 
PGN. On the other hand, the lytic activity of Sle1 could only be detected 
when I used S. aureus cells as substrate. As an overall, it can be concluded 
that some Atl forms and Sle1 are present in the CW through a non-covalent 
manner.  
 
 
Figure 5. Zymography analysis of SDS crude autolytic enzyme extracts of S. aureus 
strains. The autolytic enzymatic extracts were ran both in M. luteus and S. aureus 
substrates. Five different forms of the major autolysin Atl were seen with either 
substrates. However, only the S. aureus substrate cells allowed detection of Sle1 
activity.  
In order to detect the activity of other autolysins, the CWs of 
exponentially growing bacteria were treated with the muramidase 
mutanolysin (M1). The autolytic extract was analysed by zymogram assays 
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with S. aureus cells as substrate (Fig. 6). Only Atl forms could be detected, 
as these are not present in the atl mutant. The molecular weight of the 
bands suggests that AM and GL can be detected. However, there are a 
subset of bands between the predicted AM and GL forms, that are not 
detected with SDS extraction. Furthermore, it can visualised bands with 
lower molecular weights (< 37 kDa), which although it is suggestive that 
one of them might be Sle1, both bands can be detected in the NCTC Δ sle1 
extract. It is possible that one of the bands is M1 which has a molecular 
weight of 23 kDa. In addition, when both SDS and M1 extracts were run in 
NCTC Δ atl substrate cells, it was not observed differences in the lytic 
bands (right bottom gel with M1 extracts of NCTC 8325-4 and NCTC Δ 
isaA). 
 
Figure 6. Zymography analysis of M1 crude autolytic enzyme extracts of S. aureus 
strains. Autolytic M1 extraction only allows the detection of Atl processed forms 
which cannot be detected with SDS extraction. The extracts were run in NCTC 8325-4 
substrate cells, except the right bottom M1 extract gel, which was ran in NCTC Δ atl 
cells. 
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NCTC Δ sle1 shows binding of mCherry_PGRP-SA at the 
septum/cell-splitting region.  
 To determine whether the absence of each autolysin would result 
in the accumulation of cell surface exposed PGN recognised by PGRP-SA, I 
performed co-precipitation assays of live cells with an mCherry 
fluorescent tagged-rPGRP-SA [61]. Cells in early exponential phase were 
harvested, washed and incubated with mCherry_PGRP-SA. The amount of 
mCherry_PGRP-SA that bound to the cells was visualised by fluorescent 
microscopy (Fig. 8). These data are qualitative, since the clustering of the 
mutants impairs the precise quantification of the fluorescence signal. 
 NCTC Δ atl is the mutant that shows better binding by 
mCherry_PGRP-SA . In the absence of Sle1, mCherry_PGRP-SA bound 
exclusively at the splitting septum. Although in the other mutants (and in 
the wild-type strain), it was observable binding in spots near the cell 
septum, only in NCTC Δ sle1 was it possible to visualise the entire division 
septum through binding of mCherry_PGRP-SA. This pattern of binding is 
different from the NCTC Δ atl cells, to which the whole surface is 
recognised by mCherry_PGRP-SA [1]. The absence of other CHAP domain 
containing proteins, 02855 and LytN, did not show the same effect on the 
recognition of mCherry_PGRP-SA, nor did the absence of the 02580 
autolysin (possessing the LYZ2 domain like Atl) and the lytic 
transglycosylase IsaA.  
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A.
 
Figure 7. Co-precipitation of live cells with mCherry_PGRP-SA. Cultures in early 
exponential phase of the parental and mutant strains were incubated with 
mCherry_PGRP-SA. The protein bound to the cells was pulled down with them and the 
binding was visualised by fluorescence microscopy. Scale intensities were adjusted to 
equalise NCTC  Δ atl – mCherry_PGRP-SA. Pannel A. NCTC 8325-4, NCTC Δ atl, NCTC Δ 
lytM and NCTC Δ 02580. Pannel B. NCTC Δ isaA, NCTC Δ sle1, NCTC Δ lytN and NCTC Δ 
02855. 
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B.
 
Figure 7. Co-precipitation of live cells with mCherry_PGRP-SA. Phase images show 
that NCTC Δ atl and NCTC Δ sle1 are the mutants that show a more dramatic 
phenotype of impaired cell division. Because of the clustering of cells, it was not 
possible to properly quantify the signals. 
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mCherry_PGRP-SA binding is lower in cells at the stationary 
growth phase. 
In the wild-type cells, the binding of mCherry_PGRP-SA is very low 
(Fig. 7). Nevertheless, in some cells mCherry_PGRP-SA binds close to or at 
the septum/cell division site. In the mutants with a low binding by 
mCherry_PGRP-SA, it seems that they are also recognised mainly at this 
region. This suggests that dividing cells are more easily recognised than 
non-dividing cells. Accordingly, the binding seems to be associated with 
cell division and the activity of the autolysins, since the recognition of cells 
in the stationary growth phase is greatly reduced (Fig. 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Co-precipitation of live cells in exponential and stationary growth phase 
with mCherry_PGRP-SA. Cultures in stationary phase of the parental, atl and sle1 
strains were incubated with mCherry_PGRP-SA. Scale intensities were adjusted to 
equalise mCherry_PGRP-SA binding to NCTC Δ atl in stationary phase. The binding is 
lower when the cells are in stationary growth phase. 
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Figure 8. Co-precipitation of live cells in exponential and stationary growth phase 
with mCherry_PGRP-SA. (Legend on page 81). 
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Atl is the main autolysin associated with bacterial virulence. 
 In order to study the virulence of the autolysin mutants, in vivo 
assays were conducted in Drosophila melanogaster.  The y,w flies – immune 
wild-type flies – were infected with each bacterial strain (Fig. 9). The null 
mutants atl, lytM, isaA and 02855 showed to be less virulent than the 
parental strain. Nevertheless, NCTC Δ atl is the mutant that shows less 
virulence (Fig. 9 and 10A).  The mutant NCTC Δ sle1showed to be as 
virulent as the wild-type strain (Fig. 9 and Fig. 10B), together with NCTC Δ 
02580 and NCTC Δ lytN. 
 
 
 
Figure 9. Survival curves of y,w flies infected with the parental strain and the 
autolysins mutants. NCTC Δ atl is the mutant that shows the most significant loss of 
virulence compared to NCTC 8325-4. NCTC Δ atl is followed by both NCTC Δ lytM and 
NCTC Δ isaA which are followed by NCTC Δ 02855. Whilst y,w flies infected with NCTC 
8325-4 succumb after 24h p.i. (post infection), the time of highest probability of death 
is delayed to 36h p.i. with either NCTC Δ lytM, NCTC Δ isaA and NCTC Δ 02855. 
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A. 
 
B.
Figure 10. Survival curves for y,w flies. The survival graphs show the wild-type strain 
NCTC 8325-4 and the NCTC Δ atl as references for virulent and non-virulent bacteria, 
respectively. A. Survival curves of the mutants that are significantly less virulent than 
the wild-type strain. When compared to NCTC Δ atl, infection with either NCTC Δ lytM, 
NCTC Δ isaA or NCTC Δ 02855, these mutants are more virulent. The survival curves of 
these three mutants are in turn indistinguishable between them. B. Survival curves of 
the mutants that are not less virulent than the wild-type strain. The survival curves of 
these mutants are indistinguishable between them. 
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The null mutants lytM, isaA and 02855 are equally virulent 
in a y,w and a semmelweis background. 
The response to Lys-type PGN bacteria, particularly S. aureus 
bacteria, is highly dependent on PGRP-SA [1], [61]–[63]. Thus, we infected 
semmelweis flies of the y,w background [62], which are unable to produce 
a functional PGRP-SA, with the bacterial mutants that showed reduced 
virulence (Fig. 9 and 10A). 
When semmelweis flies were infected with each of the strains, 
interestingly NCTC Δ atl was the most virulent mutant in this background 
(Fig. 11). The wild-type strain NCTC 8325-4 was so virulent that it is not 
possible to distinguish the survivals of y,w and semmelweis flies (Fig. 12). 
However, the semmelweis flies are highly susceptible to the non-virulent 
atl mutant (Fig. 13). Regarding NCTC Δ lytM, NCTC Δ isaA and NCTC Δ 
02855, the survival curves of y,w and semmelweis are not distinguishable 
(Fig. 14-16).  
 
 
Figure 11. Survival curves of semmelweis flies infected with the parental strain and 
the less virulent mutants. The wild-type strain NCTC 8325-4 is the more virulent 
bacteria, opposite to NCTC Δ lytM.  
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Figure 12. Survival curves upon infection with NCTC 8325-4. The survival curves of 
y,w and semmelweis flies are indistinguishable (P = 0.1394). 
 
 
Figure 13. Survival curves upon infection with NCTC Δ atl. semmelweis flies are 
significantly more susceptible than y,w flies (P<0.0001). 
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Figure 14. Survival curves upon infection with NCTC Δ lytM. The survival curves of 
y,w and semmelweis flies are indistinguishable (P = 0.0691). 
 
 
 
Figure 15. Survival curves upon infection with NCTC Δ isaA. The survival curves of y,w 
and semmelweis flies are indistinguishable (P = 0.1394). 
 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
88 
 
 
Figure 16. Survival curves upon infection with NCTC Δ 02855. The survival curves of 
y,w and semmelweis flies are statistically indistinguishable (P=0.6089). 
 
Sle1 does not significantly contribute to virulence, albeit 
binding of PGRP-SA to the NCTC Δ sle1 splitting septum. 
 Since NCTC Δ sle1 showed increased binding of mCherry_PGRP-SA 
(Fig. 7) but failed to show less virulence in y,w flies (Fig. 9 and 10A), we 
enquired about the susceptibility of the semmelweis flies. The survival 
curves of y,w and semmelweis were not distinguishable (Fig. 17). The 
observed in vitro binding of mCherry_PGRP-SA to the septum and cell 
division site (Fig. 7) seems to not be sufficient to promote an efficient 
immune response by the Fly. 
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Figure 17. Survival curves upon infection with NCTC Δ sle1. The survival curves of y,w 
and semmelweis flies are indistinguishable (P = 0.7087). 
 
Subsequently, in order to evaluate whether Sle1 contributed for 
virulence in the Fly, I constructed a double mutant background NCTC Δ atl 
Δ sle1. The double mutant shows a more dramatic impairment in cell 
division than both single mutants (Fig. 18) in accordance to previous 
reports [37]. In addition, mCherry_PGRP-SA could bind to the whole 
surface of the bacteria, similar to NCTC Δ atl, and not exclusively to the 
splitting septum as NCTC Δ sle1 (Fig. 18).  
The double mutant NCTC Δ atl Δ sle1 showed to be as virulent as 
the single mutant NCTC Δ atl (Fig. 19A) and to equally dependent on PGRP-
SA recognition (Fig. 19B). Consequently, the loss of virulence of the double 
mutant is attributed to the lack of the major autolysin Atl and the absence 
of Sle1 does not significantly contribute for virulence upon septical 
infection. 
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Figure 18. Co-precipitation of live cells with mCherry_PGRP-SA. mCherry_PGRP-SA is 
able to bind to the whole bacterial surface of the double mutant NCTC Δ atl Δ sle1, 
albeit it shows some accumulation of binding close at cell division sites. Scale 
intensities were adjusted to equalise NCTC Δ atl – mCherry_PGRP-SA. 
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A.
 
 
B.
 
 
Figure 19. Survival curves of y,w and semmelweis flies by NCTC Δ atl Δ sle1 and its 
parental strains. A. Survival curves of y,w flies. B. Survival curves of semmelweis flies. 
The survival curves of NCTC Δ atl and NCTC Δ atl Δ sle1 were overlapping in both fly 
backgrounds and statistically less virulent than the parental strains. 
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Induced AMPs seem to have a secondary role upon infection 
with NCTC Δ atl and NCTC Δ atl Δ sle1. 
 Upon bacterial infection, recognition of Lys-type PGN by PGRP-SA 
and DAP-type PGN by PGRP-LC triggers either the TOLL or IMD pathways, 
respectively, which induce the expression of antimicrobial peptides 
(AMPs) [62], [64]–[67]. In order to address the role of TOLL-dependent 
AMPs against infection of NCTC Δ sle1, we determined the drosomycin 
transcript levels at 16h p.i. (Fig. 20). Infection with NCTC Δ sle1, did not 
show higher levels of drosomycin transcription. On the other hand, 
infection with both non-virulent mutants NCTC Δ atl and NCTC Δ atl Δ sle1, 
showed decreased levels of drosomycin. This may suggest that less virulent 
bacteria require less induction of AMPs probably due to an efficient 
clearance by the early immune responses of the Fly.  
 
Figure 20. Induction of drosomycin at 16h p.i. in y,w flies.  y,w flies were infected in 
the same manner as for the determination of the survival curves. NCTC Δ sle1 show a 
slight less induction of drosomycin than NCTC 8325-4, albeit not significant. Likewise, 
infection with the double mutant showed non-significant decreased levels compared 
to NCTC Δ atl. Clearly, the non-virulent mutants induce drosomycin to much lower 
levels than the virulent strains.  
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NCTC Δ lytM and NCTC Δ atl Δ sle1 are impaired in 
haemolytic activity. 
 S. aureus is a major opportunistic pathogen that presents several 
virulence factors. I aimed to study whether haemolysins could affect the 
Host responses, in order to determine bacterial factors unrelated with PGN 
recognition that could help to explain the reduced virulence of NCTC Δ 
lytM, NCTC Δ isaA and NCTC Δ 02855. In addition, the low levels of 
drosomycin in non-virulent mutants compared to virulent strains, allowed 
to surmise that bacterial factors impairing early immune responses could 
be important for virulence. Since the early immune responses rely on the 
role of haemocytes in phagocytosis and clearance, I enquired whether the 
S. aureus autolysins could be subverting the cellular responses. 
 Haemolytic assays in sheep blood, showed that NCTC Δ atl, albeit 
showing the same type of haemolytic activities, presents a different 
pattern of distribution with an extra external halo (Fig. 21A). As the 
response to NCTC Δ atl mutant is highly dependent on PGRP-SA (Fig. 13 
and 19B) [1], it can be inferred that the haemolysins are not significantly 
contributing for loss of virulence.  
The double mutant NCTC Δ atl Δ sle1 presents β-haemolysin 
activity (Fig. 21A) but is compromised in the other haemolysins, similar to 
RN 4220 (Fig. 21C). This could in part account for the less activation of 
drosomycin compared to the single mutant NCTC Δ atl (Fig. 20). Likewise, 
NCTC Δ lytM solely presents β-haemolyses (Fig. 21B) which may 
contribute for a more reduced virulence than NCTC Δ isaA and NCTC Δ 
02855 which show a wild-type haemolytic phenotype (Fig. 21B).  On the 
other hand, the virulence of the sle1 mutant (Fig. 9 and 10B), albeit binding 
of PGRP-SA (Fig. 7B), may reside in the fact that coupled with an 
insufficient PGN recognition to trigger a potent immune response, it 
retains the haemolytic ability identical to NCTC 8325-4 (Fig. 21A).  
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A.
 
Figure 21. Haemolytic activity in sheep blood. It is presented the haemolytic profile 
of the strains used in this study. On the left column is it shown an image of the 
haemolytic activity and on the right column it is shown a 3D surface plot to help in the 
visualisation of the haemolytic halos. Briefly, overnight cultures were adjusted to the 
same optical density and inoculated in solid media supplemented with 5% (v/v) sheep 
blood. 
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B.
 
Figure 21. Haemolytic activity in sheep blood. The plates were incubated at 37ºC for 
16h followed by incubation at 4ºC for 24h to better visualise and detect the activity of 
the β-haemolysin.  
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C.
 
Figure 21. Haemolytic activity in sheep blood. RN 4220 is a laboratory strain impaired 
in the expression α and δ haemolysins, thus it can only be detected β-haemolyses [68]. 
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Discussion 
The structural and chemical properties of the PGN may 
affect and regulate the activity of autolysins. 
 The CW treatment with SDS releases components that are non-
covalently linked to the CW, whilst it also denatures the proteins. 
Therefore, the treatment with SDS, which is commonly used to extract CW 
bound protein, may come with limitations on the detection of the activity 
of the enzymes. Nevertheless, this procedure successfully allowed the 
detection of different Atl forms (Fig. 5). We then enquired whether 
treatment with a muramidase, which would release bound proteins by 
PGN solubilisation, would allow the detection of different autolytic bands 
(Fig. 6).  
The improved lytic activity of GL with M. luteus cells rather than 
with S. aureus cells (Fig. 5), has been proposed to be due to a pre-requisite 
of AM digestion prior to GL digestion [22]. However, it also could be the 
case that the GL activity is controlled by modifications in the glycan strands 
that are not present in the M. luteus PGN [69]. This could be a mechanism 
similar to the O-acetylation of MurNAc which regulates the activity of the 
lytic transglycosylases in Gram-negative bacteria [70]–[72]. In addition, it 
may also be due to the different PGN structures of the S. aureus and M. 
luteus PGN, such as the degree of cross-linking, length of the glycan chains, 
differences on the peptide moiety and/or the different CW compositions, 
such as the wall teichoic acids and the teichuronic acids [69]. 
As the lytic activity of Sle1 could only be detected with S. aureus 
cells as substrate (Fig. 5), either the Sle1 activity is specific for this PGN or 
it has a substantial optimal activity in this substrate. This suggests that Sle1 
may require different PGN chemical properties than AM in order to be 
active. Indeed, the amidase activity of these proteins is attributed by 
different domains – AM possesses a PGRP domain and Sle1 a CHAP domain. 
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Overall, the results suggest that different autolysins are optimal to 
PGNs with specific characteristics/modifications. This may be a 
mechanism to control and regulate the lytic activity. 
Treatment of the CWs with mutanolysin (M1), only revealed 
processed forms of Atl in an S. aureus substrate (Fig. 6). This may be an 
indication that high molecular weight forms of Atl do not covalently bind 
to the PGN and/or that the activity of the smaller forms is susceptible to 
SDS extraction. On the other hand, it is possible that M1 does not penetrate 
well through the CW and has limited access to the PGN. In this scenario, it 
would be observed the release of Atl forms bound to only certain PGN 
chains or fragments. Interestingly, some of these Atl forms are not detected 
by SDS extraction. Overall, the results suggest that Atl may present more 
processed forms than the ones that have already been identified.  
Sle1 was not detected upon M1 treatment, in contrast to the AM 
form of Atl. It can be inferred that perhaps AM and Sle1 may localise 
temporally in different places of the cell or that Sle1 requires full 
denaturation-renaturation process in order to be active in a zymogram. If 
the SDS present in the loading buffer is not sufficient to fully denature the 
protein, it might be the case that Sle1 is not able to restore the activity. If 
the protein folds in a way that incorporates PGN molecules, the recovered 
Sle1 present in the M1 extracts could be too “close” to be able to interact 
with new PGN fragments, hence it would require a full denaturation-
renaturation cycle. To address this hypothesis, I performed an SDS 
treatment to the M1 extracts prior performing the zymograms, and still did 
not detect Sle1 activity and the activity of the Atl enzymes was greatly 
reduced (data not shown). 
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PGRP-SA accesses surface exposed septal PGN fragments 
temporarily generated during cell division. 
Cell division culminates with the splitting of the daughter cells. For 
cell splitting to occur, old PGN at the septum needs to be degraded. 
Autolysins have been shown to localise at the septum where PBPs also 
localise [73]. Atl, Sle1, LytM, LytN and IsaA have been shown to localise at 
the septum, albeit Atl, LytM and LytN are also found distributed over the 
whole cell surface [21], [33], [37], [41]. 
In order to prevent autolysis upon cell splitting, the process of 
degradation and insertion of new PGN material must be regulated in a 
spatial and temporal manner. Thus, the degradation and synthesis are 
coupled processes, which it is intuitively logical to assume that 
degradation happens (very shortly) before the insertion of new material. 
This implies that for a very short period of time it is possible the 
occurrence of some accumulation of PGN fragments both from old and new 
synthesised PGN fragments.  
In the wild-type strain NCTC 8325-4, mCherry_PGRP-SA showed a 
very low binding to exponentially growing cells (Fig. 7). However, when it 
is detected, binding by mCherry_PGRP-SA is found at or close to the septum 
region. Therefore, it appears that PGRP-SA is able to recognise PGN at the 
septum prior to the recycling and generation of the old and new PGN 
chains. Accordingly, all the autolysins mutants present in this study 
showed binding at the septum. NCTC Δ sle1 showed a higher defined 
binding of the septum than NCTC 8325-4  and the other mutants and NCTC 
Δ atl showed binding all over the cell surface, i.e. not exclusively at the 
septum region (Fig. 7, 8 and 18). Indeed, PGRP-SA only binds all over the 
cell surface when the PGN is surface exposed (e.g. the tagO mutant [61] 
and Fig. 4, Chapter III) or it is homogeneously accumulated at the cell 
surface (atl mutant [1] and Fig. 7, 8, 18).  
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The binding of PGRP-SA at the septum and cell splitting region can 
be an indirect evidence of the role of these proteins in cell growth and 
division. To a certain extent, it allows the inference of their cellular 
location. Atl is found to localise all around the cell surface and PGRP-SA 
binds all over the surface in an atl mutant. The stronger binding at the 
septum in the sle1 mutant compared to the wild-type strain, is an 
indication of the Sle1 localisation at the cell division site, where it may 
assume a specific role for an efficient cell splitting.  
Interestingly, the mutants that showed a more accentuated 
phenotype in impairment of cell division were NCTC Δ atl and NCTC Δ sle1 
which in turn are the mutants that presented either a better recognition 
by PGRP-SA or a more defined pattern of binding at the septum. This 
indicates that these are the mutants that present higher level of cell 
surfaced exposed PGN. In contrast to previous reports, NCTC Δ lytN mutant 
did not show visible compromised cell defects [33].  In accordance with 
previous reports, NCTC Δ isaA and NCTC Δ lytM also did not exhibited 
impairment in cell division or increased cell clustering [48], [58].  
 
The activity of the autolysins influence the detection of PGN 
by PGRP-SA. 
 If PGRP-SA, in a wild-type bacterium, can almost exclusively only 
detect the PGN that is temporarily generated/exposed during cell division, 
then cells in a non-dividing stage or a population in a stage of a slower 
growth rate, should be more difficult to be recognised. According to the 
hypothesis presented above, recognition by PGRP-SA plays with the 
probability to access PGN fragments that slightly accumulate for very short 
periods of time in a specific sub-cellular region. Hence, if the growth rate 
of a population is lower, the probability of finding a dividing cell that 
presents a certain level of PGN accumulation is greatly reduced.  
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 In liquid culture, bacteria show an exponential growth phase 
which is followed by a stationary growth phase. In this stage, the number 
of bacterial cells no longer increases [74]. During my experimental 
optimizations, I observed that the binding of mCherry_PGRP-SA is higher 
at early exponential phase, than at mid or late exponential phase (data not 
shown). When I incubated mCherry_PGRP-SA with cells in stationary 
growth phase, I observed a decrease in the binding of the protein (Fig. 8). 
This may substantially be due to the fact that the cells are not in a constant 
high rate of division, thus there is less PGN that is exposed (at the septum). 
In the case of the atl mutant cells in a stationary growth phase, although 
there is still a substantial accumulation of PGN fragments resultant from 
each cell division cycle, it is likely that these fragments are 1) present in 
less amounts and 2) old accumulated fragments from past division cycles 
have had time to be gradually cleaved by other autolysins. In accordance, 
at this growth stage, the mutants` cells show a less impaired cell division 
phenotype.   
 
In the absence of Sle1, PGRP-SA binds to newly synthesised 
PGN fragments, accumulated at the septum, that are not 
incorporated into the PGN mesh. 
There is a “predisposition” for the binding of PGRP-SA to occur at 
the septum region. However, the binding at the septum of NCTC Δ sle1 cells 
is more evident than the binding to other mutants which have also been 
reported to be active at the septum, such as IsaA [51]. 
Filipe and colleagues have identified that the terminal MurNAc 
residue influences immunostimulation in D. melanogaster [75]. In an isaA 
mutant, it has been detected the overexpression of the other lytic 
transglycosylase, SceD [58]. Hence, it is likely that in NCTC Δ isaA, the 
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number of MurNAc residues in a form that is not easily recognised by 
PGRP-SA is maintained.  
In collaboration, Filipe Lab and Pinho Lab5 have shown that both 
Sle1 and LytM engage in the reshaping of the flat septum into a curved 
hemisphere upon cell division [44]. The sle1 and lytM mutants show 
impairment in septum reshape which may be associated with a higher 
stiffness of the PGN in the absence of these autolysins [44]. If both mutants 
present a similar cell defect at the septum, but PGRP-SA is only able to bind 
better to NCTC Δ sle1 (Fig. 7), it is an indication that the activity of Sle1 at 
the septum is impairing the recognition by PGRP-SA. In addition, it is also 
an indirect indication that Sle1 and LytM possess different roles in the 
process of septum re-shaping.  
Sle1 and LytM can lead to the separation of two glycan strands 
from one another, albeit generating different PGN fragments (Fig. 1 and 3). 
Whereas the Sle1 amidase separates the glycans from the stem peptides, 
the LytM glycylglycine endopeptidase separates the link between the stem 
peptides of two glycan chains. This implies that septum reshape is 
dependent on the separation of the glycan strands, perhaps to 1) open up 
space for incorporation of new material and 2) to link old glycan strands 
with new synthesized PGN forms. The region where the meeting between 
the old and new CW with the join of new and old PGN occurs, may be a 
reason for the typical scars observed upon cell division [69]. This goes in 
accordance with the preferential localization of PBPs at the septum region, 
together with the localisation of the autolysins. 
Sle1 possesses amidase activity which seems to be specific for a 
PGN with certain characteristics (Fig. 5 and first section of the Discussion).  
In addition, the phenotype of cell division defects cannot be 
rescued/compensated as efficiently as the removal of other autolysins can 
                                                          
5 Pinho Lab, Laboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica 
António Xavier, Universidade Nova de Lisboa. 
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be (Fig. 7). This suggests that Sle1 may have a specific crucial role in the 
cell splitting. Accordingly, the phenotype of an atl mutant, the major 
autolysin, also cannot be compensated to wild-type levels (Fig. 7, 8 and 18). 
Since the sle1 mutant has problems in reshaping of the septum, it means 
that it is a problem of PGN stiffness [44]. Therefore, it is likely that in the 
absence of Sle1, there is a certain moment in the splitting process that the 
cell is not able to introduce the new material due to lack of physical space. 
Hence, Sle1 has a fundamental role in opening up space for septum 
reshaping by allowing the insertion of new PGN material. Then, NCTC Δ 
sle1 accumulates, specifically at the septum, fragments of newly 
synthesised PGN. PGRP-SA is able to recognise these PGN species that are 
not being incorporated within the polymer mesh.  The crucial role of Sle1 
in the aid of the insertion of new material, may be the reason for: 1) the 
impaired re-shaping of the septum in its absence; 2) its amidase activity 
which in turn is sensitive to certain PGN modifications and CW 
composition (Fig. 5 and 6, and first section of the Discussion).   
LytN possesses both N-acetylmuramyl-L-alanine amidase and D-
alanyl-glycyl endopeptidase activities (Fig. 3) [33]. It has been suggested 
that the latter activity of LytN may be equivalent to that of LytM, since the 
end result of hydrolysing either the D-alanine-glycine bond or the glycine-
glycine bond, will lead to crosslinking relaxation with a polyglycine 
extremity [33]. Then, the absence of the LytM may be compensated by 
LytN and the other two putative glycylclycines (Fig. 4). Consequently, the 
level of PGN accumulation at the septum compared with the wild-type 
strain, is not sufficient to render a higher binding by PGRP-SA. Likewise, 
the absence of LytN may be to some extent compensated by the other 
amidases and glycylglycine endopeptidases, similar to the absence of the 
putative amidase 02855. The absence of 02580, a LYZ2 domain containing 
protein, is likely to be compensated by the GL activity of Atl.  
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In sum, PGRP-SA binds to newly synthesised PGN fragments 
accumulated at the septal cell surface, due to the non-incorporation of new 
material into the PGN mesh caused by the stiffness of the septal PGN that 
was not cleaved by the specific activity of Sle1. 
 
Recognition of PGN is paramount for efficient antibacterial 
responses. 
Infection of y,w flies identified NCTC Δ atl, NCTC Δ lytM, NCTC Δ 
isaA and NCTC Δ 02855 to be less virulent than the parental strain (Fig. 9). 
However, NCTC Δ atl is significantly less virulent than either NCTC Δ lytM, 
NCTC Δ isaA or NCTC Δ 02855 (Fig. 10). Whilst upon infection with NCTC 
8325-4 the y,w flies succumb at 24h p.i., with either NCTC Δ lytM, NCTC Δ 
isaA or NCTC Δ 02855 there is a delay of 12h in the death of the flies. At 36h 
p.i. the probability of the Fly survival upon infection with these mutants 
and the wild-type strain is similar, ~20%. An isaA mutant had already been 
reported to be slightly less virulent in a mouse septic arthritis model, albeit 
not statistically significant [58]. In contrast, infection with NCTC Δ atl 
renders the flies a probability of survival of ~75% after 72h p.i. (Fig. 10). 
The reason for such reduced virulence of the atl mutant compared to the 
other less virulent mutants, is due to a better recognition by PGRP-SA. 
Accordingly, in a semmelweis background, the atl mutant is the most 
virulent mutant, close to the virulence levels of the parental strain (Fig. 11 
and 13).  On the other hand, no significant differences in the probability of 
survival of either y,w or semmelweis flies where detected for NCTC Δ lytM, 
NCTC Δ isaA and NCTC Δ 02855 (Fig. 11 and 14-16), similar to NCTC 8325-
4 (Fig. 11 and 12).  These results show that NCTC 8325-4 possesses 
pathogenicity levels that when the PGN is not recognised to a certain 
minimum levels, the Drosophila immune responses are unable to control 
the infection. Only when a certain amount of PGN is accessible to 
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recognition, can the Host counterattack the virulence of the bacteria. 
Hence, NCTC Δ lytM, NCTC Δ isaA and NCTC Δ 02855 are more virulent than 
NCTC Δ atl and the role of PGRP-SA cannot be detected. Likewise, NCTC Δ 
sle1 is as virulent as the parental strain, albeit a better recognition of the 
septal PGN by PGRP-SA (Fig. 7, 9, 11, 17 and 19). The fact that the response 
to the atl mutant is highly dependent on PGRP-SA, proves that the reduced 
virulence has to do with a better PGN recognition and not due to the 
impairment on biofilm and adherence ability or susceptibility to other 
Host components.  
The results suggest that 1) impairment of PGN detection by PGRP-
SA is paramount since a bacterium that still retains virulence factors is not 
able to stablish an infection due to the recognition of its PGN (Fig. 21); 2) 
infection with bacteria that possess high levels of pathogenicity may mask 
the detection of the fundamental role of Host PGN receptors in the immune 
response; 3) impairment of PGN recognition, i.e. immune evasion 
mechanisms, may be the first line  to protect the bacteria against the Host 
immune components, followed by the virulence factors, such as 
haemolysins, that help the bacteria to survive inside the Host (Fig. 21). The 
virulence factors may only be able to assume its role for as long as the 
bacteria remain undetectable by the Host. Furthermore, it may be that 
virulence factors might be able to compensate each other in their role on 
the subversion of the responses, but once the barriers that impair PGN 
recognition are compromised, the bacteria struggle to survive inside the 
Host.  
 
PGN recognition by PGRP-SA may aid in the clearance by 
early immune responses. 
The binding of PGRP-SA to the septum of NCTC Δ sle1 cells (Fig. 7) 
is not sufficient to promote an efficient immune response (Fig. 9, 11 and 
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17). Nevertheless, we enquired whether the absence of Sle1 in an atl 
mutant background would contribute for loss of virulence. Regarding cell 
division, the double mutant NCTC Δ atl Δ sle1 showed high impairment in 
the cell splitting corroborating previous reports [37] (Fig. 18). NCTC Δ atl 
Δ sle1 is as virulent as the single NCTC Δ atl mutant (Fig. 19). Hence, the 
loss of virulence of the double mutant is almost exclusively due to the 
absence of Atl. Accordingly, the binding of mCherry_PGRP-SA to the double 
mutant cells did not seem to be higher than to the single atl mutant cells 
(Fig. 18). 
We next wondered whether albeit not detected by monitoring the 
Host survival, the NCTC Δ sle1 would induce higher levels of AMPs. We 
verified that the levels of drosomycin were similar between NCTC 8325-4 
and NCTC Δ sle1, although the mutant showed slight lower levels of 
induction (Fig. 20). In contrast, the drosomycin levels were greatly reduced 
upon infection with either NCTC Δ atl or NCTC Δ atl Δ sle1 (Fig. 20).  
Induced late AMPs start to be generated once most of the bacteria 
has been cleared, as they assume protective roles and act to destroy the 
bacteria that escaped the immediate cellular responses [76]. 
Consequently, the high susceptibility of NCTC Δ atl and NCTC Δ atl Δ sle1 
to the Host responses (Fig. 19) coupled with the low levels of drosomycin 
(Fig. 20), is an indication that the majority of the bacteria were efficiently 
removed by cellular responses. Thus, there was little bacteria still present 
in circulation, translating into a low induction of the TOLL pathway (Fig. 1, 
Chapter III). Accordingly, the high levels of drosomycin upon infection with 
NCTC 8325-4 and NCTC Δ sle1, may be the result of a higher bacterial load 
in the haemolymph due to the failure of the cellular responses in 
controlling the bacterial load. In this scenario and accordingly to previous 
reports [76],  the induced AMPs have major roles as clearing agents to mop 
up the bacteria in order to counterbalance the inability of haemocytes to 
clear the pathogens. This is an indirect indication that immediate early 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
107 
 
responses are crucial against an S. aureus infection. In addition, since 
PGRP-SA is paramount against NCTC Δ atl infection, these early responses 
may be associated with the role of PGRP-SA recognition. It follows that, if 
PGRP-SA recognition is vital against infection and the immediate 
responses are involved against an S. aureus infection, then we are 
indirectly observing that the atl mutant is highly susceptible to cellular 
responses, which in turn are dependent on PGRP-SA. Therefore, the level 
of PGN recognised at the NCTC Δ sle1 surface is not sufficient to promote a 
better clearance by haemocytes. Indeed, the Host Labs have previously 
reported that efficient responses against an S. aureus mutant without wall 
teichoic acids rely more on PGRP-SA rather than on induced AMPs [61]. 
This observation may seem contradictory, unless one realises that 
immediate responses are paramount for clearance of the bacteria and 
assume a TOLL-independent role of PGRP-SA (see Discussion of Chapter 
III and the contents of Chapter IV). 
 
S. aureus haemolysins may compromise the clearance 
responses by haemocytes. 
Since S. aureus is a major pathogen whose virulence factors seem 
to aid in the infection of the flies, we sought to determine what factors 
could be vital for the establishment of the infection when detection of PGN 
is not significantly compromised. As the data suggests that early immune 
responses are important for bacterial clearance, we surmise that these 
virulence factors are acting upstream of the late induced responses. 
Subsequently, it should be factors that might impact the role of 
haemocytes.  
Haemolytic assays showed that NCTC Δ lytM and NCTC Δ atl Δ sle1 
are compromised in the haemolytic activity (Fig. 21). Whereas the slight 
reduced virulence of NCTC Δ isaA and NCTC Δ 02855 may to some extent 
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be due to a slight better binding of PGRP-SA at the septum (Fig. 7, 9 and 
10), for NCTC Δ lytM it may be mostly due to the impairment in haemolysin 
activity. Accordingly, in the lytM mutant it was not observed such levels of 
mCherry_PGRP-SA recognition as for NCTC Δ isaA and NCTC Δ 02855 (Fig. 
7). The reason for impairment of haemolytic activity may be due to the fact 
that the pentaglycines bridges are involved in the exposure of cell surface 
proteins [77]. In addition, the impairment of haemolytic activity of NCTC Δ 
atl Δ sle1, may account for the slight reduced drosomycin levels compared 
to NCTC Δ atl (Fig. 21). This suggests that the double mutant is being 
slightly better cleared than the single atl mutant. Nevertheless, it is evident 
that a better PGN recognition by PGRP-SA greatly aids in the clearance 
responses. 
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Conclusions 
 
 The role of autolysins appears to go beyond the maintenance of 
bacterial physiology. On one hand they are crucial for cell growth and 
proliferation which are essential for survival. On the other hand, their 
activity renders the bacteria more susceptible to Host recognition, since 
PGRP-SA (and perhaps other Host PGN receptors) are able to detect the 
PGN fragments generated during cell division.  
The recognition of PGN is paramount against a bacterial infection 
in D. melanogaster. An S. aureus atl mutant is non-virulent in immune wild-
type background flies, showing reduced levels of bacterial load in the 
course of infection [1]. Overall, the results presented in this chapter 
indicate that upon infection with pathogenic bacteria, the detection of a 
certain amount of PGN is sufficient to guarantee Host survival whilst 
clearing the bacteria, i.e. avoid an asymptomatic infection through 
establishment of the bacteria in a hidden ecological niche inside the Host. 
It is then logical that the bacteria respond through evasion 
mechanisms that impair PGN recognition. Accordingly, the data presented 
in this chapter together with the stereo-hindrance of PGN by wall teichoic 
acids [61], show that as long as the bacteria can avoid PGN recognition, 
they successfully establish an infection. This suggests that the mechanisms 
of virulence are primordially dependent on the evasion of PGN detection, 
i.e. on the survival of the bacteria.  PGN detection through binding of Host 
receptors is likely to impair proper growth and division. When impairment 
of PGN recognition is compromised, the Host successfully controls the 
infection and thus the virulence factors assume a secondary role. They are 
mostly efficient for as long as the PGN is protected from recognition. 
 In the absence of the major autolysin Atl, there is accumulation of 
PGN fragments around the cell surface which are exposed and hence 
accessible for PGRP-SA recognition [1]. The results here presented suggest 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
110 
 
that the PGN recognition is aiding in the clearance of the bacteria. Early 
immune responses are the first line against infection. They rely mainly on 
the function of haemocytes as macrophages, which internalise and clear 
the bacterial cells. The late immune responses follow the cellular 
responses. They rely mainly on the induced AMPs that are triggered upon 
PGN recognition. Since infection with the non-virulent atl mutant induces 
lower levels of drosomycin than the parental virulent strain, the AMPs 
appear to play a secondary role in this infection. As their primary function 
is to clear bacteria that escaped the early immune responses, this suggests 
that the atl mutant is being better cleared through the recognition of PGN 
by PGRP-SA. In sum, the data suggests that upon an S. aureus infection the 
early responses are determinant for bacterial clearance and that PGRP-SA 
may be involved in these early responses. In addition, as pathogenic 
bacteria, S. aureus presents virulence factors that act early on the infection 
course, most likely to subvert the early immune responses. Again, if 
detection of PGN is enough to promote bacterial clearance, then the PGN 
recognition is of uttermost importance for Host survival and thus bacteria 
present mechanisms to protect it from recognition. The importance of the 
protection of PGN detection may be a primordial survival instinct of the 
cell. A PGN with Host receptors bound to it compromises the growth and 
cell division, thus survival. This in part explains why the recognition of PGN 
from the Host side is so important and it seems to trigger both cellular 
(clearance) and humoral (induced AMPs) responses.   
Regarding the activity of the autolysins in the bacterial physiology, 
there seems to be an interplay between the PGN chemical and/or 
structural composition and autolytic activity. For instance Sle1, a major 
enzyme for efficient cell splitting, appears to be specific for a PGN that 
possesses certain (unknown) characteristics. In the absence of Sle1, there 
is accumulation of newly synthesised PGN that does not have space to be 
incorporated into the PGN mesh. Although PGRP-SA is able to recognise 
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these PGN fragments, the amount of detected PGN is not sufficient for the 
Host to trigger efficient responses against the pathogen. Thus, although 
Sle1 plays a specific crucial role in cell splitting, the other autolysins can 
control the accumulation of PGN at the septum in this mutant to a certain 
extent. Perhaps the autolysins can cleave the new PGN fragments that 
cannot be inserted to give time for other autolysins to act on the PGN 
stiffness, thus allowing a delayed septum reshaping. In addition, it can be 
assumed that because the new PGN is exposed, it is a PGN that has not been 
modified by post-incorporation modifications. This “naked” PGN that has 
not been found in the polymeric PGN [78] may be also a better substrate 
than a PGN that has suffered modifications. For instance, as revised in the 
previous Chapter, some Lysozymes are sensitive to modifications of the 
glycan chains. Lastly, it is likely that upon cell division, the amount of 
cleaved PGN is equivalent to the amount of new incorporated PGN. Since 
Sle1 seems optimal for a particular sub-type of PGN, this is an indication 
that septal PGN has characteristics that may not be found in other 
subcellular regions. Also, it is possible that an accurate quantification of 
PGRP-SA binding, allows to extrapolate the amount of new and old PGN 
that is inserted or removed during a cell division cycle. 
 It is likely that the coordination of the temporal and spatial activity 
of the autolysins is a transversal bacterial mechanism to guarantee the 
survival of the cell to avoid both lysis and the detection of PGN by Host 
components. One of the biological reasons for the observed extremely fast 
splitting of the daughter cells and septum re-shaping [44] may be to avoid 
the accumulation of certain levels of PGN at the septum that are accessible 
to Host recognition and thus endanger the survival of the bacteria. I 
propose that the sum of the activity of all autolysins is key to impair the 
detection of PGN during cell division, although the major autolysin Atl 
presents a more relevant role. 
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Material and Methods 
 
Bacterial strains and growth conditions. 
Table 1 presents the S. aureus strains used in this study. S. aureus 
strains were grown either in Tryptic Soy broth (TSB; Difco) or in Tryptic 
Soy agar (TSA; Difco), supplemented when appropriate: Erythromycin 
(Sigma-Aldrich, Germany) at 10 µg/ml, 5-bromo-4-chloro-3-indolyl β-D-
galactopyranoside (X-Gal; Apollo Scientific, UK) at final concentration at 
100 µg/ml. E. coli strains DC10B and BL21(DE3) were grown either in 
Luria–Bertani broth (LB; Difco, France) or in Luria–Bertani agar (LA; 
Difco), supplemented with 100 g/mL of Ampicillin (Sigma-Aldrich). All 
cultures were grown at 37ºC with aeration, except when stated otherwise. 
Table 1. List of strains used in this study, plasmids and primers for cloning. 
 
 
Fly Strains. 
All flies stocks were grown on standard cornmeal-agar medium at 
25ºC. Isogenic Drosophila Bloomington #6599 (y,w) flies were used as 
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wild-type flies. semmelweis flies were used as a PGRP-SA mutant 
background [62]. 
 
Construction of the bacterial mutants. 
Table 1 presents the constructed S. aureus null mutants strains, 
plasmids and primers used.  The upstream and downstream regions of the 
genes to be deleted were amplified using pair of primers denominated as 
P1/P2 and P3/P4, respectively.  The resulting PCR fragments containing 
the upstream and downstream regions of each gene were joined by 
overlap PCR using the pairs of primers P1/P4. The PCR product was 
digested with NcoI (sequence in P1 primers) and BglII (sequence in P4 
primers) (Fermentas) and cloned into the pMAD vector [79] which was 
propagated in E. coli DC10B and the inserts were sequenced. The plasmids 
were then electroporated into S. aureus RN4220 strain at 30ºC, using 
Erythromycin and X-gal selection, and transduced into NCTC8325-4 using 
phage 80a [80]. The integration of the plasmids into the chromosome and 
their excision was done as previously described [81]. Gene deletions were 
confirmed by sequencing of the amplified fragments with P1/P4 pair of 
primers. 
 
Zymography assay.  
The zymograms were performed as described in Vaz and Filipe, 
2015 [69]. For crude autolytic extract with mutanolysin, the same 
procedure was followed except that instead of incubation with 4% (w/v) 
SDS, the cells were incubated with 0.2 mg/mL of mutanolysin. 
 
Purification of mCherry_PGRP-SA. 
The recombinant protein mCherry_PGRP-SA was purified using a 
protocol adapted from previous reports [1], [61]. E. coli BL21(DE3) 
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competent cells were transformed with pET21a derivatives carrying 
mCherry_PGRP-SA. Briefly, different batch cultures in LB supplemented 
with 100 g/mL of Ampicillin (Sigma-Aldrich) were grown at 25ºC, 120 
rpm. When the cultures reached an OD600nm ~0.5, they were induced with 
addition of IPTG (Apollo Scientific, UK) at 1 mM final concentration in the 
same growth conditions for 16-18 h. The cells were harvested and washed 
once in Equilibration Buffer (50 mM Na2PO4 pH 7.4; 300 mM NaCl). The 
pellets were resuspended again in Equilibration Buffer and lysis was 
carried out by French Press at 1000 psi. The lysate was centrifuged at 
20070 x g for 20 min at 4ºC. Interestingly, the cytoplasmic proteins, i.e. the 
proteins that are left on the supernatant after lysate centrifugation, proved 
to not be functional (could not bind neither to live cells nor to PGN) and 
they did not bind avidly to the resin, thus the yield of the cytoplasmic 
fractions were very low. Only the protein in inclusions bodies (the pellets 
of the lysates), after denaturation-renaturation steps, revealed to be 
functional. Perhaps the protein that is free in the cytoplasm binds to the E. 
coli PGN upon lysis of the cells and cannot be subsequently renatured into 
its proper structure. Therefore, the supernatants were discarded and the 
pellets were kept suspended in 20 mL of Resuspension Buffer (20 mM 
Na2PO4 pH 7.4; 500 mM NaCl; 8 M urea) and left shaking on a rocker in a 
cold room for ~60 hours until they appeared homogeneous. The 
solubilised pellets were diluted down to 4 M Urea by the addition of 
Dilution Buffer  (20 mM Na2PO4 pH 7.4; 500 mM NaCl) and left again 
homogenising at 4ºC for a further 24h. The homogenates were centrifuged 
and the supernatant was mixed with TALON® Metal Affinity Resin 
(Clontech Laboratories, USA) (previously washed with Wash Solution) and 
incubated for 1 h on the rocker at 4ºC. The Protein-Talon resin complexes 
were recovered by centrifugation (supernatants kept on a falcon tube on 
ice) and washed 4 times with Wash Solution (50 mM Na2PO4 pH 7.4; 300 
mM NaCl; 4 M Urea), once with 5mM Imidazole Wash solution and once 
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with 10mM Imidazole Wash Solution. Proteins were eluted with Elution 
Buffer (50 mM Na2PO4 pH 7.4; 300 mM NaCl; 150 mM Imidazole) for 1 hr 
at 4ºC on rocker. The free-protein Talon resin was spun down by 
centrifugation and the supernatants (the pure proteins) were collected 
into a fresh falcon tube and kept on ice. The collected supernatants of the 
first Protein-resin spun down, were incubated again with the free-protein 
Talon resins (previously re-washed with Wash Solution) and the 
procedure was repeated. The supernatants from the two elution batches 
were combined and dialysed overnight in a 10K MWCO SnakeSkinTM 
Dialysis Tubing (ThermoFisher Scientific, USA) at 4ºC against 5 L PBS 1X 
pH 6.0, then 6-8h against 2 L PBS 1X pH 6.0 made fresh and finally 
overnight in 2 L PBS 1X pH 6.0 also made fresh. The proteins were 
recovered from the dialysis` bags and centrifuged to remove any residues 
of the resin. The proteins were quantified using a Nano-drop ND-1000 
spectrophotometer (Thermo Scientific, Wilmington, NC). The purity was 
accessed by SDS-PAGE [82] and visualised with Coomassie Blue followed 
by Silver Staining (both home-made solutions). Aliquots of the proteins 
were kept at 4ºC for immediate and/or constant use or they were snap 
frozen in liquid nitrogen and stored at -80ºC.  
 
Co-precipitation assays of live cells with mCherry_PGRP-SA. 
The bacterial binding assays are qualitative and were performed 
with the fluorescent recombinant protein mCherry_PGRP-SA for 
microscopy visualisation.  
Bacteria were grown to OD600nm ~0.5 or an O/N culture for 
stationary phase experiments. 1 mL aliquot was centrifuged for 5 min at 
RT, 16.1 x1000 g. The cells were washed with 500 µL of PBS 1x pH 6.0 and 
centrifuged again. They were resuspended in 0.3 mg/mL final 
concentration of mCherry_PGRP-SA in a 200 µL reaction volume, filling up 
the volume with PBS 1x pH 6.0 and incubated at RT for 5 min without 
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shaking. The “cells-mCherry_PGRP-SA” complexes were harvested for 5 
min at RT, 7.5 x1000 g. The pellets were washed twice with 200 µL of PBS 
1x pH 6.0. Finally, the pellets were resuspended in the left over volume of 
the washings and 2 µL was loaded on 1.2% (w/v) Agarose- PBS 1x pH 6.0 
slides. Images were acquired in a Zeiss Axio ObserverZ1 microscope 
equipped with a Photometrics CoolSNAP HQ2 camera (Roper Scientific 
using Metamorph software, Meta Imaging series 7.5) and analysed using 
the ImageJ software. 
 
Survival curves. 
Survival assays were performed as previously described [1]. 
Bacterial cultures were grown overnight, washed and resuspended in PBS 
(Phosphate-Saline Buffer). The OD600nm was adjusted to ~0.350 with PBS 
using. 32.2 nL of bacterial suspension was injected in thorax of 3-5 day old 
flies using a nanoinjector (Nanoject II; Drummond Scientific, Broomall, 
PA). The infected flies were kept at 30ºC and monitored for 72h every 12h. 
Estimated survival curves were analysed using the Log-rank (Mantel-Cox) 
test to determine statistical significance between the curves. The number 
of flies infected were as follows (in the order y,w and semmelweis flies, 
when applicable): NCTC 8325-4 – 187, 166; NCTC Δ atl – 129, 134; NCTC Δ 
sle1 – 70, 76; NCTC Δ lytN – 38; NCTC Δ 02855 – 38, 58; NCTC Δ 02580 – 59; 
NCTC Δ lytM – 37, 40; NCTC Δ isaA – 100, 79; NCTC Δ atl Δ sle1 – 76, 52.   All 
data were plotted and analysed using GraphPad Prism 5 (GraphPad 
Software, Inc.). 
 
Quantification of drosomycin levels. 
Female y,w flies were infected as conducted for the survival assays. 
For quantification of drosomycin transcript levels, flies were collected at 
0h p.i. and at 16h p.i.. PBS was used as a control for the induction of 
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drosomycin upon injection. The procedure was conducted as previously 
described [1]. Briefly, the flies (n = 6/sample) were homogenised and the 
total RNA was extracted using the “Total RNA Purification Plus Kit” 
(Norgen, Canada) according to the manufacturers’ instructions. The RNAs 
were quantified using a Nano-drop ND-1000 spectrophotometer (Thermo 
Scientific). 500 ng of total RNA was used to produce cDNA using “Maxima 
First Strand cDNA Synthesis Kit” (Thermo Scientific) in a T100 Thermal 
Cycler (Bio-Rad) and stored at −20°C. The housekeeping gene tbp (TATA-
box-binding protein) [83] was used as a control to normalize the transcript 
levels of drosomycin both at 0h and 16h p.i.. drosomycin and tbp levels were 
measured using the pair primers Drs(+)/Drs(−) and Tbp(+)/Tbp(−) [1]. 
qPCR reactions were performed using the SensiFast SYBR No-ROX Kit 
(Bioline, UK) according to the manufacturer’s instructions, in a Rotor-Gene 
Q real-time PCR cycler with a 72-well rotor (Qiagen). Three biological 
repeats were performed per time point. Gene expression was calculated 
on the basis of the comparative threshold cycle (CT) value [84]. The 
drosomycin CT values at 16h p.i. were normalised against tbp/PBS 
injection/0h p.i.. 
 
Haemolytic assays.  
 O/N bacterial cultures were adjusted to the same OD600nm ~2.0. 3 
µL of culture was put onto TSA supplemented with 5% (v/v) sheep blood 
(Difco, France). The plates were incubated with the lid facing upwards at 
37ºC for 16h followed by incubation at 4ºC for 24h before image 
acquisition using a Gel DocTM EZ Gel (Bio-Rad, USA). 3D surface plots were 
performed using ImageJ software. 
 
 
 
 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
118 
 
References 
 
[1] M. L. Atilano, P. M. Pereira, F. Vaz, M. J. Catalão, P. Reed, I. R. Grilo, R. G. 
Sobral, P. Ligoxygakis, M. G. Pinho, and S. R. Filipe, “Bacterial autolysins 
trim cell surface peptidoglycan to prevent detection by the drosophila 
innate immune system,” Elife, vol. 2014, no. 3, pp. 1–23, 2014. 
[2] W. Vollmer, B. Joris, P. Charlier, and S. Foster, “Bacterial peptidoglycan 
(murein) hydrolases,” FEMS Microbiol. Rev., vol. 32, no. 2, pp. 259–286, 
2008. 
[3] G. D. Shockman, R. Kariyama, and O. Massidda, “Bacterial Walls, 
Peptidoglycan Hydrolases, Autolysins , and Autolysins,” Microb Drug 
Resist, vol. 2, no. 1, pp. 95–98, 1996. 
[4] W. Vollmer, D. Blanot, and M. A. De Pedro, “Peptidoglycan structure and 
architecture,” FEMS Microbiol. Rev., vol. 32, no. 2, pp. 149–167, 2008. 
[5] T. J. Smith, S. A. Blackman, and S. J. Foster, “Autolysins of Bacillus subtilis: 
Multiple enzymes with multiple functions,” Microbiology, vol. 146, no. 2, 
pp. 249–262, 2000. 
[6] W. Weidel and H. Pelzer, “Bagshaped macromolecules -A new outlook on 
bacterial cell walls,” Adv. Enzym. and Related Areas of Mol. Biol., vol. 26, 
1964. 
[7] U. Schwarz, A. Asmus, and H. Frank, “Autolytic enzymes and cell division 
of Escherichia coli,” J. Mol. Biol., vol. 41, no. 3, pp. 419–429, 1969. 
[8] E. W. Goodell and U. Schwarz, “Release of cell wall peptides into culture 
medium by exponentially growing Escherichia coli,” J. Bacteriol., vol. 162, 
no. 1, pp. 391–397, 1985. 
[9] C. Heilmann, M. Hussain, G. Peters, and F. Gotz, “Evidence for autolysin-
mediated primary attachment of Staphylococcus epidermidis to a 
polystyrene surface.,” Mol. Microbiol., vol. 24, no. 5, pp. 1013–1024, 1997. 
[10] C. Jacobs, J. M. Frère, and S. Normark, “Cytosolic intermediates for cell wall 
biosynthesis and degradation control inducible β-lactam resistance in 
gram-negative bacteria,” Cell, vol. 88, no. 6, pp. 823–832, 1997. 
[11] C. Heidrich, M. F. Templin, A. Ursinus, M. Merdanovic, H. Schwarz, and M. 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
119 
 
A. De Pedro, “Involvement of N -acetylmuramyl- L -alanine amidases in cell 
separation and antibiotic-induced autolysis of Escherichia coli,” Mol. 
Micro., vol. 41, pp. 167–178, 2001. 
[12] A. Typas, M. Banzhaf, C. A. Gross, and W. Vollmer, “From the regulation of 
peptidoglycan synthesis to bacterial growth and morphology,” Nat Rev 
Microbiol, vol. 10, no. 2, pp. 123–136, 2012. 
[13] T. J. Wyckoff, J. A. Taylor, and N. R. Salama, “Beyond growth: Novel 
functions for bacterial cell wall hydrolases,” Trends Microbiol., vol. 20, no. 
11, pp. 540–547, 2012. 
[14] E. Frirdich and E. C. Gaynor, “Peptidoglycan hydrolases, bacterial shape, 
and pathogenesis,” Curr. Opin. Microbiol., vol. 16, no. 6, pp. 767–778, 2013. 
[15] S. E. Girardin, I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, 
D. J. Philpott, and P. J. Sansonetti, “Nod2 is a general sensor of 
peptidoglycan through muramyl dipeptide (MDP) detection,” J. Biol. Chem., 
vol. 278, no. 11, pp. 8869–8872, 2003. 
[16] C.-I. Chang, Y. Chelliah, D. Borek, D. Mengin-Lecreulx, and J. Deisenhofer, 
“Structure of tracheal cytotoxin in complex with a heterodimeric pattern-
recognition receptor.,” Science, vol. 311, no. 5768, pp. 1761–4, 2006. 
[17]  A. Bateman and M. Bycroft, “The structure of a LysM domain from E. coli 
membrane-bound lytic murein transglycosylase D (MltD).,” J. Mol. Biol., vol. 
299, no. 4, pp. 1113–1119, 2000. 
[18] J. C. Whisstock and A. M. James, “SH3 domains in prokaryotes,” Trends 
Biochem. Sci., vol. 24, no. 4, pp. 132–133, 1999. 
[19] M. Sugai, H. Komatsuzawa, T. Akiyama, Y. M. Hong, T. Oshida, Y. Miyake, T. 
Yamaguchi, and H. Suginaka, “Identification of endo-beta-N-
acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as 
cluster-dispersing enzymes in Staphylococcus aureus.,” J. Bacteriol., vol. 
177, no. 6, pp. 1491–1496, 1995. 
[20] S. Yamada, M. Sugai, H. Komatsuzawa, S. Nakashima, T. Oshida, A. 
Matsumoto, and H. Suginaka, “An autolysin ring associated with cell 
separation of Staphylococcus aureus,” J. Bacteriol., vol. 178, no. 6, pp. 
1565–1571, 1996. 
[21] T. Baba and O. Schneewind, “Targeting of muralytic enzymes to the cell 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
120 
 
division site of Gram-positive bacteria: Repeat domains direct autolysin to 
the equatorial surface ring of Staphylococcus aureus,” EMBO J., vol. 17, no. 
16, pp. 4639–4646, 1998. 
[22] F. Gotz, C. Heilmann, and T. Stehle, “Functional and structural analysis of 
the major amidase (Atl) in Staphylococcus,” Int. J. Med. Microbiol., vol. 304, 
no. 2, pp. 156–163, 2014. 
[23] N. Hirschhausen, T. Schlesier, M. A. Schmidt, F. Götz, G. Peters, and C. 
Heilmann, “A novel staphylococcal internalization mechanism involves the 
major autolysin Atl and heat shock cognate protein Hsc70 as host cell 
receptor,” Cell. Microbiol., vol. 12, no. 12, pp. 1746–1764, 2010. 
[24] D. G. Pritchard, S. Dong, J. R. Baker, and J. A. Engler, “The bifunctional 
peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30,” 
Microbiology, vol. 150, no. 7, pp. 2079–2087, 2004. 
[25] K. J. Yokoi, N. Kawahigashi, M. Uchida, K. Sugahara, M. Shinohara, K. I. 
Kawasaki, S. Nakamura, A. Taketo, and K. I. Kodaira, “The two-component 
cell lysis genes holWMY and lysWMY of the Staphylococcus warneri M 
phage ϕWMY: Cloning, sequencing, expression, and mutational analysis in 
Escherichia coli,” Gene, vol. 351, pp. 97–108, 2005. 
[26] S. Layec, B. Decaris, and N. Leblond-Bourget, “Characterization of proteins 
belonging to the CHAP-related superfamily within the Firmicutes,” J. Mol. 
Microbiol. Biotechnol., vol. 14, no. 1–3, pp. 31–40, 2007. 
[27] Y. Zou and C. Hou, “Systematic analysis of an amidase domain CHAP in 12 
Staphylococcus aureus genomes and 44 staphylococcal phage genomes,” 
Comput. Biol. Chem., vol. 34, no. 4, pp. 251–257, 2010. 
[28] J. L. Garcia, E. Diaz, A. Romero, and P. Garcia, “Carboxy-terminal deletion 
analysis of the major pneumococcal autolysin,” J. Bacteriol., vol. 176, no. 
13, pp. 4066–4072, 1994. 
[29] J. A. Hermoso, B. Monterroso, A. Albert, B. Galán, O. Ahrazem, P. García, M. 
Martínez-Ripoll, J. L. García, and M. Menéndez, “Structural basis for 
selective recognition of pneumococcal cell wall by modular endolysin from 
phage Cp-1,” Structure, vol. 11, no. 10, pp. 1239–1249, 2003. 
[30] Š. Janeček, B. Svensson, and R. R. B. Russell, “Location of repeat elements 
in glucansucrases of Leuconostoc and Streptococcus species,” FEMS 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
121 
 
Microbiol. Lett., vol. 192, no. 1, pp. 53–57, 2000. 
[31] B. De Las Rivas, J. L. García, R. López, and P. García, “Purification and polar 
localization of pneumococcal LytB, a putative endo-β-N-
acetylglucosaminidase: The chain-dispersing murein hydrolase,” J. 
Bacteriol., vol. 184, no. 18, pp. 4988–5000, 2002. 
[32] R. López, E. García, P. García, and J. L. García, “The pneumococcal cell wall 
degrading enzymes: a modular design to create new lysins?,” Microb. Drug 
Resist., vol. 3, no. 2, pp. 199–211, 1997. 
[33] M. B. Frankel, A. P. A. Hendrickx, D. M. Missiakas, and O. Schneewind, “LytN, 
a murein hydrolase in the cross-wall compartment of Staphylococcus 
aureus, is involved in proper bacterial growth and envelope assembly,” J. 
Biol. Chem., vol. 286, no. 37, pp. 32593–32605, 2011. 
[34] M. B. Frankel and O. Schneewind, “Determinants of murein hydrolase 
targeting to cross-wall of Staphylococcus aureus peptidoglycan,” J. Biol. 
Chem., vol. 287, no. 13, pp. 10460–10471, 2012. 
[35] J. J. Hahn and R. M. Cole, “Streptococcal M Antigen Location and Synthesis, 
Studied By Immunofluorescence,” J. Exp. Med., vol. 118, no. 5, pp. 659–666, 
1963. 
[36] R. M. Cole and J. J. Hahn, “Replication Streptococcus,” no. 5, pp. 722–724. 
[37] J. Kajimura, T. Fujiwara, S. Yamada, Y. Suzawa, T. Nishida, Y. Oyamada, I. 
Hayashi, J. Yamagishi, H. Komatsuzawa, and M. Sugai, “Identification and 
molecular characterization of an N-acetylmuramyl-L-alanine amidase Sle1 
involved in cell separation of Staphylococcus aureus.,” Mol. Microbiol., vol. 
58, no. 4, pp. 1087–1101, 2005. 
[38] C. Heilmann, J. Hartleib, M. S. Hussain, and G. Peters, “The multifunctional 
Staphylococcus aureus autolysin Aaa mediates adherence to immobilized 
fibrinogen and fibronectin,” Infect. Immun., vol. 73, no. 8, pp. 4793–4802, 
2005. 
[39] N. Hirschhausen, T. Schlesier, G. Peters, and C. Heilmann, “Characterization 
of the modular design of the autolysin/adhesin aaa from Staphylococcus 
aureus,” PLoS One, vol. 7, no. 6, 2012. 
[40] L. Ramadurai and R. K. Jayaswal, “Molecular cloning, sequencing, and 
expression of lytM, a unique autolytic gene of Staphylococcus aureus,” J. 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
122 
 
Bacteriol., vol. 179, no. 11, pp. 3625–3631, 1997. 
[41] L. Ramadurai, K. J. Lockwood, M. J. Nadakavukaren, and R. K. Jayaswal, 
“Characterization of a chromosomally encoded glycylglycine 
endopeptidase of Staphylococcus aureus,” Microbiology, vol. 145, no. 4, pp. 
801–808, 1999. 
[42] M. J. J. B. Sibbald, T. Winter, M. M. Van Der Kooi-Pol, G. Buist, E. 
Tsompanidou, T. Bosma, T. Schäfer, K. Ohlsen, M. Hecker, H. Antelmann, S. 
Engelmann, and J. M. Van Dijl, “Synthetic effects of secG and secY2 
mutations on exoproteome biogenesis in Staphylococcus aureus,” J. 
Bacteriol., vol. 192, no. 14, pp. 3788–3800, 2010. 
[43] A. Dreisbach, J. M. Van Dijl, and G. Buist, “The cell surface proteome of 
Staphylococcus aureus,” Proteomics, vol. 11, no. 15, pp. 3154–3168, 2011. 
[44] J. M. Monteiro, P. B. Fernandes, F. Vaz, A. R. Pereira, A. C. Tavares, M. T. 
Ferreira, P. M. Pereira, H. Veiga, E. Kuru, M. S. VanNieuwenhze, Y. V. Brun, 
S. R. Filipe, and M. G. Pinho, “Cell shape dynamics during the staphylococcal 
cell cycle,” Nat. Commun., vol. 6, p. 8055, 2015. 
[45] V. K. Singh, M. R. Carlos, and K. Singh, “Physiological significance of the 
peptidoglycan hydrolase, LytM, in Staphylococcus aureus,” FEMS 
Microbiol. Lett., vol. 311, no. 2, pp. 167–175, 2010. 
[46] S. G. Odintsov, I. Sabala, M. Marcyjaniak, and M. Bochtler, “Latent LytM at 
1.3A resolution,” J. Mol. Biol., vol. 335, no. 3, pp. 775–785, 2004. 
[47] M. Firczuk, A. Mucha, and M. Bochtler, “Crystal structures of active LytM,” 
J. Mol. Biol., vol. 354, no. 3, pp. 578–590, 2005. 
[48] A. Delaune, O. Poupel, A. Mallet, Y. M. Coic, T. Msadek, and S. Dubrac, 
“Peptidoglycan crosslinking relaxation plays an important role in 
staphylococcus aureus walkr-dependent cell viability,” PLoS One, vol. 6, no. 
2, 2011. 
[49] U. Lorenz, K. Ohlsen, H. Karch, M. Hecker, A. Thiede, and J. Hacker, “Human 
antibody response during sepsis against targets expressed by methicillin 
resistant Staphylococcus aureus,” FEMS Immunol. Med. Microbiol., vol. 29, 
no. 2, pp. 145–153, 2000. 
[50] S. R. Clarke, K. J. Brummell, M. J. Horsburgh, P. W. McDowell, S. A. S. 
Mohamad, M. R. Stapleton, J. Acevedo, R. C. Read, N. P. J. Day, S. J. Peacock, 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
123 
 
J. J. Mond, J. F. Kokai-Kun, and S. J. Foster, “Identification of in vivo-
expressed antigens of Staphylococcus aureus and their use in vaccinations 
for protection against nasal carriage.,” J. Infect. Dis., vol. 193, no. 8, pp. 
1098–1108, 2006. 
[51] N. Sakata, S. Terakubo, and T. Mukai, “Subcellular location of the soluble 
lytic transglycosylase homologue in Staphylococcus aureus,” Curr. 
Microbiol., vol. 50, no. 1, pp. 47–51, 2005. 
[52] Z. F. Domain, “Protein Sequence Motifs,” Biol, vol. 148, pp. 107–116, 1992. 
[53] B. W. Dijkstra and A. M. W. H. Thunnissen, “‘Holy’ proteins II: The soluble 
lytic transglycosylase,” Curr. Opin. Struct. Biol., vol. 4, no. 6, pp. 810–813, 
1994. 
[54]  A. R. Mushegian, K. J. Fullner, E. V Koonin, and E. W. Nester, “A family of 
lysozyme-like virulence factors in bacterial pathogens of plants and 
animals.,” Proc. Natl. Acad. Sci. U. S. A., vol. 93, no. July, pp. 7321–7326, 
1996. 
[55] J. V. Hoeltje, D. Mirelman, N. Sharon, and U. Schwarz, “Novel type of murein 
transglycosylase in Escherichia coli,” J. Bacteriol., vol. 124, no. 3, pp. 1067–
1076, 1975. 
[56] W. Keck, F. B. Wientjes, and U. Schwarz, “Comparison of two hydrolytic 
murein transglycosylases of Escherichia coli,” Eur. J. Biochem., vol. 148, no. 
3, pp. 493–497, 1985. 
[57] H. Engel, B. Kazemier, and W. Keck, “Murein-metabolizing enzymes from 
Escherichia coli: Sequence analysis and controlled overexpression of the 
slt gene, which encodes the soluble lytic transglycosylase,” J. Bacteriol., vol. 
173, no. 21, pp. 6773–6782, 1991. 
[58] M. R. Stapleton, M. J. Horsburgh, E. J. Hayhurst, L. Wright, I. M. Jonsson, A. 
Tarkowski, J. F. Kokai-Kun, J. J. Mond, and S. J. Foster, “Characterization of 
IsaA and SceD, two putative lytic transglycosylases of Staphylococcus 
aureus,” J. Bacteriol., vol. 189, no. 20, pp. 7316–7325, 2007. 
[59] N. Sakata and T. Mukai, “Production profile of the soluble lytic 
transglycosylase homologue in Staphylococcus aureus during bacterial 
proliferation,” FEMS Immunol. Med. Microbiol., vol. 49, no. 2, pp. 288–295, 
2007. 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
124 
 
[60] M. Sugai, T. Akiyama, H. Komatsuzawa, Y. Miyake, and H. Suginaka, 
“Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus 
bacteriolytic enzymes by polyacrylamide gel electrophoresis,” J. Bacteriol., 
vol. 172, no. 11, pp. 6494–6498, 1990. 
[61] M. L. Atilano, J. Yates, M. Glittenberg, S. R. Filipe, and P. Ligoxygakis, “Wall 
teichoic acids of staphylococcus aureus limit recognition by the drosophila 
peptidoglycan recognition protein-SA to promote pathogenicity,” PLoS 
Pathog., vol. 7, no. 12, 2011. 
[62] T. Michel, J. M. Reichhart, J. A. Hoffmann, and J. Royet, “Drosophila Toll is 
activated by Gram-positive bacteria through a circulating peptidoglycan 
recognition protein.,” Nature, vol. 414, no. 6865, pp. 756–759, 2001. 
[63] C. I. Chang, S. Pili-Floury, M. Hervé, C. Parquet, Y. Chelliah, B. Lemaitre, D. 
Mengin-Lecreulx, and J. Deisenhofer, “A Drosophila pattern recognition 
receptor contains a peptidoglycan docking groove and unusual L,D-
carboxypeptidase activity,” PLoS Biol., vol. 2, no. 9, 2004. 
[64] B. Lemaitre, J.-M. Reichhart, and J. A. Hoffmann, “Drosophila host defense: 
Differential induction of antimicrobial peptide genes after infection by 
various classes of microorganisms,” Immunology, vol. 94, no. December, 
pp. 14614–14619, 1997. 
[65] M. Rämet, P. Manfruelli, A. Pearson, B. Mathey-Prevot, and R. A. B. 
Ezekowitz, “Functional genomic analysis of phagocytosis and 
identification of a Drosophila receptor for E. coli.,” Nature, vol. 416, no. 
6881, pp. 644–648, 2002. 
[66] M. Gottar, V. Gobert, T. Michel, M. Belvin, G. Duyk, J. a Hoffmann, D. 
Ferrandon, and J. Royet, “The Drosophila immune response against Gram-
negative bacteria is mediated by a peptidoglycan recognition protein.,” 
Nature, vol. 416, no. 6881, pp. 640–644, 2002. 
[67] K.-M. Choe, T. Werner, S. Stöven, D. Hultmark, and K. V Anderson, 
“Requirement for a peptidoglycan recognition protein (PGRP) in Relish 
activation and antibacterial immune responses in Drosophila.,” Science, 
vol. 296, no. 5566, pp. 359–362, 2002. 
[68] K. Traber and R. Novick, “A slipped-mispairing mutation in AgrA of 
laboratory strains and clinical isolates results in delayed activation of agr 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
125 
 
and failure to translate δ- and α-haemolysins,” Mol. Microbiol., vol. 59, no. 
5, pp. 1519–1530, 2006. 
[69] F. Vaz and S. R. Filipe, “Preparation and Analysis of Crude Autolytic Enzyme 
Extracts from Staphylococcus aureus,” Bio-protocol, vol. 5, Iss 24, pp. 1-12, 
2015.  
 [70] J. T. Weadge, J. M. Pfeffer, and A. J. Clarke, “Identification of a new family of 
enzymes with potential O-acetylpeptidoglycan esterase activity in both 
Gram-positive and Gram-negative bacteria.,” BMC Microbiol., vol. 5, p. 49, 
2005. 
[71] J. T. Weadge and A. J. Clarke, “Identification and characterization of O-
acetylpeptidoglycan esterase: A novel enzyme discovered in Neisseria 
gonorrhoeae,” Biochemistry, vol. 45, no. 3, pp. 839–851, 2006. 
[72] J. T. Weadge and A. J. Clarke, “Neisseria gonorrheae O-acetylpeptidoglycan 
esterase, a serine esterase with a Ser-His-Asp catalytic triad,” Biochemistry, 
vol. 46, no. 16, pp. 4932–4941, 2007. 
[73] D. Scheffers and M. Pinho, “Bacterial cell wall synthesis: new insights from 
localization studies,” Microbiol. Mol. Biol. Rev., vol. 69, no. 4, pp. 585–607, 
2005. 
[74] R. Kolter, D. A. Siegele, and  A. Tormo, “The stationary phase of the bacterial 
life cycle.,” Annu. Rev. Microbiol., vol. 47, pp. 855–874, 1993. 
[75] S. R. Filipe, A. Tomasz, and P. Ligoxygakis, “Requirements of peptidoglycan 
structure that allow detection by the Drosophila Toll pathway.,” EMBO 
Rep., vol. 6, no. 4, pp. 327–333, 2005. 
[76] E. R. Haine, Y. Moret, M. T. Siva-jothy, and J. Rolff, “Antimicrobial defence 
and persistent Infection in Insects,” Science., vol. 322, no. November, pp. 
1257–1259, 2008. 
[77] O. Schneewind, A. Fowler, and K. F. Faull, “Structure of the cell wall anchor 
of surface proteins in Staphylococcus aureus.,” Science, vol. 268, no. 5207, 
pp. 103–106, 1995. 
[78] W. Vollmer, “Structural variation in the glycan strands of bacterial 
peptidoglycan,” FEMS Microbiol. Rev., vol. 32, no. 2, pp. 287–306, 2008. 
[79] M. Arnaud, A. Chastanet, and M. De, “New Vector for Efficient Allelic 
Replacement in Naturally Gram-Positive Bacteria New Vector for Efficient 
CHAPTER II. Recognition of peptidoglycan determines efficient antibacterial responses 
 
126 
 
Allelic Replacement in Naturally Gram-Positive Bacteria,” Appl. 
Enviromental Microbiol., vol. 70, no. 11, pp. 6887–6891, 2004. 
[80] L. E. Reddick and N. M. Alto, “Bacteria Fighting Back – How Pathogens 
Target and Subvert the Host Innate Immune System,” Mol Cell, vol. 54, no. 
2, pp. 321–328, 2014. 
[81] P. M. Pereira, H. Veiga, A. M. Jorge, and M. G. Pinho, “Fluorescent reporters 
for studies of cellular localization of proteins in Staphylococcus aureus,” 
Appl. Environ. Microbiol., vol. 76, no. 13, pp. 4346–4353, 2010. 
[82] U. K. Laemmli, “Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4.,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. 
[83] B. P. Matta, B. C. Bitner-Mathé, and M. Alves-Ferreira, “Getting real with 
real-time qPCR: A case study of reference gene selection for morphological 
variation in Drosophila melanogaster wings,” Dev. Genes Evol., vol. 221, no. 
1, pp. 49–57, 2011. 
[84] T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the 
comparative CT method,” Nat. Protoc., vol. 3, no. 6, pp. 1101–1108, 2008. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER III. PGRP-SA and PGRP-LC recognise both Lys and DAP residues of the peptidoglycan in vivo 
 
127 
 
CHAPTER III 
PGRP-SA and PGRP-LC recognise both Lys and 
DAP residues of the peptidoglycan in vivo 
 
 
 
 
 
Contributions to this Chapter: 
Filipa Vaz1,2 designed the experiments, analysed the data and performed 
all of the following experimental procedures: purification and quantification 
of the proteins and peptidoglycans, co-precipitation assays, constructed the 
mutant flies, all the in vivo studies on survivals, CFUs and ex vivo studies on 
haemocytes. 
                                                          
1 Laboratory of Cell Biology, Development and Genetics, Department of 
Biochemistry, University of Oxford, South Parks Rd OX1 3QU Oxford UK.  
2 Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de 
Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, 
Avenida da Republica, 2780-157 Oeiras Portugal. 
 
CHAPTER III. PGRP-SA and PGRP-LC recognise both Lys and DAP residues of the peptidoglycan in vivo 
 
128 
 
Gonçalo Covas2 participated in the optimization of the peptidoglycan 
quantification method, developed the Hemo buffer and constructed the 
recombinant protein mCherry_PGRP-LC. 
Richard Parton1 helped in the microscopy imaging of the mCherry_PGRPs 
binding to live cells and in the development of the time-lapse microscopy 
technique. 
Sergio Filipe2 and Petros Ligoxygakis1 designed the experiments 
and analysed the data. 
 
Acknowledgements:  
Tomasz Czarny and Dr. Eric D. Brown, McMaster University, for the Bacillus 
subtilis strains. 
Dr. Claudine Neyen, Global Health Institute, Swiss Federal Institute of 
Technology, for the GFP-PGRP-LCx flies. 
Teresa Baptista da Silva, ITQB Antonio Xavier-UNL, for technical support. 
David Pinto, Dr. Andrew Jefferson, Dr. Cassandravictoria Innocent and Dr. Ian 
Dobie for technical advice, Micron Oxford Advanced Bioimaging Unit (funded 
from Wellcome Trust Strategic Award no. 091911). 
 
 
 
 
CHAPTER III. PGRP-SA and PGRP-LC recognise both Lys and DAP residues of the peptidoglycan in vivo 
 
129 
 
Summary 
 
 In this Chapter I present data that whilst contradicting the current 
model of bacterial recognition in Drosophila melanogaster, it also helps to 
clarify some literature reports. Some reports were not entirely in 
accordance and others although not conflicting, were not in total 
communion with the model. 
 According to Janeway, as pattern recognition receptors, PGRPs 
should present affinity to several types of peptidoglycan (PGN). Instead, 
the current model is based on the specificity of PGRP-SA and PGRP-LC 
towards Lys- vs. DAP- type PGN, respectively. Why would two major 
immune receptors be limited in the detection of PGN due to the 
discrimination of a single molecule? I performed in vitro studies of PGRP-
SA and PGRP-LC binding to two Gram-positive bacteria that present a Lys 
– Staphylococcus aureus – and a DAP – Bacillus subtilis – residue in their 
PGN. Subsequently, I addressed the biological role of the observed in vitro 
bindings through survival assays by infection of flies mutated in PGRP-SA, 
PGRP-LC and both PGRP-SA/PGRP-LC. In addition, I enquired whether an 
exposed PGN at the cell surface, would turn the bacteria more susceptible 
to recognition by these PGRPs. 
 I propose that the wall teichoic acids (WTA) and the outer 
membrane of Gram-positive and Gram-negative bacteria, respectively, are 
conserved bacterial immune evasion strategies towards the recognition by 
host PGN receptors. In particular, WTA impair recognition of Lys- and 
DAP- type PGN by both PGRP-SA and PGRP-LC, which do not discriminate 
between these two residues. It is the access to the PGN through the cell 
wall and not the specificity of the PGRPs that dictates the recognition and 
downstream triggering of the immune responses. 
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Introduction 
 
In Drosophila, according to the current model of bacterial 
recognition and Host response, the Peptidoglycan Recognition Proteins 
(PGRPs) possess discriminatory ability between DAP- and Lys- type 
peptidoglycan (PGN). It is thought that PGRP-SA, the main receptor of the 
TOLL pathway, in vivo binds exclusively to Lys-type Gram-positive 
bacteria, such as Staphylococcus aureus (Fig. 1) [1], [2]. Likewise, it is 
thought that PGRP-LC, the main receptor of the IMD pathway, specifically 
binds to DAP-type bacteria – Gram-negative and Gram-positive rod shape 
bacteria, such as Escherichia coli and Bacillus subtilis, respectively (Fig. 2) 
[3]–[5]. The observed binding specificity of these two PGRPs, have been 
presented as the reason for the in vivo observation of the differential 
activation of the pathways [6].   
 
PGRPs – the conserved innate immune receptors in Animals 
 
 In 1996, Yoshida and colleagues identified in Bombyx mori that 
the recognition of PGN and fungi β-1,3 glucan happened through 
distinctive specific receptors that converge to activate the 
prophenoloxidase cascade (PPO) cascade [7]. A haemolymph protein with 
high affinity for PGN, devoid of lytic activity thus excluded to be a lysozyme 
protein, was identified as the bacterial receptor. Therefore, they named it 
Peptidoglycan Recognition Protein (PGRP) and soon after proteins with 
such features started to be identified in other animals. Similar to the PPO 
activation in B. mori, 4 years later it was clear that in D. melanogaster both 
Fungi and Bacteria activate the same cascade, the TOLL pathway, albeit 
through different receptors [1]. This happens through the recognition of 
PGN of Gram-positive bacteria by PGRP-SA. It is now known that PGRPs 
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are a family of conserved innate immune receptors present in almost all 
animals from Invertebrates (mollusks, echinoderms and insects) to 
Vertebrates (mammals including Humans) [8]. They have not been 
identified in Plants and lower metazoa, including nematodes such as 
Caenorhabditis elegans. 
 The PGRPs contain a C-terminal conserved homologous domain, 
the PGRP domain. It is responsible for the PGN-binding ability, it is about 
165 amino acids long, it shares ~30% sequence similarity with the 
bacteriophage T7 lysozyme [9] and structural homology to the 
peptidoglycan-binding type 2 amidase domain [8], [10]–[13]. In fact, some 
PGRPs can only be structurally differentiated from type 2 amidases by the 
presence of an N-terminal fragment, absent in the amidases [14]. This 30-
50 amino acids terminus is known as “PGRP-specific fragment” and it is the 
region with highest sequence and conformational variability among all 
PGRPs. The function remains unknown but as it forms a hydrophobic 
groove opposite to the PGN-binding pocket, it is presumed to serve as a 
docking site for effector and signalling molecules [14], such as in the case 
of PGRP-SA – GNBP1 (Fig. 6) [15]–[17]. Almost all PGRPs have two closely 
spaced conserved cysteines in the middle of the domain that form a 
disulphide bond, which is needed for the integrity and activity of PGRPs 
[1]. 
 PGRPs are classified according to function, cellular localization 
and transcript length. Regarding transcript length there are three groups: 
short (S), intermediate (I) (exclusive to mammals) and long (L). It is the 
classification of the transcript length that was used as a nomenclature for 
PGRPs. Hence, PGRP-S, PGRP-I and PGRP-L. For Invertebrate PGRPs this 
nomenclature still stands, but the designation of the Vertebrate PGRPs was 
replaced to PGLYRP by the Human Genome Organization Gene 
Nomenclature Committee: PGLYRP-1, PGLYRP-2, PGLYRP-3 and PGLYRP-
4, equivalent to the PGRP-S, PGRP-L, PGRP-Iα and PGRP-Iβ, respectively. 
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The short PGRPs, PGRP-S and PGLYRP-1, are about 200 amino acids long 
and 18-20 kDa size, have a signal peptide and only one PGRP domain. In 
contrast, most PGRPs –L and –I, are at least twice as large and may have 
more than one PGRP domain and undergo alternative splicing generating 
different isoforms. 
  Functionally, phylogenetic studies divide PGRPs into two 
categories: the ones that retained the amidase activity – the catalytic 
PGRPs – and the ones that lost this activity. Non-amidase Insect PGRPs are 
involved in the trigger of signal transduction pathways and proteolytic 
cascades. Non-amidase Mammalian PGRPs are bactericidal and signalling 
capabilities are not known. They are sub-categorize into two branches 
regarding tissue expression: PGLYRP-1, present in phagocytic granules 
[18] and PGLYRP-3 and PGLYRP-4 that are present on skin and mucous 
membranes [19].  
 Regarding the sub-cellular compartment, PGRPs can be secreted, 
transmembrane or cytoplasmic. Nevertheless, the same PGRP protein can 
show variant forms in all of these compartments. For example, PGRP-LE 
lacks a signal peptide but possesses intracellular and extracellular variants 
(Fig. 2). All mammalian PGLYRPs are both intracellular and secreted.  
 
The TOLL pathway in Drosophila Immunity 
The components of the TOLL pathway were initially identified as 
being involved in early embryonic development in D. melanogaster, 
particularly in the Dorso-Ventral axis [20]. The findings of the genetic 
control during the early developmental stage, rendered C. Nusslein-
Volhard, E. F. Wieschaus and E. B. Lewis the Nobel Prize in Medicine in 
1995. With the unravelling of these genes, it became known the Drosophila 
NF-kB homolog, Dorsal [21] (Fig. 1 and Fig. 5 of Chapter I). Although 
mammalian TLRs seem to have no role in development [22][21]–[23], in 
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Drosophila they are involved both in immunity [24] and developmental 
processes [21]–[23]. The discovery of the Toll receptor (Toll-1) [25] and 
subsequently the function of the TOLL pathway in antifungal response in 
Drosophila [24] was again vital to stablish the similarities and 
conservation of innate immune mechanisms in invertebrates and 
mammals.  The discovery of the toll in innate immunity and the 
mammalian TLRs, earned J. Hoffmann and B. Beutler the Nobel Prize in 
Physiology or Medicine in 2011.  
There are three extracellular cascades that trigger the TOLL 
pathway: Persephone (PSH) which is directly activated by virulence 
factors of Fungi and Gram-positive bacteria [26], [27]; the Gram-
negative binding protein-3 (GNBP3) that recognizes β-glucans 
present in the Fungal cell wall and the PGRP-SA that recognises PGN. 
Next it is described the triggering of the TOLL pathway by bacteria 
through recognition of PGN (Fig. 1).  
Extracellular medium – recognition of the pathogens: 
1. Recognition of PGN by PGRP-SA. 
 Lys-type PGN is mainly recognized by PGRP-SA which stablishes 
a complex with GNBP1. Also, PGRP-SD is a receptor with partial 
redundancy to the PGRP-SA–GNBP1 complex [28], [29]. It appears that 
PGRP-SD can also recognize DAP-type PGN from Gram-negative bacteria 
[30]. GNBP1 showed endomuramidase activity and in low cross-linked 
Lys-type PGN, it was proposed to produce new glycan reducing ends that 
are presented to PGRP-SA [29], [31]. In contrast, it has been suggested that 
full-length GNBP1 has no enzymatic activity [32], but the functionality of 
the recombinant GNBP1 was not determined. 
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Figure 1. Schematic summary of the activation of the TOLL pathway by PGN 
recognition. Unlike its mammalian counterpart, the Drosophila Toll receptor does not 
interact directly with the PAMP, rather the PAMP is recognised by secreted receptors. 
PGRP-SA is the main receptor for bacterial recognition of the TOLL pathway. In 
contrast to IMD, the intracellular steps of the TOLL cascade are yet to be better 
understood.  
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2. Activation of the modular serine protease ModSP. 
 The complex PGN – PGRP-SA – GNBP1 activates ModSP, a 
modular Serine protease conserved in insect immune reactions. ModSP is 
the first non-receptor of the cascade. It integrates the signals both from the 
PGN recognition by PGRP-SA and from GNBP3 sensing of Fungi [32]. 
3. Activation of Grass and serine proteases. 
The ModSP serine protease activity acts upon Grass which 
activates a set of 4 serine proteases: Sphinx1, Sphinx2, Spirit and Spheroid 
[26], [32], [33]. 
4. Activation of the Spatzle processing enzyme (SPE). 
 The activity of the serine proteases activates SPE so that it will 
cleave its substrate, the full length Spatzle [34], which in turn will interact 
with the Toll (Toll-1) receptor. SPE is the point where pathogen 
recognition information is integrated via the three different recognition 
pathways that can activate the TOLL cascade: PSH cascade together with 
the Fungal and Bacterial recognition that already converged in the 
upstream step at ModSP.  
5. Activation of Spatzle. 
 Spatzle (Spz) is synthesized and secreted as an inactive 
precursor consisting of a pro-domain and a C-terminal region (C-106). In 
non-signalling conditions, the pro-domain masks the hydrophobic C-106 
region. SPE cleavage of the pro-domain of Spz, induces conformational 
changes and exposes the C-106 regions that are critical for binding to Toll 
[35]. Still, the pro-domain remains associated with the C-terminus until 
binding to Toll [36]. 
 
Extracellular-membrane interface – activation of the Toll receptor: 
6. Binding of Spz to a dimeric Toll receptor. 
 The binding of 2 Spz dimers via C-106 to the extracellular N-
terminus of 2 Toll receptors, triggers a conformational change in the Tolls 
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that activate intracellular downstream signalling. Unlike mammalian 
TLRs, Toll receptor does not interact directly with PAMPs [37].  
 
Intracellular-cytoplasmic medium – activation of the non-active TFs: 
7. Formation of heterotrimeric complexes Toll-adaptor proteins. 
 Endocytosis is paramount for efficient Toll signalling [38]. Upon 
activation of the Toll, there is recruitment of the adaptor proteins: Myd88, 
Tube and the kinase Pelle. Thus, it is formed a heterotrimeric complex 
between the TIR intracellular domains of Toll and the death domains (DD) 
of the adaptor proteins, where Tube is flanked by Myd88 and Pelle [39]–
[41] [41]–[43]. As such, MyD88 and Pelle do not come into contact with 
each other. Instead, two distinct DD of Tube separately bind MyD88 and 
Pelle [41].  
8. Activation of Cactus. 
 From the oligomeric Toll-MyD88-Tube-Pelle complex, the signal 
proceeds to the phosphorylation and degradation of the IkB Cactus. The 
nuclear translocation of both Dorsal and Dif (Dorsal-related immunity 
factor) requires Cactus degradation [44] which is thought to happen 
through phosphorylation by Pelle [45]. 
9. Activation of Dorsal and Dif. 
 After Cactus degradation, it is thought that Dorsal (and/or Dif) 
interacts with Pelle, Tube, and Cactus [46]–[48] and upon activation 
translocate to the nucleus. 
 
Intracellular-nucleus compartment – expression of the AMPs: 
10. Induction of the expression of AMPs. 
 Dorsal and Dif bind to the NF-kB sequences present in the 
promoter region of the Toll-dependent antimicrobial peptides (AMPs), 
thus inducing their transcription [49]. The antifungal peptide Drosomycin 
seems to be the major AMP of the Toll humoral response. Dif was identified 
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in Drosophila as a dorsal-related immune responsive gene that does not 
participate in Dorso-Ventral patterning. Dif mediates TOLL-dependent 
AMPs expression both in larvae and adults [50], [51] whereas Dorsal 
seems be active only in larvae [69].  
 
The IMD pathway in systemic responses 
 
The IMD pathway has major roles in gut immunity. In contrast to 
TOLL, IMD is exclusively triggered by PGN via both extracellular and 
intracellular sensing, particularly by the DAP-type PGN of Gram-negative 
bacteria and Gram-positive Bacilli (Fig. 8) [113]. 
 
Extracellular-membrane interface – recognition of DAP-type bacteria: 
1. PGRP-LC and PGRP-LE recognize DAP-type PGN. 
 DAP-type PGN is mainly recognised by the isoforms of the 
transmembrane type II receptor PGRP-LC through their extracellular 
PGRP domains [5]. This recognition can happen with the aid of 
extracellular PGRP-LE composed only by the PGRP domain [52]. In 
addition, PGRP-LE is also involved in intracellular recognition of DAP-type 
PGN. More recently, it has been shown that PGRP-SD activates the IMD 
pathway and it presents PGN to PGRP-LC [53]. 
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Figure 2. Schematic summary of the activation of the IMD pathway. PGRP-LC is the 
main receptor of the IMD pathway, which unlike PGRP-SA is a transmembrane protein. 
PGRP-LE functions as an extracellular receptor and interacts with PGRP-LC to trigger 
the cascade.  
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Intracellular-cytoplasmic medium – activation of the non-active TFs: 
2. Recruitment of the cytoplasmic protein Imd. 
 Intracellular signalling happens through the RHIM-like motifs3 
found both in PGRP-LC and -LE [52], [54] that mediate binding to the 
receptor Death domain containing protein Imd, homologous to 
mammalian RIP1 (Fig. 5, Chapter I) [55]. Subsequently, Imd associates 
with Drosophila FADD4 via a homotypic death-domain interaction [56]. 
FADD then recruits and interacts via the DD with the homologue of 
mammalian caspase-8, DREDD5 [57]–[59].  
3. Activation of Imd. 
 DREDD is present in the cytoplasm in its non-active form. 
Activation of DREDD happens through ubiquitination by the dIAP-26. 
Ubiquitinated DREDD cleaves and removes a fragment of 30 amino acids 
at the N`-terminal of Imd. This cleavage exposes a binding site in Imd for 
dIAP-2 [60]. Subsequently, the cleaved form of Imd is the substrate for 
dIAP-2 ubiquitination through its RING domain7. The 30 amino acid free 
ubiquitinated Imd is the scaffold for the recruitment of the next 
downstream components [61]. 
4. Activation of Relish. 
 In the last steps of the cytoplasmic cascade, upon activation of 
Imd, there is the recruitment of TAK18 and its adaptor TAB29 [62]. It is 
thought that TAK1 triggers activation of the IKK complex (Kenny and Ird5). 
Activated IKK will then phosphorylate the NF-kB transcription factors 
Relish [63]. Phosphorylation of Relish is key to enhance/activate its role as 
                                                          
3 Receptor-interacting protein (RIP) homotypic interaction domain. 
4 The Drosophila homologue of FAS-associated death-domain protein. 
5 Apical caspase death-related Ced-3/Nedd2-like protein. 
6 Drosophila Inhibitor of apoptosis-2. 
7 Zinc finger domain involved in mediating protein-protein interactions. 
8 Transforming growth factor -β (TGFβ)- activated kinase 1. 
9 TAK1-associated binding protein 2. 
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a transcription factors [63]. However, the full-length Relish does not 
translocate to the nucleus. Independently of IKK phosphorylation, Relish 
must be cleaved into two forms by DREDD. Thus, DREDD cleaves Relish at 
multiple N-terminal sites splitting into Rel-49 ankyrin repeat fragment 
that remains cytoplasmic and Rel-68 where the NF-kB part resides 
[63][64].  
 
Intracellular-nucleus compartment – expression of the AMPs: 
5. Induction the expression of AMPs by Rel-68. 
 Phosphorylated Rel-68 translocate into the nucleus, binds to the 
DNA NF-kB sequences and induces the expression of the AMPs. Diptericin 
is the main AMP that is expressed through the IMD pathway. 
 
The bacterial recognition model 
 
In 1997, Lemaitre and colleagues [6] published a study regarding 
the induction of AMPs upon infection of adult flies with live cells of both 
Gram-positive and Gram-negative bacteria. They observed a preferential 
induction of the IMD-dependent AMPs with Gram-negative bacteria and 
DAP-type PGN Gram-positive Bacilli. The Toll-dependent AMPs showed a 
higher expression with Lys-type PGN Gram-positive bacteria.  
In 2001, Michel and colleagues [1] showed that the activation of 
the TOLL pathway by bacteria and fungi happens through distinct 
recognition processes, whereby bacterial recognition is dependent on the 
haemolymph circulating protein PGRP-SA. PGRP-SA semmelweis mutant 
flies showed to be highly susceptible to infection by Gram-positive bacteria 
DAP-type PGN Bacillus megaterium and Lys-type PGN Streptococcus 
faecalis. In contrast, upon infection by Gram-negative bacteria, these 
mutants were not susceptible to E. coli and only a small percent of the 
population succumbed with Erwinia carotovora carotovora.  
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A year later in 2002, three publications reported the role of PGRP-
LC as a pattern recognition receptor of the IMD pathway that recognises 
Gram-negative bacteria. Ramet and colleagues [3] identified PGRP-LC as a 
cell surface receptor specifically involved in Gram-negative bacteria 
phagocytosis and induction of AMP synthesis. Gottar and colleagues [4], 
identified PGRP-LC as a component of the IMD pathway acting upstream 
of Imd, whose mutant flies showed reduced survival to Gram-negative 
infections but not to Gram-positive or fungal infections. Choe et al. 2002 
[5], identified PGRP-LC (PGRP-LCx) as an absolutely required receptor for 
the induction of AMPs mediated by Relish. However, conflicting to some 
extent with the previous reports, TOLL-dependent AMPs also failed to be 
expressed to normal levels in the PGRP-LCx mutants when infected with E. 
coli. In addition, these mutants, in contrast to the wild-type flies, 6h post-
infection (p.i.), showed no detectable induction of Diptericin with the 
Gram-positives Micrococcus luteus and Bacillus subtilis and the Gram-
negative Enterobacter cloacae. 
In 2003, Leulier and colleagues [65] reported that DAP-type PGN 
is the most potent inducer of IMD and Lys-type PGN of the TOLL pathway. 
Consequently, the authors proposed that the ability of Drosophila to 
discriminate between Gram-positive and Gram-negative bacteria relies in 
the recognition of specific forms of PGN regarding the residue at the third 
position of the stem peptide.   
Finally in 2004, four publications helped to finally shape and support 
the current model of DAP- vs. Lys- type PGN discrimination by PGRP-LC 
and PGRP-SA and that this discriminatory ability is the reason behind the 
observed preferential activation of IMD vs. TOLL pathways for Gram-
negative and Gram-positive DAP-type PGN bacteria vs. Gram-positive Lys-
type PGN bacteria, respectively. Stenbak and colleagues [66], reported that 
the two structural features of Gram-negative PGN – the presence of DAP 
and the 1,6 - anhydro form of the terminal N-acetylmuramic acid (MurNAc) 
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residue of the glycan chain – allow PGN discrimination between Gram-
negative and Gram-positive bacteria. Moreover, they concluded that the 
IMD pathway is activated by Gram-negative PGN but not by Lys-type PGN. 
Kaneko et al. 2004 [67] corroborated these results as they concluded that 
the stem peptide of the Gram-negative PGN is sufficient to activate the IMD 
pathway. Moreover, they also observed that the recognition of monomeric 
PGN requires different PGRP-LC isoforms, as they showed that upon 
recognition of tracheal cytotoxin (TCT), PGRP-LCx interacts with PGRP-
LCa. Finally, two crystal structures of PGRP-SA were published. Chang and 
colleagues [2] showed PGN co-precipitation assays using 20 mM Tris-HCl 
pH 7.8; 300 mM NaCl buffer with recombinant PGRP-SA expressed in 
insect cell lines. They observed that the rPGRP-SA bound to the DAP-type 
PGN of the Gram-negative bacteria E. coli and Pseudomonas aeruginosa. 
These results suggest that Michel and colleagues observation of a PGRP-
SA-independent response upon infection with whole live E. coli cells is not 
related to the inability of PGRP-SA to bind to DAP-type PGN [4]. In addition, 
they observed that rPGRP-SA bound to Lys-type PGN bacteria M. luteus and 
S. faecalis but binding to the Gram-positive amidated DAP-type PGN B. 
subtilis and non-amidated DAP-type PGN B. megaterium was undetectable. 
Overall, these results corroborate Leulier et al. 2003 [65]. As for the 
presented rPGRP-SA crystal structure, it was analysed by superimposition 
with the PGRP-LB structure [14]. They concluded that PGRP-SA possesses 
a weak hydrolytic activity towards DAP-type PGN of E. coli characterised 
as an L,D-carboxypeptidase. Reiser and colleagues [68] also proposed a 
PGRP-SA crystal structure. They did not predict an L,D-carboxypeptidase 
activity, however they suggest that PGRP-SA might possess a lytic activity 
belonging to the serine proteases family. 
In 2005, Filipe and colleagues [31] identified that the minimal 
structure needed to activate the TOLL pathway is a muropeptide dimer 
with a free reducing end of the MurNAc residue. Similar to Leulier et al. 
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2003 [65] for the induction of the IMD pathway by DAP-type PGN, 
muramidase treated PGN from M. luteus and S. aureus did not induce the 
TOLL pathway. 
Interestingly, Mellroth et al. 2005 [69] provided very conflicting 
results from in vitro PGN-PGRP co-precipitation assays. They showed that 
PGRP-LCx and also PGRP-SA to some extent, were promiscuous to DAP-, 
Ornithine- and Lys-type PGNs. Nevertheless, in 2006, more support to the 
model of PGN discrimination by PGRPs was added by Chang et al. 2006 
[70] and Swaminathan et al. 2006 [71]. Chang and colleagues [70] 
published the crystal structure of the complex TCT-PGRP-LCx-PGRP-LCa. 
This report was again vital to corroborate the current model of bacterial 
recognition by PGRPs as it reported again the specificity of PGRP-LC for the 
DAP residues. Swaminathan et al. 2006 [71], by using PGN analogues and 
TCT determined the binding constants of Human and Drosophila PGRPs. 
They concluded that PGRPs use dual strategies to discriminate PGN: 1) by 
the composition of PGN stem peptide and 2) by the composition of peptide 
cross-bridge. 
Finally, in 2008 Leone and colleagues [30] published the crystal 
structure of rPGRP-SD and again favoured the model of DAP- vs. Lys- type 
PGN discrimination by PGRPs. The pull down assays failed to detect 
binding of PGRP-SA to DAP-type PGN of B. subtilis corroborating Chang et 
al. 2004 [2]. 
 
A “small step” towards a new bacterial recognition model 
 
Although the model of bacterial recognition is well stablished, 
there are still some conflicting results in the literature. As a PRR, a major 
PGRP should, theoretically, be able to identify a specific bacterial 
component in a broad range of different bacteria. Thus, the model of PGRPs 
specificity and discrimination of the stem peptide, the most variable region 
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of the PGN molecule, conflicts with this idea. 
In order to understand the specificities of PGRP-SA and PGRP-LC 
to the PGN, I worked with S. aureus and B. subtilis as bacterial models.  As 
Gram-positive bacteria they present a similar cell wall (CW) composition 
whilst harbouring distinct PGN types regarding the peptide moiety, Lys- 
and amiDAP (amidated DAP)- type PGN, respectively.  
Bacteria present numerous strategies that allow them to survive 
inside the host, to stablish an infection and cause disease. The microbial 
cell surface is the interface between the Host and the pathogen, thus it is 
where we find major virulence components and factors of immune 
evasion. The virulence factors are compounds produced by the bacteria 
that aid directly to their pathogenicity and generally cause damage or 
alteration of the normal physiology and function of the host cells. The 
microbial factors of immune evasion involve strategies that subvert the 
role of immune components. As such, these are generally components that 
hide the pathogen from immune receptors, harvest the function of an 
immune cell or signalling cascade and/or also cause destruction of the 
immune cells. These strategies are commonly shared by bacteria and the 
effect is transversal to different Hosts. Accordingly, the Host groups have 
identified two different bacterial CW factors that are immune evasion 
mechanisms: the Wall Teichoic Acids (WTA) [72] and the major autolysin 
Atl [73]. Both through different mechanisms, impair the recognition of 
PGN by PGRP-SA. The absence of these components translates into loss of 
virulence by the bacteria. Genetic knock-out mutants of WTA in S. aureus 
and B. subtilis [74], [75], have the PGN exposed at the cell surface (Fig. 3).  
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Figure 3. Schematic representation of the cell wall of a Gram-positive wild-type vs. 
a WTA mutant bacteria. The tagO gene encodes the first enzyme of the biosynthetic 
pathway of the WTA. Thus, in the genetic knock-down mutant strains S. aureus Δ tagO 
(NCTC 8325-4 Δ tagO) [74] and B. subtilis Δ tagO (EB6 Δ tagO) [75], the PGN is 
substantially more exposed and directly accessible/vulnerable to the Host immune 
receptors. 
Using these bacterial mutants, I studied the recognition of PGRP-
SA and PGRP-LC and the effect of these polymers in shielding the different 
PGNs from both PGRPs. To study the binding abilities of the PGRPs, 
recombinant non- and fluorescently- tagged PGRP-SA and the PGRP 
ectodomain of PGRP-LCx were used in co-precipitation assays. These 
assays were performed using either live bacterial cells or purified PGN, 
which was quantified and adjusted to the same number of moles of 
MurNAc. Moreover, the assays were conducted in the Haemolymph buffer 
(Hemo buffer, Materials and Methods section), a buffer with a composition 
is closer to the haemolymph than the buffers regularly used in in vitro 
experiments. To address the biological significance of the in vitro data, I 
constructed PGRP-SA, PGRP-LC and PGRP-SA/PGRP-LC mutant flies in a 
similar genetic background and followed their survival upon septic 
infection. 
 
 
 
CHAPTER III. PGRP-SA and PGRP-LC recognise both Lys and DAP residues of the peptidoglycan in vivo 
 
146 
 
Results 
 
PGRP -SA and -LC bind to live cells of both WTA mutants. 
As previously reported, mCherry_PGRP-SA binding to S. aureus 
cells is only detected when WTA are absent (Fig. 4A) [72]. Unexpectedly, it 
was observed that mCherry_PGRP-SA can bind to the B. subtilis Δ tagO 
mutant cells.  Also contradicting most of the literature, mCherry_PGRP-LC 
is able to bind to S. aureus Δ tagO cells (Fig 4B).  
When carefully looked at, although the PGRPs bind to the whole 
surface of the Δ tagO mutants, it appears that some regions present more 
bound PGRP than others. This may be due to a higher concentration of PGN 
in those regions and/or the presence of forms of PGN that are more easily 
bound by the PGRPs.  
Figure 5 shows the expression of a fluorescently tagged version of 
the native form of PGRP-LCx [76] expressed in haemocytes infected with 
bacteria. These results corroborate the results of the in vitro assay with 
mCherry_PGRP-LC. In addition, GFP-PGRP-LCx can bind to both wild-type 
and mutant cells of both S. aureus and B. subtilis. 
The data suggest that PGRP-SA and PGRP-LC are promiscuous 
towards the third residue of the PGN peptide moiety. Although the binding 
of PGRP-SA to the DAP-type PGN has been reported, it has not been 
detected for the B. subtilis PGN. Thus, although the current model does 
reckon some promiscuity of PGRP-SA, it imposes that this binding is not 
important in vivo for the host survival and that the modification of the DAP 
residue into amiDAP, affects the stability of the binding of the protein to 
the PGN [2], [30], [68]. Regarding PGRP-LC, it is not considerate to be as 
promiscuous as PGRP-SA, although in vitro assays have shown such 
promiscuity [69].  
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A.
 
 
Figure 4. Co-precipitation of live cells with mCherry_PGRP-SA and mCherry_PGRP-
LC. Cultures in early exponential phase of the parental and Δ tagO mutants of both S. 
aureus and B. subtilis were incubated in Hemo Buffer with equal concentrations of 
either mCherry_PGRP-SA (Panel A) or mCherry_PGRP-LC (Panel B).  
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B.
 
 
Figure 4. Co-precipitation of live cells with mCherry_PGRP-SA and mCherry_PGRP-
LC. The protein bound to the cells was pulled down with them and the binding was 
visualised by microscopy. Because of the clustering of the Δ tagO mutants, it was not 
possible to properly quantify the signals. Scale intensities were adjusted to equalise S. 
aureus Δ tagO – mCherry_PGRP-SA. 
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Figure 5. GFP-PGRP-LCx binding to live bacterial cells. Haemocytes expressing GFP-
PGRP-LCx were extracted from third-instar larvae and kept in Schneider media 
supplemented with Fetal Calf Serum. After adherence to the glass slide, they were 
infected with the bacteria. It is presented snapshots of the interaction of the 
haemocytes and the bacteria, that was monitored for 12h every 15min acquisition. 
GFP-PGRP-LCx can be found at the lamellipodia, at the cytoplasm and in the outside 
environment.  
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PGRP-SA and PGRP-LC bind to both Lys- and DAP- type PGN.    
The PGN from the wild-type and mutant Δ tagO cells of both S. 
aureus and B. subtilis was purified and quantified to conduct co-
precipitation assays with non-fluorescent forms of the rPGRPs. The assays 
using the very non-physiological Tris-NaCl buffer showed no detection of 
rPGRP-SA binding to B. subtilis PGN, as previously reported [2], [30] (Fig. 
6A). As the buffer compositions got more similar to the physiological 
conditions – PBS 1X pH 6.0 and Hemo Buffer – not only did the PGRPs show 
a higher affinity for the substrate but only then it was detected binding of 
rPGRP-SA to the amiDAP-PGN of B. subtilis. Under conditions similar to the 
haemolymph, rPGRP-SA and rPGRP-LC showed similar binding to the S. 
aureus Lys-type PGN (Fig. 6B). Regarding the binding to the B. subtilis DAP-
type PGN, co-precipitation of rPGRP-SA-PGN occurs at ca. 4x106 while 
rPGRP-LC-PGN at 6x106. This higher binding of PGRP-LC might not be due 
to a preference to the DAP-residue towards Lys. Instead, it may have to do 
with the inherent differences of the glycan chains as it has been shown that 
the MurNAc residue seems to be paramount for PGRPs recognition and 
trigger of the immune cascades [65], [66]. Accordingly to what the Host 
groups had previously observed [72], a decreased cross-linking in S. 
aureus Δ tagO did not affect the binding affinity to rPGRP-SA (nor to rPGRP-
LC) (Fig. 6B). In fact, the S. aureus Δ tagO PGN appears to have different 
physical-chemical characteristics: this PGN presents itself as a suspension 
of several insoluble small PGN clusters that do not compact as tightly as 
the other PGN suspensions.  Thus it is harder to settle down, it forms a not 
so well compact pellet and as a consequence it is easier to be (accidently) 
aspirated with the supernatant throughout the procedure.  
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B. 
 
Figure 6. Co-precipitation of PGN with rPGRP-SA and rPGRP-LC. PGN suspensions 
previously adjusted to the same number of moles of MurNAc were incubated with 
equal concentrations of either rPGRP-SA or rPGRP-LC. PGN is insoluble in an aqueous 
solution hence the amount of protein that binds is pulled down with it. Each assay was 
repeated in two different days and the bars represent the mean with standard 
deviation. Panel A. shows the rPGRPs binding to the wild-type S. aureus and B. subtilis 
PGNs, using different buffers. The results from the Tris-NaCl buffer corroborate the 
previously reported non-binding affinity of PGRP-SA to B. subtilis PGN [2], [30]. 
However, when approaching more biological conditions the binding affinity for the 
PGNs increased and it was detected the binding of PGRP-SA to B. subtilis. Panel B. 
shows pull down assays of the rPGRPs in Hemo Buffer with PGNs from the parental 
and the Δ tagO strains. There seems to be no preference for a Δ tagO-PGN compared 
to the respective wild-type PGN.  
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PGRP -SA and -LC are important against infection by Lys- and 
DAP- type PGN bacteria in the Host. 
In order to address the importance of PGRP-SA and PGRP-LC 
against infection by S. aureus and B. subtilis, I constructed a double mutant 
deficient in both proteins. The semmelweis flies express a non-functional 
form of PGRP-SA and are highly susceptible to infection by Gram-positive 
bacteria [1].  PGRP-SAseml possesses a single substitution of the cysteine 
(Cys) at the position 54 (of the protein without the signal peptide) by a 
tyrosine. As a consequence, there is disruption of the disulphide bridge 
occurring between Cys48 and Cys54 [1], [2]. PGRP-LCΔE12 are flies that do 
not express PGRP-LC due to a deletion of the entire coding region and are 
compromised against infection by Gram-negative bacteria [4]. The 
semmelweis flies and the PGRP-LCΔE12 flies were used to construct a double 
mutant semmelweis/PGRP-LCΔE12 and the correspondent single 
semmelweis and PGRP-LCΔE12 mutants. To further assess the importance of 
these receptors, the heterozygous flies of each mutant were also used for 
in vivo studies as controls, since they share a more similar genetic 
background than any wild-type Fly.  
Cultures in the stationary growth phase were injected in the flies 
that were kept at 25ºC and monitored for 72h, every 12h. Infection with S. 
aureus and B. subtilis wild-type bacteria indeed confirm the importance of 
PGRP-SA and PGRP-LC, respectively (Fig. 7 and Fig. 9). However, 
contradicting the previous studies, it was observed that PGRP-SA and 
PGRP-LC are both important upon infection by both bacteria. For any of 
the four bacteria injected, the homozygous double mutant 
semmelweis/PGRP-LCΔE12 was more susceptible than all the other mutant 
backgrounds tested (Fig. 7-11).  
Figure 7 presents the survival data and CFUs/Fly upon infection 
with B. subtilis wild-type cells. The heterozygous double mutant was more 
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susceptible than the heterozygous single mutants (Fig. 7A). Similarly, the 
homozygous double mutant was more susceptible than the single mutants 
(Fig. 7B) and the double heterozygote (Fig. 7C). The B. subtilis Δ tagO 
mutant showed drastic loss of virulence since only the homozygote double 
mutant was susceptible to infection (Fig. 8). Figures 9 and 10 show the 
survival curves for S. aureus and S. aureus Δ tagO, respectively. Again, the 
double mutant is more susceptible to infection than any of the other 
mutant flies. 
Regarding the importance of PGRP-LC, upon infection with both B. 
subtilis and S. aureus, it was not observed significant differences between 
the heterozygous and homozygous PGRP-LCΔE12 flies (Fig. 7C and 9C). 
However, when the WTA are absent the role of PGRP-LC was evident. The 
PGRP-LCΔE12 homozygous flies were more susceptible to S. aureus Δ tagO 
than the correspondent heterozygous flies (Fig. 10C).  
The role of PGRP-SA is evident upon infection with either B. subtilis 
and S. aureus parental strains, since the lack of the two copies of the PGRP-
SAWT gene proved to be more susceptible than the presence of only one 
copy (Fig. 7C and 9C). 
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Figure 7. Survival data for B. subtilis. Panel A. Survival curves of the heterozygotes. 
The heterozygous double mutant was more susceptible than the heterozygotes 
semmelweis and PGRP-LCΔE12 that were indistinguishable.  Panel B. Survival curves of 
the homozygotes. The double mutant homozygous was more susceptible than 
semmelweis and PGRP-LCΔE12, however semmelweis was more susceptible than PGRP-
LCΔE12. Panel C. Survival curves of the heterozygotes and homozygotes. The double 
homozygote was more susceptible than any of the heterozygotes and single 
homozygotes, hence both PGRPs are important against infection. Panel D. 
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Log10CFUS/Fly at 0h, 24h and 36h p.i.. In accordance to the survival probability data, 
B. subtilis bacteria were able to grow inside the flies regardless of the genotype, 
without detectable differences in the bacterial load between each genotype. 
A.
 
B.
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Figure 8. Survival curves for B. subtilis Δ tagO infections. Panel A. Survival curves of 
the heterozygotes. Panel B. Survival curves of the homozygotes. Panel C. Survival 
curves of the heterozygotes and homozygotes. Only the homozygous double mutant 
semmelweis/PGRP-LCΔE12 was susceptible to infection. Panel D. Log10CFUS/Fly at 0h, 
24h and 36h p.i.. The heterozygous flies semmelweis and semmelweis/PGRP-LCΔE12 
showed a reduction of CFUs in contrast to the homozygotes whilst PGRP-LCΔE12 
homozygotes were able to control the CFUs levels, similar to the heterozygote. 
CHAPTER III. PGRP-SA and PGRP-LC recognise both Lys and DAP residues of the peptidoglycan in vivo 
 
159 
 
A.
 
B.
 
CHAPTER III. PGRP-SA and PGRP-LC recognise both Lys and DAP residues of the peptidoglycan in vivo 
 
160 
 
C.
 
D.
 
Figure 9. Survival curves for S. aureus infections. Panel A. Survival curves of the 
heterozygotes. Panel B. Survival curves of the homozygotes. Panel C. Survival curves 
of the heterozygotes and homozygotes. Panel D. Log10CFUs/Fly at 0h, 24h and 36h p.i.. 
PGRP-LCΔE12 heterozygous flies were more resistant to infection than both 
semmelweis and semmelweis/PGRP-LCΔE12 heterozygous, which were 
indistinguishable. However, the double heterozygote succumbed earlier than 
semmelweis heterozygotes, hence it suggests the importance of PGRP-LC. 
Accordingly, the double homozygous mutant is more susceptible than both single 
mutants, although PGRP-LCΔE12 is more resistant than semmelweis. S. aureus is able to 
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grow in the flies regardless of the genotype, without detectable differences in the 
bacterial load. 
A. 
 
B.
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Figure 10. Survival curves for S. aureus Δ tagO infections. Panel A. Survival curves of 
the heterozygotes. PGRP-LCΔE12 heterozygous was more resistant than semmelweis 
and semmelweis/PGRP-LCΔE12 heterozygous that were equally susceptible. Panel B. 
Survival curves of the homozygotes. To reveal the importance of PGRP-LC both copies 
of the gene must be removed. The double homozygous mutant was more susceptible 
than the single mutants. Panel C. Survival curves of the heterozygotes and 
homozygotes. Panel D. Log10CFUs/Fly at 0h, 24h and 36h p.i.. S. aureus Δ tagO was 
able to grow inside the Hosts and although the bacterial load was higher in the 
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homozygotes than the respective heterozygotes, significant differences were only 
seen at 36h for semmelweis heterozygous vs. semmelweis homozygous. 
 
Figure 11 presents the survival curves in the double mutant 
semmelweis/PGRP-LCΔE12 background for the B. subtilis and S. aureus wild-
type and Δ tagO strains. The WTA mutants were less virulent than the 
parental strains and it corroborates the previous findings on the stereo-
hindrance effect of the WTA in concealing the S. aureus PGN from PGRP-SA 
[72].  
When injected with PBS, the flies did not succumb and remained 
healthy (Fig. 12), similar to the injection of the mutant B. subtilis Δ tagO, 
(apart from infection the homozygous semmelweis/PGRP-LCΔE12 mutant). 
Finally, Table 1 presents a summary of the results regarding the 
statistical analysis between the survivals of the infected flies. 
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Figure 11.  Survival curves of semmelweis/PGRP-LCΔE12 flies. The graphic at the top 
shows the plot of the survival curves for the B. subtilis strains and bellow for the S. 
aureus strains. The WTA mutants were less virulent than the parental strains, 
P<0.0001 for B. subtilis vs B. subtilis Δ tagO and P=0.0086 for S. aureus vs S. aureus Δ 
tagO. 
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Figure 12.  Survival curves upon PBS injection. The PBS injected/infection came from 
the same solution batch used to prepare the bacterial cells for infections. Thus, the 
survivals show that not only were the flies healthy but also that the PBS solution used 
was sterile and the volume injected did not affect the survival of the flies.  
 
Table 1. Summary of the statistical analysis of the survival data. 
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Discussion 
 
 The data here presented shows that both PGRP-SA and PGRP-LC 
are promiscuous for Lys- and DAP- type PGN and that both PGRPs detect 
the bacteria and contribute to survival of the host. Thus, this implies that 
it is not the peptide moiety of the PGN that determines PGRPs recognition. 
Rather, it is the accessibility through the WTA layer in the CW. This data is 
conflicting with the current model of bacterial PGN detection in the Fly. 
Leulier and colleagues [65] were the firsts to study the in vivo effect of 
the injection of PGN on the expression of the AMPs in Drosophila. However, 
due to the procedure used for PGN purification, one can conclude that the 
activation of the IMD pathway by DAP-type PGN has been well 
characterized but the same might not be the case for the Lys-type PGN. The 
procedure to obtain pure PGN from Gram-negative and Gram-positive 
bacteria is dependent on the different CW compositions [77]. The first step 
of PGN purification is the boiling of the cells in an SDS solution. This step 
is common to both Gram-negative and Gram-positive bacteria. In Gram-
negative bacteria, the SDS removes the outer membrane (OM), hence what 
is harvested is the PGN with (little) proteins attached. Thus, after 
treatment with Trypsin, DNase and RNase it is obtained pure PGN polymer. 
For purification of the Gram-positive PGN, three more steps need to be 
added to this procedure: 1) mechanical break of the cells so that the trypsin 
and the nucleases can pass through the PGN layer; 2) treatment with 
different solvents to remove non-covalently material attached to the PGN 
and 3) incubation with Hydrofluoric acid that specifically cuts the 
phosphodiester bonds between the WTA and the muramic acid. According 
to the materials and methods section of Leulier et al. 2003, it is not referred 
the incubation of the Gram-positive CW neither with acid or alkaline 
conditions. Therefore, it seems that it was injected Gram-negative PGN and 
Gram-positive CW. In addition, the amount of PGN injected from Gram–
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negatives and the Gram-positive CW is then expected be very different 
since the WTA contribute substantially for the CW weight. Thus, when the 
authors speculated why the B. subtilis PGN is a less potent inducer of the 
IMD than the Gram-negative PGN by arguing the presence of amiDAP, it 
could be due also or instead to both the presence of WTA and the amount 
of B. subtilis PGN injected compared to the Gram-negative PGN injected. 
Nevertheless, the authors commented on the presence of the OM and the 
surprising recognition of PGN by PGRP-LC. They pointed out that the OM 
is a shield to PGN detection which it is implied in the data I present. 
Furthermore, assuming that the OM protects PGRP-LC from accessing the 
PGN, they speculated that PGRP-LC may recognise PGN fragments released 
by the turnover and growth of the bacteria. Indeed, it was later  shown that 
PGRP-LCx recognises monomeric forms of PGN [70]. Interestingly, they 
observed that both the Gram-negative and Gram-positive PGN after 
muramidase treatment failed to activate an immune response in the Fly. 
Hence, they hypothesised that the size of the polymer chain and the 3D 
dimensional organization of the macromolecule is crucial for bacterial 
sensing. 
Stenbak et al. 2004 [66] also studied the effect of PGN and PGN 
derivatives on the induction of AMPs expression. The authors concluded 
that the Fly discriminates between Gram-negative and Gram-positive 
bacteria by differentiating between DAP and Lys residues. Regarding the 
B. subtilis DAP-type PGN, they corroborate Leulier et al. 2003 as they also 
observed that it induces the IMD in a lower extent than the Gram-
negatives. Since they used a similar protocol for PGN purification as Leulier 
and colleagues, it seems that the study was on Gram-positive CW and not 
pure PGN. Nevertheless, the authors propose that this less activation has 
to do with the amiDAP residue and the absence of the anhydrous-MurNAc 
form at the end of the glycan chains. In addition, they also propose that 
since the terminal anhydrous residue locks the MurNAc in a fixed 
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configuration, beta configuration, this is important for PGRP recognition. 
They argue that this might be the reason why only polymeric Gram-
negative PGN and the anhydrous form but not the fragments generated by 
muramidase treatment have the capacity to strongly activate the IMD 
pathway. Thus, the absence of the anhydrous form in the muropeptides of 
the Gram-positive PGN, would result in the fact that only polymeric PGN 
but not muropeptides from Lys-type PGN could be recognised by PGRP. 
Again, they corroborate Leulier et al. 2003 [65] regarding the muramidase 
treatment after which Lys-type PGN does not induce the Toll target 
Drosomycin, similar to what Filipe et al. 2005 observed [31]. They 
concluded that perhaps a fixed MurNAc configuration is important for 
efficient recognition of both PGRP-LC and PGRP-SA and thus influence the 
recognition of PGN. 
Studies with pure PGN however always come with limitations that may 
not be possible to completely remove. Regarding the Gram-negative PGN, 
the full length intact polymer can be injected, whereas for the Gram-
positive PGN, due to the mechanical break of the cells, the polymer has 
inherently suffered some breakage. This may or may not influence to a 
certain level the in vivo detection by PGRPs or induction of AMPs 
expression. Moreover, as the PGN polymer is insoluble and the needles 
used to inject the fruit flies have a very small width, the amount of PGN that 
is injected will most likely have considerable variations that only with a 
wide number of biological repeats can be accurately assessed the systemic 
infection by pure PGN. Therefore, the use of live bacteria with exposed PGN 
at the surface presents itself as a way to overcome these constraints. In 
addition, another limitation of biochemical studies regarding host 
receptors, are the in vitro conditions used, which are usually far from the 
physiological conditions.  
In this study, I used a buffer closer to the haemolymph composition 
than any other used so far and Gram-positive bacteria that do not possess 
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WTA but share an almost identical PGN composition as the parental strains 
(Fig. 13). Moreover, I confirmed that the CWs of both WTA mutants are 
totally devoid of polymers and furthermore they present a similar sugar 
composition (Fig. 14). 
 
 
 
Figure 13. Muropeptide profiles of pure PGNs. Pure PGN was digested with the 
muramidase Mutanolysin and the resultant muropeptides were separated by HPLC. It 
can be observed that the Δ tagO mutants present a muropeptide composition similar 
to the parental strains. It is also observed the much reduced cross-linking of the S. 
aureus Δ tagO [74], which is not observed for the B. subtilis Δ tagO compared to the 
parental strain. 
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Figure 14. Sugar composition of pure CWs pre-incubated with HCl. Purified CW was 
incubated with HCl and the sugar species were separated by HPAEC-PAD. It can be 
concluded that both Δ tagO mutants present the same sugar composition, albeit 
different muropeptide specie, and are completely devoid of WTA or other type of CW 
polymers. The hydrolysis of the parental CWs was incomplete as it is still detected 
MurNAc residues, most likely due to the presence of the WTA that may affect the 
efficiency of the hydrolysis. 
 
PGRP-SA and PGRP-LC bind to Lys- and DAP- type PGN. 
As expected, when the WTA of S. aureus are absent it was detected the 
binding by mCherry_PGRP-SA and when the WTA of B. subtilis are absent 
it was detected the binding by mCherry_PGRP-LC (Fig. 4). However, 
contradicting what was expected according to the current model, it was 
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also detected binding of mCherry_PGRP-SA to B. subtilis Δ tagO and binding 
of mCherry_PGRP-LC to S. aureus Δ tagO (Fig. 4). These results suggest that 
PGRP-SA is able to recognise amiDAP-type PGN, PGRP-LCx is promiscuous 
for the third residue of the PGN and WTA can shield different PGN types 
from the recognition of different PGRPs, and not specifically from PGRP-
SA.  
Since PGRP-LCx is a transmembrane protein, although it has been 
reported that it can be found in the haemolymph the protein bearing the 
PGRP ectodomain [76]. Hence, the recombinant protein construct could 
possess a different level of affinity than the native protein, thus raising the 
possibility that in in vivo conditions, the transmembrane form could not be 
able to bind to the cells. To address this question, haemocytes expressing 
GFP-PGRP-LCx [76] were infected with the different bacterial types (Fig. 5). 
Similar results were obtained, i.e. the native protein bound to the surface 
of the WTA mutant bacteria of both S. aureus and B. subtilis. Moreover, GFP-
PGRP-LCx could bind to the parental bacteria as well. 
On one hand, the binding of the rPGRPs could be not so specific to the 
PGN since components of the CW could be promoting some non-specificity 
due to protein-protein interactions mediated by charge. On the other hand, 
if the PGRPs can indeed bind to both types of PGN when WTA are absent 
in live bacteria, then the same should be observed when using pure PGN of 
the parental strains. To address these questions, co-precipitation assays 
with pure quantified PGN were performed. Binding of the rPGRPs to the 
PGN of the parental strains showed that they are indeed able to bind to the 
pure substrate (Fig. 6A and 6B). Moreover, it is shown that under more 
physiological conditions such as the Hemo Buffer, PGRP-SA can bind to 
amiDAP. Thus, the reason why Chang et al. 2004 [2] and Leone et al. 2008 
[30] failed to detect binding of PGRP-SA to amiDAP-type PGN was the use 
a non-physiological buffer. Regarding the binding of PGRP-LC, Mellroth et 
al. 2005 [69] had also detected that this PGRP was able to bind in vitro to 
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different types of PGN, in accordance with these results. However, the 
biological importance of these results were considered to be none. The 
work from Chang et al. 2006 [70] helped to define the current model 
whereby there is a structural discrimination between DAP- vs. Lys- type 
PGN by PGRP-LC and PGRP-SA, respectively. On the analysis of their data 
regarding the crystal structure of the complex TCT-PGRP-LCx-PGRP-LCa, 
the authors ascertain the stability of the PGRP-LC binding to the DAP 
residue in monomeric PGN. However, they refer that in the case of a 
polymeric PGN, a Lys residue would not destabilise the binding interaction 
as if it was present in a monomeric form similar to TCT. This interpretation 
corroborates my results and Mellroth`s regarding the non-specificity of 
PGRP-LCx to Lys-, Ornithine- or DAP- type PGN. In addition, Mellroth et al. 
2005 also showed that PGRP-SA, like PGRP-LCx, possesses promiscuity 
towards the third residue of the stem peptide, although not addressing an 
amiDAP PGN. The binding of PGRP-LCx to the PGNs tested seemed to be 
similar to all, whereas the binding of PGRP-SA showed stronger and 
weaker affinities. This led the authors to conclude that PGRP-SA presents 
preferences for certain PGN substrates. However, this preferences might 
not be correlated to the third residue of the peptide chain, but rather to 
different PGN structures and the nature of the glycan chains. When 
Swaminathan et al. 2006 [71] concluded that PGRPs discriminate PGN 
through the stem peptide and the peptide cross-bridge, the authors refer 
that the binding of PGRPs to the PGN derivatives, although highly selective, 
was of low affinity. This low affinity could help to explain why they failed 
to observe binding to different PGN forms. 
The rPGRPs showed similar bindings to the PGN of the parental 
and mutant strains (Fig. 6C). Therefore, the binding of the PGRPs to the 
mutant cells (Fig. 4 and 5) was indeed because of a more exposed PGN at 
the cell surface, corroborating the use of such mutant strains to study PGN 
recognition by host receptors. In addition, the binding of PGRP-LC to B. 
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subtilis PGN showed to be higher than the binding to the S. aureus PGN (Fig. 
6C), in accordance with the binding to the live cells of the tagO mutants 
(Fig. 4B). Interestingly, the binding of PGRP-SA to the B. subtilis PGN is also 
higher than to the S. aureus PGN (Fig. 6C). This result may appear 
contradictory to the binding to the cells of the S. aureus Δ tagO mutant, 
where PGRP-SA shows better binding than to the B. subtilis Δ tagO cells. 
However, due to the characteristics of the physical-chemical properties of 
the S. aureus Δ tagO PGN, the comparison of the binding to this particular 
PGN with the B. subtilis Δ tagO PGN may come with limitations. Further 
studies would be needed to address this question. 
PGRP-SA and PGRP-LC are important against infection by 
bacteria with either Lys- or DAP- type PGN. 
To address the biological importance of the binding assays in vivo, 
I infected semmelweis, PGRP-LCΔE12 and semmelweis/PGRP-LCΔE12 mutant 
flies, both homozygotes and heterozygotes (Fig. 7-11 and Table 1). Upon 
B. subtilis and S. aureus infections, the heterozygotes semmelweis and 
PGRP-LCΔE12 were equally susceptible (Fig. 7A and 9A). However, for both 
bacterial infections, the homozygotes showed different susceptibilities, 
being semmelweis more susceptible than PGRP-LCΔE12 (Fig. 7B and 9B). In 
addition, the heterozygote vs. homozygote semmelweis show that the lack 
of two copies of the PGRP-SAwt gene is more detrimental for the host than 
still having one wild-type copy (Fig. 7C and 9C). The same is not observed 
between one and two copies of the PGRP-LC gene. This suggests that 
although the rPGRP-LC binds better to both PGNs than rPGRP-SA (Fig. 6C), 
in vivo PGRP-SA may be more important for host survival against both 
bacterial types than PGRP-LC. Whereas S. aureus is a major opportunistic 
pathogen bearing an arsenal of virulence factors, B. subtilis is an innocuous 
soil bacteria. Then, it is not surprising to find that the Fly is much more 
susceptible to S. aureus. Consequently, the late humoral responses like the 
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AMPs, may not be crucial as a first step to fight infection. Hence, it is likely 
that the Fly is strongly relying on immediate immune responses against 
this infection. If indeed the immediate responses are paramount against an 
S. aureus infection and the semmelweis mutants are highly susceptible, 
more than PGRP-LC, this indicates that PGRP-SA has a role independent of 
the TOLL pathway whereby it participates in early immune responses. 
Accordingly, although B. subtilis is non-virulent, the number of bacteria 
injected is high. Thus, perhaps in the case of a high bacterial load, 
independently of the pathogenicity of the bacteria, the flies need to rely 
more on immediate responses, than on late responses. This rationale 
justifies the fact that, similar to S. aureus, upon B. subtilis infection the 
semmelweis flies were more susceptible than PGRP-LCΔE12 flies (Fig. 7 and 
9). 
Both WTA mutants of B. subtilis and S. aureus showed reduced 
virulence compared to the parental strains (Fig. 11). The B. subtilis Δ tagO 
mutant has a drastic loss of virulence since only the homozygote double 
mutant is susceptible to infection (Fig. 8 and 11). Nevertheless, after 24h 
p.i. the CFUs inside the Fly increased in the homozygote strains but 
decreased or stabilised in the heterozygotes (Fig. 8D). This could be due to 
the fact that when one of the receptors is missing, as the bacteria are not 
being so efficiently destroyed, it gives time for the bacteria to 
activate/access mechanisms of survival. It may be through suppressor 
mutations, and/or the finding of an ecological niche inside the host that 
allows them to hide from the defences, and/or induction from the 
environmental stimuli of the PhoP/PhoR system that induces the 
expression of teichuronic acids [78]–[80]. These hypothesis are not 
mutually exclusive. Upon infection with S. aureus Δ tagO, contrary to the 
parental infection, the homozygotes PGRP-LCΔE12 flies were more 
susceptible than the heterozygotes (Fig. 10C).  Thus, only when the WTA 
are absent, can the role of PGRP-LC be detected. This indicates that indeed 
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the WTA are shielding the S. aureus PGN from PGRP-LC. Furthermore, the 
results indicate that a more exposed PGN is not turning the bacteria more 
susceptible to other host components such as lysozymes. If a more exposed 
PGN would render the bacteria more susceptible to lysozymes, then it 
should be observed an equal susceptibility between the heterozygotes and 
homozygotes for both semmelweis and PGRP-LCΔE12 backgrounds.  
 
 
WTA impair recognition of Lys- and DAP- type PGN by both 
PGRP-SA and PGRP-LC, compromising the host survival. 
In conclusion, the double homozygous mutant semmelweis/PGRP-
LCΔE12 showed to be more susceptible to infection by any of the bacterial 
types than the correspondent heterozygote and the single hetero and 
homozygous mutants (Fig. 7-11 and Table 1). Therefore, both PGRP-SA 
and PGRP-LC are important for host survival whether by a Lys- or a 
(ami)DAP- type PGN bacteria. Furthermore, the WTA have a dramatic 
effect on the virulence of the bacteria. In the case of a bacteria devoid of 
pathogenicity factors like B. subtilis, WTA revealed to be essential for 
survival in the host. The absence of WTA in B. subtilis presents a dramatic 
impact on the growth and on the shape of the bacteria, which was a main 
issue during the construction of the mutant strain (Tomasz Czarny, 
personal communication). The extent to which these factors can influence 
the virulence of the bacteria upon a septic infection cannot be fully 
addressed with the work undertaken. Nevertheless, the data here 
presented shows that the WTA can impair the recognition of different 
types of PGN by both PGRPs and not specifically from PGRP-SA to Lys-type 
PGN bacteria [72], [73]. In the same way that the WTA impair accessibility 
of the PGRPs to the PGN, perhaps the OM exerts the same effect in the 
Gram-negative bacteria. This hypothesis is in accordance with Leulier and 
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colleagues [65] when they speculated that the OM could shield PGN from 
PGRP-LC. Hence, the studies from Michel et al. 2001 [1], Ramet et al. 2002 
[3], Gottar et al. 2002 [4] and Choe et al. 2002 [5], were possibly the first 
reports on the effect of the CW composition in impairing PGN recognition. 
When Michel et al. 2001 [1] observed the differential susceptibility 
between Gram-positive and Gram-negative bacteria in semmelweis flies, 
they were perhaps the firsts to observe the impairment of CW factors on 
PGRP-SA accessibility to the PGN. They observed that semmelweis where 
more susceptible to a Bacilli specie that presents WTA and non-amiDAP-
type PGN as they were to a Lys-type PGN bacteria. Thus, in the beginning 
of the study of PGRPs, there was no indication that the DAP and Lys 
residues where determinant for bacterial recognition. Accordingly, Chang 
and colleagues detected binding of rPGRP-SA to purified DAP-type PGN [2]. 
Choe et al. 2002 [5] clearly showed that PGRP-LCx is paramount for the 
expression of the AMPs induced by IMD pathway, but they did not show 
evidence for a preference of this receptor to a particular PGN type. In fact 
they showed that TOLL-dependent AMPs also failed to be expressed to 
normal levels in the PGRP-LCx mutants. In addition, these mutants, in 
contrast to the wild-type flies, 6h p.i. showed no detectable levels of 
Diptericin upon infection with the Gram-positive bacteria M. luteus and B. 
subtilis and the Gram-negative Enterobacter cloacae. These reports 
corroborate the data here presented and even suggest that there may be a 
cross-talk between IMD and TOLL that can be mediated by PGRP-LC. 
Corroborating a cross-talk between IMD and TOLL, Gottar et al. 2002 [4] 
also observed that PGRP-LC mutants did not express Drosomycin to the 
wild-type levels upon an M. luteus infection and, in addition, they also 
showed that albeit the PGRP-LC mutants showed a more dramatic 
phenotype, the semmelweis mutant presented, to some extent, decreased 
levels of IMD-dependent AMPs upon E. coli infection.  
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Conclusions 
 
The results I present in this chapter are conflicting with the current 
model of bacterial recognition by PGRPs in Drosophila melanogaster. 
Regarding the recognition of PGN, I show that PGRP-SA and PGRP-LC are 
promiscuous for the peptide moiety of the PGN since they do not 
discriminate the Lys from the DAP residue and that PGRP-SA is able to bind 
to amidated DAP residues in polymeric PGN. This recognition by PGRPs is 
paramount against infection. PGRP-SA and PGRP-LC not only play roles 
against infection by both bacterial types but also seem to have redundant 
roles and to be able to compensate the absence of one another to some 
extent. When flies are deficient in both receptors, they are highly 
susceptible to infection, even when the bacteria have exposed PGN at the 
cell surface like the WTA mutant strains. Accordingly, it appears that CW 
composition and not the PGN composition determines the efficient 
detection of bacteria by PGRPs.  
Since immune strategies are commonly shared by major bacterial 
pathogens, it is also intuitive to realise that the evasion mechanism 
provided by the WTA is transversal to Gram-positive bacteria and to 
different PGRPs. I propose a model whereby the OM of the Gram-negative 
bacteria and the WTA of Gram-positive bacteria shield PGN from the 
recognition by host receptors. Therefore, this model points towards a 
major role of the WTA, and its functional homologous OM, as conserved 
bacterial mechanisms of immune evasion. Ultimately, this suggests that 
classical virulence factors such as toxins might play a secondary role in 
comparison to the strategies of immune evasion, since whether it is a 
major pathogen or an innocuous soil bacteria, all of them present a 
protective barrier at their surface that covers their PGN layer. This 
corroborates the conclusions of Chapter II, since the data strongly suggests 
that impairment of PGN recognition is vital for bacterial survival in the 
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Host and that the virulence factors can promote the success of an infection, 
for as long as the bacteria can avoid PGN detection. 
According to Janeway [81], the evolution of Pattern-recognition 
receptors (PRR) reaches a tie with the Pathogen Associated Molecular 
Patterns (PAMP). The PRR detect the conserved and exclusive components 
of the pathogens whose probabilities of change are greatly reduced. Hence, 
as the pathogen cannot change these PAMP, it has responded with an array 
of virulence factors and evasion strategies.  It is then quite interesting why 
would Lys- and DAP- type PGNs be discriminated by PGRP-SA and PGRP-
LC: 1) the third residue is the most variable position of the stem peptide 
and 2) PGRP-SA and PGRP-LC are main receptors of evolutionary 
conserved immune cascades that if so true, they would have limited 
capacities in detecting bacteria due to a discrimination of a single 
molecule. While being promiscuous for the PGN composition, particularly 
to the variable part of the macromolecule, it implies that the PGRPs are 
mainly recognizing the most conserved region, i.e. the glycans. Therefore, 
it is likely that these PGRPs might show different susceptibilities to 
secondary modifications of the macromolecule. In addition, chemically the 
DAP residue is a derivative of the Lys residue by the addition of a carboxyl 
group (Fig. 5, Chapter I), and the amiDAP is a modification of the DAP 
residue. Thus, the evolution of an Immune System bearing two principal 
PRR, PGRP-SA and PGRP-LC, that would discriminate Lys from DAP, and 
that one itself, PGRP-SA, would discriminate amiDAP from DAP, appears to 
be highly unlikely. 
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Materials and Methods 
 
Bacterial strains and culture. 
The plasmid IP15793 (Drosophila Genomics Resource Center) 
containing the PGRP-LCx isoform, was used to amplify the PGRP domain 
(region 966 bp to1500 bp of the CDS) with the pair of primers forward and 
reverse, respectively: “GGGAAGGGAATTCAACCAAACGGACTTGGATG” ; 
“TGCGGCCGCAAGCTTTTAGTGATGGTGATGGTGATGGATTTCGTGTGACCA
GTGCGG” (sequences from 5` to 3`). Subsequently, the fragment was 
cloned into the EcoRI and EagI restriction sites of the pET21a backbones 
of the mCherry_PGRP-SA and rPGRP-SA vectors [72]. A 6x His-tag was 
added to the last coding triplet, before the stop codon, similar to the PGRP-
SA constructs. 
E. coli strains DH5α and BL21(DE3) (both for construction and 
expression of the recombinant proteins), B. subtilis EB6 and EB6 Δ tagO 
(EB1451) [75] strains were grown either in Luria–Bertani broth (LB; Difco, 
France)10 or in Luria–Bertani agar (LA; Difco). S. aureus strains NCTC 
8325-4 (reference strain from R. Novick) and NCTC Δ tagO [72] were 
grown either in Tryptic Soy broth (TSB; Difco) or in Tryptic Soy agar (TSA; 
Difco). All cultures were grown at 30ºC with aeration, except when 
infected flies were crushed and plated for CFUs, the LA and TSA plates 
were incubated at 25ºC.  
 
 
 
 
 
                                                          
10 All reagents were purchased from Sigma-Aldrich (Germany), except when stated otherwise. 
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Fly Strains. 
All flies, stocks and crosses, were grown on standard cornmeal-
agar medium at 25ºC. 
 For construction of the double mutant semmelweis/PGRP-LCΔE12, 
the I and III chromosome of semmelweis flies [1] and PGRP-LCΔE12 flies [4] 
were balanced through cross with Bl#27336 flies (FBst0027336 from 
Bloomington Drosophila Stock Center, FlyBase, Genotype 
TI{TI}Pis1/FM7a; P{hs-Pis.MYC}3/TM2). For each F1 of these two 
independent crosses, flies with both balancers were selected and the cross 
between female virgins seml/FM7 and TM2/+ with males FM7/y and 
TM2/PGRP-LCΔE12 was set. Of this progeny, it was selected female virgin 
flies that phenotypically presented both balancers and male flies that were 
not FM7 (hence were seml genotype) but presented TM2 phenotype. 
Several single crosses between such females and males were set. After the 
laid of the eggs and confirming the viability to larvae, the parents were 
killed and checked for the PGRP-LCΔE12 gene. Briefly, gDNA was extracted 
and the PGRP-LCΔE12 was amplified by PCR using the primers 
“CACACGCTGCCATATCAGAC” and “TATCGGTTTTCCTGGGTGAG” [82]. The 
PCR fragment of the PGRP-LC gene would be 9344 bp but it was not 
amplified since it was not allowed enough extension time. The PGRP-LCΔE12 
gene showed a 212 pb fragment. Only the single crosses of which both 
female and male showed amplification were kept.  The PGRP-LCΔE12 PCR 
products along with the PCR products of the semmelweis/PGRP-SA gene 
(primers in 5` to 3` sequence “TTAGATCTTAGCACATCAACATC” and 
“GACTACTGCAATTACTTGTAGTTG”) were sent to sequencing to confirm 
the genotypes. The progeny of females and males that did not present 
balancers, i.e. homozygous for both semmelweis and PGRP-LCΔE12 genes 
were collected. Finally, single crosses between these females and males 
were set to obtain a homogeneous population of homozygous flies for seml 
and PGRP-LCΔE12. Three different lines were obtained, of which both the 
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parents and progeny genotype was confirmed by PCR and sequencing.  For 
construction of the single mutants, the respective mutant flies balanced 
with the Bl#27336 flies were used and it was followed a similar approach 
as for the double mutant. Thus, the semmelweis, the PGRP-LCΔE12 and the 
double mutant are in a similar genetic background. 
 For microscopy of the GFP::PGRP-LCx binding to live bacterial 
cells, w UAS-GFP::PGRP-LCx [76] female virgins were crossed with 
HmlΔGal4. 
Purification of recombinant PGRP-SA and PGRP-LC proteins. 
The recombinant proteins PGRP-SA and PGRP-LC with and without 
the mCherry fluorescent tag were purified as described in Chapter II. 
 
Purification of Peptidoglycan. 
The CWs and PGNs of S. aureus and B. subtilis parental and mutant 
strains were purified and analysed as previously described [31] and the 
procedure is here briefly described. 
 
Cell wall purification.  
 Cultures were grown at 30ºC, 180 rpm in TSB or LB, accordingly, 
and when they reached an OD600nm ~1.0 they were placed in an ice/ethanol 
bath. This quick chilling of the cultures avoids further activity of lytic 
enzymes that may modify the CW and PGN and serves in further removing 
some surface proteins. The cells were harvested and boiled in 4% (w/v) 
SDS for 30 min. The SDS was washed out using warm ddH2O by 
centrifugation. Since the Gram-positive cell wall is resistant to breakage by 
SDS, the cell walls were mechanically broken (to maintain the 
peptidoglycan mesh intact from modifications by lytic enzymes).  Broken 
cell walls were resuspended in 50 mM Tris-HCl pH 7.0 with MgSO4 20 mM 
final concentration, DNase to 10 μg/mL and RNase to 50  μg/mL and 
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incubated at 37ºC for 2 h with shaking. Trypsin at 100 μg/mL 
(Worthington Biochemical Corp., USA) and CaCl2 at 10 mM final 
concentrations were added and incubated at 37ºC overnight (O/N). 
Trypsin degrades the enzymes added before and the cellular proteins. 
CaCl2 prevents auto-degradation of trypsin, thus guarantees that the 
enzyme remains active cleaving all proteins/enzymes present in the 
suspensions. SDS to 1% (w/v) final concentration was added and the 
mixes were boiled for 15 min. After harvest of the suspensions, pellets 
were treated with 8 M LiCl, 100 mM EDTA pH 7.0 and pure Acetone-
ultrasound water bath. These treatments remove any non-covalently 
linked compounds that may be bound to the cell walls. After washing with 
ddH2O, the final resuspension is made in MilliQ H2O and transferred into 
pre-weighted tubes and lyophilised O/N (without heat) in a Speed Vac 
apparatus. The pure cell wall dry-weight is calculated and they are 
adjusted to a final concentration of 20 mg/mL with MilliQ H2O. They can 
be stored for long periods of time at -20ºC. 
 
PGN purification. 
 PGN was purified by incubation the CWs with 46% Hydrofluoric 
Acid (HF) in a ratio of 2 mL of HF per 10 mg of CW, at 4ºC for 48 h, stirring. 
Under these conditions, HF cleaves the phosphodiester bonds between the 
wall teichoic acids and the MurNAc residues. As a non-controlled 
secondary reaction, it is likely that the acetate is lost from O-acetylated 
MurNAc of the S. aureus PGN, because the ester bond of O-linked acetate is 
significantly weaker than the amide bond of N-linked acetate, even in mild 
alkaline or acidic conditions [83]. After HF treatment, the pure PGN was 
washed with 100 mM Tris-HCl pH 7.0 until complete removal of the acid 
and the pH values of the supernatants were neutral. Finally, the purified 
PGNs were resuspended in MilliQ H2O and transferred into pre-weighted 
tubes and lyophilised O/N (without heat) in a Speed Vac apparatus. The 
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dry-weight was determined and the PGNs were suspended in MilliQ H2O 
to a final concentration of 10 mg/mL. They can be stored for long periods 
of time at -20ºC. 
 
Separation and analysis of the muropeptides. 
50 μL of PGN (10 mg/mL) was incubated in 50 μL of 25 mM 
NaHPO4 pH 5.5 and 2 μL of Mutanolysin at 10 mg/mL, O/N at 37ºC, 1200 
rpm. Mutanolysin is a muramidase more robust than most Lysozymes to 
glycan modifications. 100 μL of MilliQ H2O was added to the samples 
followed by 5 min boiling to denature the mutanolysin. The suspensions 
were centrifuged to remove the denatured mutanolysin and any polymeric 
PGN that was still insoluble. The supernatants were collected into a fresh 
tube to which it was added 200 μL of 0.5 M Borate Buffer pH 9.0 with 25 
μL of fresh 50 mg/mL NaBH4 and incubated at room temperature (RT) for 
2 h. The reduction of the muropeptides ensures that the PGN species will 
be latter on separated regarding the size without charge interferences. The 
reaction is stopped by lowering the pH to 2.0 with 85% ortho-phosphoric 
acid. Finally the samples were centrifuged and the supernatants were 
collected into a fresh tube and stored at -20ºC until further use. The 
muropeptides were separated in an HPLC system using a Reverse Phase C-
18 Hypersil column (ODS-Hypersyl, 5 μm, 4.6×250 mm Thermo Scientific) 
at a flow rate of 0.5 mL/min for 160 min with a Methanol gradient from 
5% to 30% (v/v) in 100 mM NaH2PO4 pH 2.0. The eluted muropeptides 
were detected by UV absorption at 206 nm. 
 
Quantification of Peptidoglycan using HPAEC-PAD. 
Sugar components of the purified PGNs were analysed using 
HPAEC-PAD (High Performance Anion Exchange Chromatography coupled 
with Pulsed Amperometric Detection). After quantification of the 
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Glucosamine and Muramic acid in each PGN sample, the final PGN 
suspensions were adjusted to the same amount of Muramic acid for further 
studies.  
 
Hydrolysis of PGN into its basic constituents. 
Three repeats for each PGN sample and three different batches of 
quantification were performed because as PGN is insoluble in aqueous 
solution, these repeats minimise potential errors in the quantification. The 
pure PGN suspension was left O/N stirring at RT for maximum 
homogenization. 20 μL of the suspensions were hydrolysed in 3 M HCl at 
95ºC for 2 h (150 μL reaction volume). The hydrolysed suspension was 
lyophilized until it was completely dried and resuspended in 500 μL of 
MilliQ H2O and lyophilized O/N. Finally, the acid-free hydrolysed material 
was resuspended in 150 μL MilliQ H2O. 
 
Separation of the monosaccharides. 
10 μL of the samples were injected in a Thermo Scientific™ Dionex™ 
ICS-5000 system, in 18 mM NaOH constant and a gradient of 1 M 
NaCH3COO and MilliQ H2O. The MilliQ H2O as all the eluents were in MilliQ 
H2O of resistivity ≥ 18 M𝛀, filtered with 0.2 μm ϕ pore filter and degassed 
for 15 min in an ultrasonic bath. Between the eluents pump and the 
injection valve it was used a BorateTrapTM column to remove borate 
contamination from eluents. An AminoTrapTM (Thermo 
Scientific™ Dionex™ AminoTrap™) was used as a pre-treatment column to 
remove the amino acids from the samples, thus only the sugars passed to 
the CarboPac PA10 column (Thermo Scientific™ CarboPac™ PA10) where 
they were separated. Each injection was done in triplicates. 
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Control samples. 
Controls for the HCl hydrolysis. 
To access if the hydrolysis had been complete, it was injected non-
HCl treated Glucosamine, Muramic acid, N-acetylglucosamine and N-
acetylmuramic acid. If the hydrolysis was complete, only 
Glucosamine and Muramic acid should be detected because the N-acetyl 
groups were removed by the acid treatment. Also these same samples HCl 
treated were injected, to determine if the hydrolysis had not destroyed the 
sugar molecules. After HCl treatment, only Glucosamine and Muramic acid 
should be detected and the areas of the peaks should be similar to the areas 
of the non-hydrolysed Glucosamine and Muramic acid standards because, 
theoretically, it was injected the same concentration for all of them. 
 
Controls to confirm the purity of the PGN. 
Injection of 1 mM of Ribitol, Glycerol and Mannosamine (HCL and 
non-HCL treated) to determine whether the PGN was indeed pure or still 
had WTAs attached. 
 
Controls for quantification of Glucosamine and Muramic acid. 
Injection of fresh solutions of Glucosamine and Muramic acid, at 
different concentrations - 1 mM followed by 1/2 dilutions until 31.25 µM. 
The area of these peaks in the chromatogram were used to plot the 
calibration curve that if r2~1, the equation was used for the quantification 
of Glucosamine and Muramic acid in each PGN sample. It is then assumed 
that all the molecules of N-acetylglucosamine and N-acetylmuramic acid 
were converted into Glucosamine and Muramic acid, respectively. 
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Quantification of Glucosamine and Muramic acid. 
 The area of each peak corresponding to either Glucosamine or 
Muramic acid was quantified using the Thermo Scientific™ Dionex™ 
Chromeleon™ Chromatography Data System software and thus the 
correspondent number of moles was calculated. PGN suspensions to be 
used in the co-precipitation assays were made in MilliQ H2O and they were 
diluted to the same number of moles of Muramic acid of the PGN that was 
more diluted.  
 
Co-precipitation assays. 
The co-precipitation or pull down assays intended to determine 
the binding affinity of the PGRPs to both pure PGN and to live cells, i.e. 
whole bacteria. The PGN pull down assays are quantitative assays 
performed with the non-fluorescent tagged rPGRPs and analysed by SDS-
PAGE [84]. Due to the non-solubility of the PGN in aqueous solutions, the 
amount of protein that binds is harvested with it. The bacterial binding 
assays are qualitative and were performed with the mCherry_PGRPs for 
microscopy visualisation.  
 
PGN co-precipitation assays. 
PGN suspensions at 2.89x10-1 nmol of Muramic acid/µL of PGN 
were thoroughly mixed and 20 µL were taken and spun down for 3 min at 
RT, 16.1 x1000 g. The supernatants were carefully removed, in particular 
the NCTC Δ tagO who’s PGN does not pellet well like the others and hence 
it is easily aspirated. To the pellets it was added 0.3 mg/mL final 
concentration of either PGRP-SA or PGRP-LC in a 200 µL reaction volume, 
filling up the volume with the reaction buffer (20 mM Tris-HCl pH 8.0; 300 
mM NaCl or PBS 1X pH 6.0 or Hemo Buffer – 7.3 mM Na2SO4.10H2O; 34 mM 
NaH2PO4.H2O; 5 mM Na2HPO4.7H2O; 25 mM KCl; 2 mM CaCl2; 14.4 mM 
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MgCl2.6H2O; pH 6.0-6.2 adjusted with NaOH). The mixes were incubated at 
25ºC for 30 min, without shaking and then centrifuged for 5 min at RT 0.8 
x 1000 g. The pellets were washed with 200 µL of reaction buffer and 
centrifuged for 5 min at RT, 3.2 x 1000 g. The pellets were finally 
resuspended in 20 µL of 2X SDS Loading Buffer and boiled for 5 min. The 
samples were centrifuged for 3 min at RT, 16.1 x 1000 g. The supernatants 
were recovered (20 µL) into a fresh tube. This collection step allows the 
loading on the gel to be quick, clean and guarantee that only the 
supernatant and not bits of PGN were loaded, which is important for 
comparing and quantifying the binding affinities. The full supernatant 
volume was loaded on a 12% SDS-PAGE gel. The bands were visualized by 
Coomassie Blue Staining and both imaging and quantification were 
performed using a Gel DocTM EZ Gel (Bio-Rad, USA). For quantification 
purposes of the bindings, each experiment was repeated in two different 
days, with two different batches of buffers (made fresh). The error bars 
represent the mean with standard deviation. The data was plotted and 
analysed using GraphPad Prism 5 (GraphPad Software, Inc.). 
 
Live bacteria co-precipitation assays. 
The binding assays of mCherry_PGRP-SA and mCherry_PGRP-LC 
with live cells were conducted as before, expect that it was used Hemo 
Buffer instead of PBS 1X pH 6.0. The agarose slides were performed as 
before because it does not dissolve in Hemo buffer. Images were acquired 
with a GE Healthcare DeltaVision Elite integrated imaging system, in the 
conventional mode at 25ºC using an Olympus 150x 1.45 NA TIRF Objective 
(Olympus, USA). 
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Survival curves and CFUs. 
Bacterial cultures were grown overnight and the OD600nm was 
adjusted with the appropriate medium culture as follows: B. subtilis 5.0, B. 
subtilis Δ tagO 7.0, S. aureus 0.5 and S. aureus Δ tagO 0.7. 500µL of these 
cultures was centrifuged at RT for 10min, 3380 x g. The cells were washed 
once with 1mL of PBS and resuspended in 500µL of PBS. The suspensions 
of the S. aureus strains were further diluted 1/100 in PBS. 32.2 nL of 
bacterial suspension was injected in thorax of 3-5 day old flies using a 
nanoinjector (Nanoject II; Drummond Scientific, Broomall, PA). The 
infected flies were kept at 25ºC and monitored for 72h every 12h. 
Estimated survival curves were analysed using the Log-rank (Mantel-Cox) 
test to determine statistical significance between the curves. For 
determination of the CFUs, infected flies were collected at different time-
points, homogenized and plated in the appropriate media and incubated at 
25ºC for 24h-48h. The number of flies infected for survival curves 
following the order semmelweis, PGRP-LCΔE12, semmelweis/PGRP-LCΔE12, 
semmelweis heterozygote, PGRP-LCΔE12 heterozygote, semmelweis/PGRP-
LCΔE12 heterozygote were: B. subtilis – 181, 92, 182, 98, 63, 93; B. subtilis Δ 
tagO – 181, 91, 180, 91, 92, 90; S. aureus – 127, 93, 125, 93, 93, 94; S. aureus 
Δ tagO – 97, 126, 97, 95, 94, 96. CFUs were determined for at least 2 
independent infections and the statistical analysis was performed by 
Unpaired Student´s-t test.  The error bars represent the mean with 
standard deviation. All data was plotted and analysed using GraphPad 
Prism 5 (GraphPad Software, Inc.). 
 
Time-lapse microscopy. 
Macrophage preparation. 
Three third instar larvae were washed in 1 mL of ddH2O followed 
by 50% (v/v) bleaching and vortex. The larvae were quickly washed three 
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times with autoclaved MilliQ H2O and left swimming whilst the slides were 
prepared. Into previously washed metal slides (100% (v/v) Ethanol) with 
a 1.0 mm coverslip it was put Schneider medium supplemented with 5% 
(v/v) Fetal Calf Serum. The larvae were bled into the medium and the 
macrophages were let settle for 1h at RT in a humid chamber. 
 
Preparation of the bacteria. 
200 µL of an O/N culture were harvested at RT and washed with 
Schneider medium. The cells were resuspended in 200 µL of Schneider 
with 0.5 µL of a DAPI solution (at 1 mg/mL in MilliQ H2O) and incubated 
for 5 min at RT, without shaking. The cells were washed with 200 µL of 
Schneider and resuspended in 100 µL of Schneider. Finally, they were 
dilute 1/10 in Schneider in a 200 µL final volume. 
 
Imaging of the macrophages with the bacteria. 
To the macrophages slide, 200 µL of the bacterial suspension was 
added and an YSI 5775 Standard Membrane (YSI Incorporated, Japan) was 
glued on top. Acquisition was done at 25ºC in a humid chamber for 12 h 
every 15 min in a GE Healthcare DeltaVision Elite integrated imaging 
system, using an Olympus MPLAPON-Oil immersion objective (100X 
1.40A). 
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Summary 
 
 The data presented in Chapters II and III suggest that PGRP-SA 
plays a TOLL-independent role in early immune responses. Results from 
Chapter II allow to infer that recognition of PGN by PGRP-SA can aid in the 
clearance in an AMP-independent manner. Survival data from both 
Chapters II and III, show that the flies succumb early in infection, 
particularly before or coincident with the reach of the AMPs synthesis. 
Thus, an efficient response appears to be dependent in immediate 
constitutive responses of clearance. Furthermore, flies lacking a functional 
PGRP-SA showed reduced survival compared to flies lacking PGRP-LC, 
which suggests that PGRP-SA has a particular role associated with these 
immediate responses. Thus, I aimed to understand whether PGRP-SA is 
involved in phagocytosis. Here, I show that PGRP-SA participates in 
phagocytosis and clearance of both Lys- and DAP- type PGN bacteria, 
together with PGRP-LC. I show that PGRP-SA has optimal binding and lytic 
activity at low pH, suggesting that it is active inside the phagolysosomes. 
Moreover, I show that the WTA impair the phagocytosis-clearance process 
by shielding the PGN from these PGRPs. 
 In addition, I demonstrate that the macrophages present two ways 
of clearance upon phagocytosis. One is the already established canonical 
route of phagocytosis-exocytosis. The other is the induction of apoptosis 
upon phagocytosis. This later strategy appears to be employed when the 
macrophages find hard to control and destroy the bacteria, whether due to 
pathogenicity factors whether due to a high bacterial load which 
unbalances the rate of phagocytosis and clearance. Finally, the process of 
apoptosis to promote clearance is impaired when the macrophages are 
compromised both in PGRP-SA and PGRP-LC. Thus, this apoptotic process 
is triggered by factors associated with the clearance of the bacteria. 
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Introduction 
 
Phagocytosis and Drosophila immunity 
 
 Etymologically, phagocytosis is a Greek word that comes from 
“phagein” – to eat – , “kytos” – a big animal – and “-osis” that means process.  
Thus, phagocytosis is the process by which a cell engulfs large particles, 
usually over 0.5 µm in diameter. This primordial and fundamental process 
present from unicellular to multicellular organisms was first described by 
Élie Metchnikoff in 1882. This discovery rendered him and Paul Elrich the 
Nobel Prize in 1908.  Phagocytosis is paramount for homeostasis, because 
it is the first step of clearance. In development and tissue remodelling, 
phagocytosis is the final step of the apoptotic process [1], [2] and in 
immune responses, clearance occurs upon phagocytosis of the 
microorganism. Metazoans present cells that specifically perform 
phagocytosis, the professional phagocytes, such as the macrophages, 
which patrol the host to promote clearance of dying cells and 
microorganisms. Therefore one can assume that macrophages are 
primordial components of the Innate Immune System as they or their 
homologues are found in all Metazoans. The Drosophila melanogaster 
blood cells, haemocytes, are responsible for phagocytosis. 
Phagocytosis is initiated upon the interaction of opsonins3 at the 
surface of the particle with receptors at the surface of the macrophage. 
Upon phagocytosis, the internalized particle will be destroyed through a 
sequential process of engulfment, destruction and excretion (Fig. 1). The 
macrophages are composed by lamellipodia and filopodia. The 
lamellipodia are extensions of the actin cytoskeleton to the outer of the cell 
                                                          
3 Any component that binds to a cell and turns it more susceptible to be phagocytosed. 
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surface. They propel the macrophage or anchor them onto a surface. The 
filopodia are cytoplasmic projections that extend beyond the lamellipodia. 
They participate in the sensing of chemicals and other stimuli from the 
surrounding environment, in macrophage movement and migration and in 
the engulfment of pathogens. Thus, all phagocytic signalling pathways 
activate cytoskeleton-remodelling molecules and the dynamics of the 
cytoskeleton is exploited in order to achieve particle internalisation. For 
instance, the Drosophila TM9SF4 is important for bacterial phagocytosis 
due to its function in the morphology of cell adhesion and actin 
cytoskeleton [3]. Different phagocytic systems show different cytoskeleton 
requirements and are composed of a series of ligands, receptors and 
signalling pathways. 
The history of phagocytosis is intimately associated with 
Immunology and the understanding of host resistance to infection. 
Conversely, pathogens developed different mechanisms to evade or 
subvert the phagocytosis or the clearance. Many microorganisms have 
conceived strategies of evasion whether by remaining extracellular or 
invading other type of host cells. Others have found ways to not only 
survive but even to replicate within macrophages. While it may be 
advantageous for an intracellular pathogen to preserve the function of the 
host cell for its replication, most intracellular pathogens can actively 
induce programmed cell death, such as apoptosis.   
Phagocytosis participates in host defences through the uptake and 
clearance of infectious agents and contributes to inflammation. It is a type 
of cellular response that in Insect Immunity it belongs to the constitutive 
and early immune responses. Phagocytosis is conducted by the Drosophila 
blood cells, haemocytes, which have been successfully used as a model of 
‘professional’ mammalian phagocytosis [4]. 
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Figure 1. Steps of the phagocytosis-exocytosis process. 1. Phagocytosis, i.e. 
internalization of the particle through engulfment; 2. Formation of the phagosome by 
the fusion of the cell membrane around the particle; 3. Fusion of the phagosome with 
a lysosome that contains hydrolytic enzymes resulting in the phagolysosome 
containing the particle to be digested and the enzymes at a low pH. It is within this 
vesicle that the particle is destroyed, i.e. the clearance occurs; 4. Upon clearance, the 
residual body contains the debris and undigested material; 5. Exocytosis with release 
of the residual body contents to the outside of the cell. 
 
There are three types of functional haemocytes that have different 
roles throughout the developmental stages and respond to environmental 
stimuli: plasmatocytes, crystal cells and lamellocytes. Plasmatocytes 
represent ca. 90% of the total circulating haemocytes in all developmental 
stages. They are involved in phagocytosis of apoptotic bodies and of 
pathogens. They are the Drosophila professional macrophages and in this 
Chapter, I will address them as macrophages. Crystal cells participate in 
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the melanization process and engulfment of parasites whose size is too 
large to follow a canonical phagocytosis route. These two types of 
haemocytes circulate in the haemolymph and/or can be found sessile. 
Lamellocytes participate in the encapsulation of foreign bodies that are too 
large to be phagocytosed and are exclusively differentiated in response to 
specific immune challenges, such as wasp parasitism.  
Several genes involved in phagocytosis, both receptors and 
components involved in actin-cytoskeleton and cell-cell contact have been 
identified in Drosophila. Regarding the phagocytic receptors, some of the 
ligands are yet to be identified. Up to date, ca. 12 phagocytic receptors have 
been identified: Croquemort [5], [6], Draper [7], and Nimrod C4/Six-
microns-under (NimC4/SIMU) [8], Eater [9], Nimrod C1 [10], Down 
syndrome cell adhesion molecule (Dscam) [11], Peste [12], Drosophila 
scavenger receptor class C, type I (dSR-CI), Integrin βυ [13], [14] , Integrin 
αPS3/βυ [15], PGRP-LC [16] and PGRP-SC1 [17].  
 
Phagocytosis and Programmed Cell Death 
  
It is thought that macrophages were primordially involved in 
removal of apoptotic bodies and their role in pathogen uptake is an 
adaptive function [5]. In accordance to this line of thought, it has recently 
been shown that macrophages require priming through phagocytosis of 
apoptotic corpses to function in response to foreign bodies [18]. Indeed, 
programmed cell death (PCD) is vital in multicellular organisms for 
development and homeostasis and thus the clearance of such dying cells is 
essential (Table 1). The concept of PCD was defined in 1964 by Lockshin 
and Williams, as a process that occurs in predictable places at predictable 
times during embryogenesis, implying that cells are programmed to die 
during the development of the organism [19]. Later, Kerr et al. 1972 
described the morphological changes of cell death during development 
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and proposed the term apoptosis. Three morphologically distinct types of 
physiological cell death were identified in tissues of mouse and rat 
embryos [20]: type I (apoptotic cell death), type II (autophagic cell death), 
and type III (necroptotic cell death).  
Table 1. Types of Programmed Cell Death. 
 
Apoptosis is an active mode of cell death in the sense that it is a 
death process that is initiated by the cell in a well-orchestrated and 
controlled manner. Paradoxically, it is a passive and peaceful mode of 
death because it evokes minimal inflammation and avoids disturbance to 
the neighbouring cells and onto the surrounding medium. It is the type of 
PCD that cells undergo during development, tissue remodelling and wound 
healing. As such, the apoptotic cell death (type I cell death) is characterized 
by a sequence of specific morphological changes. There is condensation of 
the organelles and cytoplasm, thus the cell volume decreases and the cell 
density increases [21]. The cell membrane starts to form buds, the budding 
process, and it is accompanied with shrinkage of the entire nucleus and 
DNA fragmentation or karyorrhexis, which is a hallmark of apoptosis. It is 
commonly observed sharply delineated chromatin masses lying against 
the nuclear membrane and persistence of the nucleolar structure until 
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very late stages [22]. Also, there is loss of specialized surface structures 
such as microvilli and cell–cell contacts. Subsequently, there is the 
formation of membrane-confined apoptotic bodies containing a variety of 
compacted but well-preserved cytoplasmic organelles and nuclear 
fragments [23].  Phagocytic ingestion is the ultimate fate of cells 
undergoing apoptosis. Ingestion of apoptotic cells occurs very rapidly to 
prevent the exposure of surrounding cells and tissues to any potentially 
harmful contents [20]. In the absence of phagocytosis, apoptotic cells 
proceed to a stage called secondary necrosis. Secondary necroptotic cells 
resemble necrotic cells, but differ in having gone through an apoptotic 
stage, thus their nuclei are fragmented or condensed.  
Necrosis is often considered a passive process since it lacks the 
signalling events of controlled cell death and it is a rapid and sudden type 
of death. In opposite to apoptosis, the cells burst and release in an 
uncontrolled manner all of the content to the surrounding medium. Thus, 
it induces strong inflammation and stress to the neighbouring cells. It 
typically occurs under extreme physicochemical conditions. However, 
there is growing evidence that there are types of programmed necrosis, 
designated necroptotic cell death. It appears it may be as well controlled 
and programmed as apoptotic cell death and that it results from extensive 
cross talk between several biochemical and molecular events at different 
cellular levels [24]. A particular type of necroptosis is pyroptosis, which is 
a death by necrosis that is highly inflammatory and generally occurs after 
infection of intracellular pathogens. Necrosis (type III cell death) is 
characterized by swelling of the organelles and the cytoplasm, followed by 
collapse of the plasma membrane and lysis of the cells [20]. The cytoplasm 
becomes increasingly translucent and, finally, the plasma membrane is 
disrupted, and cell contents start to leak out, hence causing inflammation. 
As a consequence of the prominent swelling of the cytoplasm, this type of 
cell death is also designated as oncosis [25].  
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Autophagy (type II cell death) is characterized by the presence of 
double membrane autophagic vacuoles [20], [26]. It is most prominently a 
survival mechanism activated in cells undergoing different forms of 
cellular stress. When the cellular stress continues, cell death may continue 
by autophagy alone, or may develop apoptotic or necroptotic features [27].  
  
Is PGRP-SA involved in phagocytosis? 
 
  Taking into account the data presented in the previous Chapters, 
Staphylococcus aureus kills the flies very rapidly. Its pathogenicity is 
probably attributed to its arsenal of virulence factors. Nevertheless, upon 
an S. aureus infection one must consider that perhaps what is paramount 
for Host survival are processes involved in the immediate immune 
responses. The data presented in Chapter II, shows that the reason for the 
reduced virulence of the atl mutant is due to a better recognition of PGN 
by PGRP-SA which may be promoting clearance in an AMP-independent 
manner. Furthermore, as observed in Chapter III, the mutant flies 
semmelweis and semmelweis/PGRP-LCΔE12 succumb earlier than the 
heterozygotes flies upon infection (Fig. 7 of Chapter II) and in a manner 
much more dependent on PGRP-SA than PGRP-LC (Fig. 7 and [28], [29]). 
Therefore, if immediate immune responses are key against S. aureus 
infection and PGRP-SA is particularly important for host survival, then the 
results suggest that PGRP-SA is involved in immediate early responses. 
Accordingly, it has been reported by the Host groups, that the semmelweis 
flies are more susceptible to an S. aureus Δ tagO infection than Dif-Key flies, 
which are flies impaired in AMP expression [28]. So far, this topic has been 
overlooked in Drosophila immunity and the focus on the late AMPs 
expression and induction of the immune cascades has been extensively 
studied using several different bacterial types. In addition, PGN has been 
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shown to be required for phagocytosis of S. aureus [14] and two PGRPs 
have been identified as phagocytic receptors [16], [17]. 
In sum, the data points towards the importance of immediate 
responses that are dependent on PGRP-SA. I aimed to understand the 
impact of cellular immunity and particularly whether PGRP-SA plays a role 
in such responses. Therefore, I studied whether this PGRP is involved in 
phagocytosis, since PGRP-LC has already been identified as a phagocytic 
receptor [16]. In addition, PGRP-LC was identified as being exclusively 
involved in phagocytosis of Escherichia coli due to its specificity to DAP-
type PGN. As in the previous Chapter, I demonstrated that such specificity 
does not exist (for both receptors), I also aimed to understand if in the 
absence of WTA, i.e. with a more exposed PGN at the cell surface, both 
PGRP-SA and PGRP-LC could play roles in phagocytosis, similar to the 
recognition and activation of the immune cascades.  
I performed ex vivo time-lapse microscopy studies using D. 
melanogaster macrophages. Moesin belongs to the conserved family of 
ERM (ezrin-radixin-moesin) proteins. They function as molecular linkers 
between the actin cytoskeleton and the transmembrane receptors, but also 
localise at the nucleus [30]. Therefore, tracking Moesin localisation allows 
to follow the dynamics of the phagocytic processes at the cell membrane. 
Flies expressing a GFP-Moesin fusion have been used to study changes in 
cell shape during developmental stages [31]. Hence, I used GFP-Moesin 
larvae as a reference for a wild-type background. 
To study the effect of both PGRP-SA and PGRP-LC, I used larvae 
from the crosses of female semmelweis or semmelweis/PGRP-LCΔE12 virgin 
flies with GFP-Moesin male flies. The larvae collected for these experiments 
regarding the role of the PGRPs were male larvae. Thus, the macrophages 
extracted were homozygous for PGRP-SAseml, since the gene is present in 
chromosome I and heterozygous for PGRP-LC (chromosome III).   
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To address whether both PGRPs could also be promiscuous in 
phagocytic processes for the Lys- vs. DAP- type PGN, I used the same 
mutant bacterial strains of S. aureus and Bacillus subtilis. Lastly, if indeed 
cellular responses are vital against infection from the parental strains, then 
perhaps the WTA may also be involved as immune evasion mechanisms 
against phagocytosis and bacterial clearance. 
Briefly, third instar larvae were bled and the haemolymph was 
collected. The macrophages were allowed to settle and attach to the 
microscope slide (Video 1A). Afterwards, they were infected with the 
bacteria and imaged for 18h every 3min acquisition (Video 1B). The 
macrophages were visualised under the FITC channel for imaging of the 
GFP-Moesin which allowed to follow the phagocytic processes and the 
outcome upon infection (shown in green). The bacteria were previously 
stained with DAPI (shown in purple-pink) and when complementation 
experiments were conducted, it was added the TRITC channel for 
visualization of the mCherry_PGRP-SA protein (shown in blue). 
Unfortunately, mCherry_PGRP-LC showed to be toxic to the macrophages, 
thus it was not possible to perform complementation studies of this 
receptor in the semmelweis/PGRP-LCΔE12 macrophages (data not shown).  
  A.                                                     B. 
Macrophage.mov
                        
Macrophage with bacteria.mov
 
Video 1. Macrophages attached to the microscope slide in Schneider media or 
infected with bacteria. Video A. shows fixed macrophages attached to the slide 
through their lamellipodia. Filopodia are typically observed upon movement of the 
macrophages or during the engulfment of particles when they extend as “arms” to 
grab the material to be internalised, as it can be seen in Video B. when they are in the 
presence of bacteria. 
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Results 
 
Wild-type bacteria induce a fast mode of death in 
macrophages. 
Upon infection with S. aureus, the macrophages quickly show signs 
of high levels of cellular stress. They appear to enter a route of apoptotic 
death (Video 2 and Fig. 2). As described in Table 1, this type of cellular 
death is characterized by shrinking of the cell volume and karyorrhexis. On 
the other hand, B. subtilis are innocuous bacteria devoid of such virulence 
factors. Although it does not induce such a fast death of the macrophages 
like S. aureus, it was still observed the beginning of an apoptotic death, 
suggested by the shrinking of the cells (Video 4 and Fig. 2). In contrast, in 
the absence of bacteria, the macrophages did not enter a route of cellular 
death (Video 6).  When macrophages were infected with heat-killed S. 
aureus cells, there were no signs of induction of cellular death of the 
macrophages. The macrophages appeared healthy and able to control the 
infection through a canonical route of clearance phagocytosis-exocytosis 
after 18h post infection (p.i) (Video 7). When death of the macrophages 
happened, it appeared to be due to other factors than the presence of 
bacteria.  
 
WTA mutant bacteria are less virulent to the macrophages. 
The absence of WTA rendered the bacteria more susceptible for 
phagocytic-clearance processes. In the case of S. aureus Δ tagO, the 
macrophages survived for a longer period and initiated later a cellular 
death (Video 3 and Fig. 2). With the parental bacterial strain, the 
macrophages death started shortly after infection, ca. 1h15 p.i., whereas 
with the S. aureus Δ tagO mutant it was detected beginning of death  ca. 
~4h30 p.i.. As for B. subtilis Δ tagO, the macrophages did not die nor 
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presented any indication of cellular stress, in contrast to an infection with 
the parental strain (Video 5 and Fig. 2).  
 
GFPMoe_Saureus.mov  
Video 2. GFP-Moesin macrophages infected with S. aureus bacteria. 
GFPMoe_Saureus_tagO.mov  
Video 3. GFP-Moesin macrophages infected with S. aureus Δ tagO bacteria. 
GFPMoe_Bsubtilis.mov  
Video 4. GFP-Moesin macrophages infected with B. subtilis bacteria. 
GFPMoe_Bsubtilis_tagO.mov  
Video 5. GFP-Moesin macrophages infected with B. subtilis Δ tagO bacteria. 
GFPMoe_Schneider.mov  
Video 6. GFP-Moesin macrophages in Schneider media. 
GFPMoe_HeatKilled_Saureus.mov
 
Video 7. GFP-Moesin macrophages infected with heat-killed S. aureus cells. 
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Figure 2. Snapshots of GFP-Moesin macrophages infected with bacteria. It is shown 
snapshots of every 15min acquisition of the macrophages infected with bacteria from 
the videos 2-5, from time points 0-1h45 p.i.. It is clear that infection with S. aureus is 
very virulent to the macrophages when compared to any other bacteria. After 1h15 
they cease the dynamics of the filopodia and actin cytoskeleton. On the contrary, the 
B. subtilis Δ tagO mutant is devoid of virulence since the macrophages remain healthy 
and start spreading to engage in the phagocytic processes.  
PGRP-SA appears to be involved in bacterial clearance. 
 When semmelweis-GFP-Moesin macrophages were infected with 
each of the bacteria, I observed the same outcome of the macrophages, 
albeit the mutant macrophages appeared less healthy and succumbed to 
infection earlier than the GFP-Moesin macrophages (Videos 8-11 and Fig. 
3). Upon infection with S. aureus and S. aureus Δ tagO, the macrophages 
seem less dynamic in their movements of the filopodia and actin 
cytoskeleton (Videos 8 and 9). This may be an indication that perhaps 
there is some impairment in the canonical route of phagocytosis of these 
bacteria and there is an early triggering of an apoptotic death. An infection 
with B. subtilis strongly triggered death of the macrophages,  when 
compared to the wild-type background GFP-Moesin, and some 
macrophages do not survive the 18h of the time-lapse experiment (Video 
10). Regarding infection with B. subtilis Δ tagO, although I could not 
observe  cellular death, some macrophages presented signs of cellular 
stress: they ceased to be as dynamic as normal, over-expressed GFP-Moesin 
and the cells started to shrink (Video 11). 
Common to all infections, is the presence of bacteria inside the 
macrophages that seem to retain their shape. Thus, it appears that the 
bacteria are phagocytosed but accumulate in the cytoplasm because they 
are not being cleared and destroyed. This observation suggests that PGRP-
SA may have a role in bacterial clearance (see discussion).  
The addition of mCherry_PGRP-SA to the media followed by 
infection, restored the phenotypes to levels similar to the GFP-Moesin 
macrophages (Videos 13-16 and Fig. 4). The macrophages survive longer 
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and initiated later an apoptotic cell death when compared to the control 
mutant macrophages in non-rescue conditions (absence of 
mCherry_PGRP-SA).  
Regarding cellular localisation, whether in the absence of bacteria 
(Video 17), whether upon infection (Videos 13-16), mCherry_PGRP-SA 
was found mainly inside the macrophages. It was detected co-localised 
with the DAPI signal of the bacteria, extracellularly and intracellularly. 
Intracellularly, it was also found both at the cytoplasm and at the cell 
surface, most likely at the cell membrane. 
 
GFPMoe_seml_Saureus.mov
 
Video 8. Semmelweis-GFP-Moesin macrophages infected with S. aureus bacteria. 
GFPMoe_seml_Saureus_tagO.mov
 
Video 9. Semmelweis-GFP-Moesin macrophages infected with S. aureus Δ tagO 
bacteria. 
GFPMoe_seml_Bsubtilis.mov
 
Video 10. Semmelweis-GFP-Moesin macrophages infected with B. subtilis bacteria. 
GFPMoe_seml_Bsubtilis_tagO.mov  
Video 11. Semmelweis-GFP-Moesin macrophages infected with B. subtilis Δ tagO 
bacteria. 
GFPMoe_seml_Schneider.mov
 
Video 12. Semmelweis-GFP-Moesin macrophages in Schneider media. 
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Figure 3. Snapshots of Semmelweis-GFP-Moesin macrophages infected with 
bacteria. It is shown snapshots of every 15min acquisition of the macrophages 
infected with bacteria from the videos 8-11, from time points 0-1h45 p.i.. It is visible 
the presence of bacteria that retain almost their natural shape, particularly for S. 
aureus Δ tagO and B. subtilis, accumulating inside the macrophages. 
 
GFPMoe_seml_Saureus_mChPGRPSA.mov  
Video 13. Semmelweis-GFP-Moesin macrophages infected with S. aureus bacteria 
rescued with mCherry_PGRP-SA. 
GFPMoe_seml_Saureus_tagO_mChPGRPSA.mov  
Video 14. Semmelweis-GFP-Moesin macrophages infected with S. aureus Δ tagO 
bacteria rescued with mCherry_PGRP-SA. 
GFPMoe_seml_Bsubtilis_mChPGRPSA.mov   
Video 15. Semmelweis-GFP-Moesin macrophages infected with B. subtilis bacteria 
rescued with mCherry_PGRP-SA. 
GFPMoe_seml_Bsubtilis_tagO_mChPGRPSA.mov  
Video 16. Semmelweis-GFP-Moesin macrophages infected with B. subtilis Δ tagO 
bacteria rescued with mCherry_PGRP-SA. 
GFPMoe_seml_mChPGRPSA.mov  
Video 17. Semmelweis-GFP-Moesin macrophages in Schneider media rescued with 
mCherry_PGRP-SA. 
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Figure 4. Snapshots of Semmelweis-GFP-Moesin macrophages complemented with 
mCherry_PGRP-SA infected with bacteria. It is shown snapshots of every 15min 
acquisition of the macrophages infected with bacteria from the videos 13-16, from 
time points 0-1h45 p.i.. Interestingly, mCherry_PGRP-SA seems to mainly localise 
inside the cell, rather on the outside and it co-localises with the DAPI signal, hence it 
is bound to the bacteria. 
Both PGRPs seem to contribute to bacterial clearance. 
 When semmelweis/PGRP-LCΔE12-GFP-Moesin macrophages were 
infected with S. aureus, there was still death by apoptosis (Video 17 and 
Fig. 5). However, in contrast to what had been observed before, when these 
mutant macrophages were infected with S. aureus Δ tagO and B. subtilis 
bacteria, the macrophages died through necroptosis (Video 18-19 and Fig. 
5). In addition, these double mutant macrophages were also more 
susceptible to the non-virulent B. subtilis Δ tagO mutant (Video 20 and Fig. 
5).  
Similar to the single mutant background semmelweis-GFP-Moesin 
macrophages, these double mutant macrophages appear to be less 
dynamic regarding the filopodia movements with both S. aureus strains 
(Video 18). Moreover, it is also seen that the phagocytosed bacteria 
accumulate in the cytoplasm retaining almost their shape. This suggests 
that they were not being efficiently destroyed and so both PGRP-SA and 
PGRP-LC are involved in the clearance processes and the absence of both 
is more severe than the absence of a functional PGRP-SA.  
When these mutant macrophages were rescued with 
mCherry_PGRP-SA, the phenotypes upon infections were almost restored 
to the GFP-Moesin phenotypes (Videos 22-25 and Fig. 6) and I could no 
longer observe accumulation of bacteria inside the macrophages. 
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GFPMoe_semlLC_Saureus.mov  
Video 18. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with S. aureus 
bacteria. 
GFPMoe_semlLC_Saureus_tagO.mov
 
Video 19. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with S. aureus Δ 
tagO bacteria. 
GFPMoe_semlLC_Bsubtilis.mov  
Video 20. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with B. subtilis 
bacteria. 
GFPMoe_semlLC_Bsubtilis_tagO.mov  
Video 21. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with B. subtilis Δ 
tagO bacteria. 
GFPMoe_semlLC_Schneider.mov  
Video 22. Seml/PGRP-LCΔE12-GFP-Moesin macrophages in Schneider media. 
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Figure 5. Snapshots of seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with 
bacteria. It is shown snapshots of every 15min acquisition of the macrophages 
infected with bacteria from the videos 18-21, from time points 0-1h45 
p.i..Comparatively to the other macrophages, the macrophages infected with S. 
aureus appear very unhealthy and initiate an apoptotic death shortly after infection 
(the lamellipodia is retracted and the cells are shrinking). 
 
GFPMoe_semlLC_Saureus_mChPGRPSA.mov
 
Video 23. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with S. aureus 
bacteria rescued with mCherry_PGRP-SA. 
GFPMoe_semlLC_Saureus_tagO_mChPGRPSA.mov
 
Video 24. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with S. aureus Δ 
tagO bacteria rescued with mCherry_PGRP-SA. 
GFPMoe_semlLC_Bsubtilis_mChPGRPSA.mov
 
Video 25. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with B. subtilis 
bacteria rescued with mCherry_PGRP-SA. 
GFPMoe_semlLC_Bsubtilis_tagO_mChPGRPSA.mov
 
Video 26. Seml/PGRP-LCΔE12-GFP-Moesin macrophages infected with B. subtilis Δ 
tagO bacteria rescued with mCherry_PGRP-SA. 
GFPMoe_semlLC_Schneider.mov
 
Video 27. Seml/PGRP-LCΔE12-GFP-Moesin macrophages in Schneider media rescued 
with mCherry_PGRP-SA. 
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Figure 6. Snapshots of seml/PGRP-LCΔE12-GFP-Moesin macrophages complemented 
with mCherry_PGRP-SA infected with bacteria. It is shown snapshots of every 15min 
acquisition of the macrophages infected with bacteria from the videos 23-26, from 
time points 0-1h45 p.i.. In the S. aureus Δ tagO video, it is observed an example of 
death by necrosis from a macrophage that had not up taken mCherry_PGRP-SA.  
PGRP-SA shows binding and lytic activity at low pH. 
In the absence of a functional PGRP-SA, the macrophages 
accumulated bacteria in the cytoplasm and seemed to be impaired in 
clearance (Videos 7-10 and 17-20). This suggested that PGRP-SA is 
involved both in bacterial recognition and clearance processes. Upon 
phagocytosis, the phagosome containing the bacteria fuses with the 
lysosomes containing hydrolytic enzymes (Fig. 1). It is inside this 
phagolysosome that the bacteria will be destroyed, hence where it occurs 
the process of clearance. Typically, phagolysosomes present a very low pH 
that aids in the clearance process and enzyme activity. Hence, if indeed 
PGRP-SA is involved in the clearance process, it should be found with the 
bacteria enclosed in the phagolysosomes. Consequently, it should be able 
to bind to the bacteria and exert lytic activity at low pH.  
Accordingly, when wild-type bacteria S. aureus and B. subtilis were 
incubated with mCherry_PGRP-SA at pH 3, the protein showed a very high 
binding ability to these cells (Fig. 7). In contrast, when the pH approached 
the physiological pH of the haemolymph (pH 6), this binding was no longer 
detected (Fig. 8 and Fig. 2 of Chapter II). 
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Figure 7. Co-precipitation of live bacterial cells with mCherry_PGRP-SA at pH 3. 
Cultures in early exponential phase of the parental strains of B. subtilis and S. aureus 
were incubated with mCherry_PGRP-SA in 25 mM Glycine Buffer pH 3. The cells were 
imaged with a Texas Red filter at a very low exposition time of 30 ms. When using the 
same microscope and setting conditions the analysis of the these bindings are 
normally performed using an exposition time of 500 ms [28], [29]. 
In order to analyse a potential lytic activity of PGRP-SA, I 
performed Zymogram assays. Briefly, these assays consist of an SDS-PAGE 
gel where it is incorporated a substrate. The proteins to be studied are ran 
on the gel using standard protocol conditions. After the run, instead of 
staining the proteins, the gel is incubated in a buffer that will allow the 
proteins to renaturate. Finally, instead of staining the proteins as in a 
standard SDS-PAGE, it is stained the gel, i.e. the substrate. If the protein has 
lytic activity the substrate is degraded, therefore in the region where the 
proteins lies in the gel there is no substrate present. Therefore,  it is 
visualised a clear band at the place of the protein in the gel. 
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Figure 8. Co-precipitation of live S. aureus cells with mCherry_PGRP-SA at different 
pH. The left panel shows the binding of mCherry_PGRP-SA at pH 3 to S. aureus cells 
using optimal exposition time of 100 ms for visualisation of the binding. The right 
panel presents the binding of mCherry_PGRP-SA at different pH. The scale intensities 
were adjusted to the binding at pH 3. It was used a higher exposure time of the Texas 
Red as it would be possible to not detect binding at other pH due to using very low 
exposition times.  
Autoclaved cells of Micrococcus luteus, Microbacterium 
nematophilum and S. aureus were used as a substrates. When both 
mCherry_PGRP-SA and rPGRP-SA were analysed through the zymogram 
assay, I detected lytic acitvity of the protein, particularly at pH 3 (Fig. 9 and 
Fig. 10). M. nematophilum is a natural pathogen of C. elegans [32]. It is a 
Gram-positive bacterium that appears to have a very particular and 
intricate PGN composition resistant to the muramidase Mutanolysin from 
Streptomyces globisporus (personal communication from Hodgkin and 
Filipe Lab). In sum, it can be concluded that PGRP-SA possesses lytic 
activity, being able to cleave different types of PGN substrates while not 
inhibited by major PGN modification like most of the Lysozymes and 
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Muramidases (such as M. nematophilum) and to the O-acetylation of the 
muramic acid residue (such as S. aureus).  
 
Figure 9. Zymography assay of the lytic activity of mCherry_PGRP-SA at pH 3. The 
gels were incubated O/N at 37ºC in a Renaturing Buffer Tris-Glycine at pH 3. LytA is 
the major autolysin of Streptococcus pneumoniae with amidase activity and it was 
used as a negative control of the assay. The different colours of blue in the gels are 
associated with the different properties of these cells to be stained by the Methylene 
Blue. 
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Figure 10. Zymography assay of the lytic activity of rPGRP-SA at pH 6. To ascertain 
that the observed activity was related with the PGRP-SA protein and not by a non-
specific activity of the mCherry_PGRP-SA, an assay with the rPGRP-SA was performed 
using S. aureus cells. In this zymogram it was used a buffer at pH 6 and a higher 
concentration of rPGRP-SA than the one used for mCherry_PGRP-SA. Lysozyme was 
used as a negative control. 
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Discussion 
 
The process of bacterial clearance is believed to be highly 
dependent on the cellular responses of the Innate Immune System. 
Professional phagocytes, i.e. macrophages, uptake the pathogen through 
phagocytosis. Phagocytosis is inherently linked to the process of 
destruction and clearance. Up to date, the canonical route of clearance is 
the phagocytosis-exocytosis unidirectional flow (Fig. 1). However, it has 
been recently reported that this elegant and simple mechanism of 
pathogen destruction does not occur most of the times. Instead, the 
macrophages activate an apoptotic death upon phagocytosis [33].  Non-
pathogenic bacteria and bacteria that are easily killed by the macrophages 
have been reported to induce apoptosis after phagocytosis [33].  Evidence 
suggests that phagocytosis-induced apoptosis may be a natural response 
of the macrophages to different bacteria. In addition, an efficient clearance 
process is inherently dependent of an efficient recognition of the bacteria 
by the host receptors, as the phagocytosis process begins with the action 
of the opsonins that promote the uptake of the bacteria by the 
macrophages. 
There are three main modes of PCD which morphologically present 
characteristic distinctive features: apoptosis, necrosis and autophagy [20]. 
Nevertheless, the discrimination between cell death processes should rely 
on the observation of the morphology of the dying cells, on the detection 
of biochemical parameters of cell death and ultimately on the interaction 
of the macrophages that will phagocyte the dying cells [34]. In the present 
study, only morphological data was acquired regarding the death of the 
macrophages. Therefore, the analysis of the mode of death of the 
macrophages may be subject to re-adjustments upon future experiments. 
Hence, the interpretation of the results that I present next should be taken 
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as working hypothesis which will guide me to plan future experiments and 
conclude the work I present in this chapter.  
 
Bacterial-induced apoptosis. 
Pathogenic bacteria present numerous ways to subvert the host 
immune responses. S. aureus is a major Gram-positive pathogen that 
presents a number of virulence factors which compromise cellular 
responses, such as the expression of haemolysins and toxins (Fig. 11). 
Although it has been identified several mechanisms by which S. aureus 
subverts the phagocytosis and clearance, there is still not clarity in the field 
regarding the interaction with the macrophages. Nevertheless, it has been 
shown that it is able to replicate within human macrophages [35], [36] and 
that once inside the macrophages it upregulates antiapoptotic factors [37].  
Upon infection with S. aureus, the macrophages very early show 
signs of stress that culminated in cellular death (Video 2). It was observed 
ruffling of the membrane, retraction of the lamellipodia and ceasing of the 
filopodia movement. Moreover, it was evident the shrinkage of the cell size 
accompanied with the condensation of the DNA. Ultimately, the DNA 
presented signs of karyorrhexis. These observations strongly suggest that 
S. aureus infection induced apoptotic death of the macrophages. Therefore, 
the following data interpretation is based on the hypothesis that S. aureus 
triggered an apoptotic death in the macrophages. 
 In contrast, infection with heat-killed S. aureus cells did not trigger 
death and the dead bacteria were easily up taken and cleared (Video 7). 
These results suggest that the macrophages trigger apoptosis as a 
response towards the activity of the bacterial virulence factors, although 
to some extent the process of heat-killing might compromise at some level 
the integrity of the cell wall and render these cells more easily recognised 
and killed. This helps to explain the previous observed upregulation of 
antiapoptotic factors by S. aureus [37]. In addition, the need that the 
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bacteria have to impair macrophages apoptosis is an indirect evidence that 
induction of apoptosis upon phagocytosis is a natural immune response to 
promote the clearance. Moreover, this also helps to understand that the 
reported activation of caspases by the α–haemolysin [38], is not due to the 
haemolysin itself but rather it is a response of the cell towards the effect of 
the toxin. Before the cell is destroyed by the activity of the haemolysin, it 
induces apoptosis. 
When the macrophages were infected with the S. aureus Δ tagO 
mutant, the cellular death by a presumed apoptosis, happened later on in 
the infection course (Video 3). There was still induction of death 
(apoptosis), because the mutant bacteria bears the virulence factors of the 
parental strain, considering that the absence of WTA is not significantly 
impairing the activity of virulence factors (Fig. 11). Hence, the delay in the 
induction of apoptosis is due to a faster clearance of these bacteria (see last 
topic of the Discussion). As they are destroyed faster, it also takes longer 
for the activity of the virulence factors to achieve the wild-type levels 
required for the triggering of the apoptosis. 
To this type of apoptosis induced by bacterial factors, I will 
onwards refer to as “bacterial-induced apoptosis” (Fig. 12). This type of 
apoptotic death is a response of the macrophages against harm caused by 
the bacteria and it is different from the reported phagocytosis-induced 
apoptosis [33]: 1) the bacterial-induced apoptosis is dependent on the 
pathogenicity of the bacteria; 2) the apoptotic death is a slow process of 
death, in contrast to this apoptotic death which is unusually fast because it 
was triggered by a high sudden stress; 3) when the bacteria preserve their 
pathogenicity, the induction of apoptosis is delayed only when they are 
more easily destroyed, albeit the process of death is still faster than a death 
that is not caused by harmful virulence factors.  
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Figure 11. Haemolytic expression pattern in sheep blood. S. aureus presents 
haemolysins that are able to degrade red blood cells. The S. aureus Δ tagO mutant 
seems to retain the ability to express the same type of haemolysins to which the red 
blood cells of sheep are sensitive to. In contrast, B. subtilis is devoid of such lysins.  
 
Phagocytosis-induced apoptosis. 
 Infection with the innocuous soil bacteria B. subtilis also showed 
signs that can be interpreted as an apoptotic mode of death in the 
macrophages, although in a less potent manner than S. aureus. After 18h of 
infection, the macrophages had not yet finished the process of (apoptotic) 
death (Video 4). In contrast, the B. subtilis Δ tagO mutant did not induce 
any visible stress to the macrophages and appears to be easily 
phagocytosed and killed, through the canonical way of phagocytosis-
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exocytosis (Video 5). As B. subtilis is devoid of virulence and both wild-type 
and mutant strains present the same PGN muropeptide composition (Fig. 
13, Chapter II), it can be concluded that a more exposed PGN is rendering 
the cells more vulnerable to clearance and thus the macrophages are able 
to easily contain the infection. This implies that due to a more exposed 
PGN, the macrophages are able to efficiently and rapidly destroy the 
mutant cells. Hence, there is no cellular stress conditions that would 
require/induce an apoptotic death in order to control the infection. 
Therefore, the presence of the WTA is a bacterial cell wall factor that 
prevents an efficient killing after phagocytosis (see last section of the 
Discussion).  
In sum, upon infection with non-virulent bacteria, when the 
bacterial load is high and the rate of phagocytosis is higher than the rate 
by which the bacteria can be destroyed, the macrophages may trigger an 
apoptotic death – the phagocytosis-induced apoptosis (Fig. 12) [33]. This 
phagocytosis-induced apoptosis (Fig. 12) [33], may be a strategic 
mechanism of clearance by which the macrophages cope with the 
saturation of bacteria attached to their lamellipodia and inside the cell 
coupled with accumulation of bacteria in phagosomes/phagolysosomes. 
 
Apoptosis may be a Host mechanism of bacterial clearance. 
The fact that when bacteria are more easily cleared, the apoptosis 
upon phagocytosis becomes delayed or unnecessary, is an indication that 
apoptosis is a mechanism to promote bacterial clearance.  
Apoptosis presents itself as a type of PCD that helps the 
macrophages to continue/finish the process of clearance as it culminates 
in phagocytosis. The macrophages promote the clearance by forming the 
apoptotic bodies containing the bacteria and cellular fragments that will 
be phagocytosed (Fig. 12). This may be an advantage to the Host, rather 
than a death by necroptosis. The death by necroptosis results in the burst 
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of the cell with release of its contents, it induces inflammation and it would 
release the still viable bacteria and incomplete digested bacterial products 
into the blood stream. In table 2 it is presented the three types of proposed 
pathways of phagocytosis-clearance. 
 
Table 2. Phagocytosis-clearance pathways. 
 
 
A new look into the phagocytic ligand-receptors. 
There has been growing evidence of a dual role of phagocytic 
receptors both in phagocytosis of apoptotic cells and of bacteria. The 
Drosophila phagocytic receptors present in haemocytes that are involved 
in phagocytosis of apoptotic bodies are: Croquemort [5], [6], Draper [7], 
and NimC4/SIMU [8]. As for bacterial phagocytosis, the haemocyte 
phagocytic receptors are: Eater [9], Nimrod C1 [10], Dscam [11] and Peste 
[12]. Other bacterial phagocytic receptors expressed in other tissues than 
haemocytes are the PGRP-LC [16] and PGRP-SC1 [17]. 
The dSR-CI is thought to be involved in phagocytosis of both 
apoptotic bodies and microorganisms due to its broad polyanionic binding 
ability [39]. Integrin βυ [13], [14] and Integrin αPS3/βυ [15] have also 
been identified as phagocytic receptors of both apoptotic bodies and 
bacteria. Interestingly, later on Draper was reported to also be involved in 
phagocytosis of S. aureus [40].  
Integrin βυ was reported to bind to the S. aureus PGN and that this 
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binding was required for phagocytosis [23]  and Draper was shown to bind 
to LTA of S. aureus [40]. According to a line of thought in which apoptosis 
may be a mechanism of bacterial clearance, it is then possible that the 
apoptotic bodies can present bacterial products at the surface to promote 
their engulfment. Hence, perhaps the authors have observed the 
phagocytosis of apoptotic bodies formed upon bacterial phagocytosis. . 
The binding of Draper to LTA is an indirect evidence of this, since it has 
been shown that these wall polymers are not exposed at the surface and 
access to them requires the degradation of PGN [41]. 
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Figure 12. Phagocytosis-apoptosis process. The macrophages induce apoptosis whilst 
containing bacteria enclosed in phagosomes and phagolysosomes. These will be 
incorporated by the apoptotic bodies. The bacteria will be phagocytosed again and a 
new cycle of phagocytosis-clearance is initiated. This process is likely to be repeated 
for as long as it is necessary to completely destroy the bacteria. 
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PGRP-SA and PGRP-LC participate in clearance of both Lys- 
and DAP- type PGN bacteria. 
When functional PGRP-SA is absent, it appears that the phagocytic 
ability is not compromised, i.e. the internalisation of the bacteria is not 
affected (Videos 7-10). In semmelweis-GFP-Moesin macrophages, it was 
observed bacteria inside the macrophages that seem to retain their shape, 
and thus are likely to be alive, in contrast to what was observed in the wild-
type GFP-Moesin macrophages. In the absence of bacteria, when the 
semmelweis macrophages were complemented with mCherry_PGRP-SA, 
although predicted to be extracellular and circulating in the haemolymph, 
the protein was found localised inside the cell (Video 12-16). When these 
macrophages were infected with bacteria, then the protein co-localised 
with the bacteria thus being found both outside, inside at the cytoplasm 
overlapping with the bacterial DAPI staining or even at the cell surface of 
the macrophage. Moreover, it was no longer detectable so many intact 
bacteria inside the macrophage. These results show that these mutant 
macrophages are compromised in the clearance and thus PGRP-SA plays a 
role in this process for both Lys- and DAP- type PGN bacteria.  
 Similar to the single mutant macrophages, the semmelweis/PGRP-
LCΔE12-GFP-Moesin macrophages also showed accumulation of 
phagocytosed bacteria in their cytoplasm which retained almost their 
shape, again suggesting that the bacteria are not been being efficiently 
destroyed (Videos 18-21). Since these macrophages showed to be much 
more compromised in the response upon infection than the semmelweis 
macrophages (see next section of the Discussion), PGRP-LC is also involved 
in the clearance whether by a Lys- or DAP- type PGN bacteria.  
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PGRP-SA and PGRP-LC are opsonins of both Lys- and DAP- 
type PGN bacteria. 
So far it has been shown that apoptosis is triggered upon 
phagocytosis when the process of clearance is compromised. Moreover, it 
was observed that both PGRP-SA and PGRP-LC engage in the process of 
clearance. As such, the observation of an impaired clearance resulting in 
the uncontrolled death of the double mutant macrophages, corroborates 
the above findings (Videos 18-21 and Fig. 4). 
Regarding the S. aureus infection, the macrophages in a very early 
stage of infection show signs of apoptotic death, suggesting that the 
infection is very acute (Video 16 and Fig. 5). Hence, from a very initial stage 
of interaction, the double mutant macrophages sense the virulence of S. 
aureus as the wild-type macrophages do, responding quickly against 
infection through a fast triggering of apoptosis.  
When semmelweis/PGRP-LCΔE12–GFP-Moesin macrophages were 
infected with S. aureus Δ tagO and B. subtilis bacteria, the macrophages 
died by necroptosis (Videos 19-20 and Fig. 5).   
Perhaps, due to a high number of bacterial cells and/or difficulty in 
the clearance by the presence of WTA, B. subtilis infection triggers 
phagocytosis-induced apoptosis under most circumstances. Upon absence 
of both PGRPs, the clearance of the bacteria is more compromised than in 
the absence of PGRP-SA. Therefore, the growth of B. subtilis is not so well 
contained and the macrophages cannot manage an apoptotic death and 
succumb by necroptosis.  
Similarly for S. aureus Δ tagO, even with a more exposed PGN, 
because these PGRPs are needed for clearance and not just recognition, the 
macrophages are highly impaired in controlling the bacterial growth. 
As for the infection with B. subtilis Δ tagO, the macrophages die 
through apoptosis. Perhaps because this mutant strain is highly 
compromised in growth and cell division, on one hand it takes longer to 
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induce signalling dangers and on the other hand it is this feature that 
allows the macrophage to detect lack of clearance and still have time to 
begin an apoptotic death.  
When these double mutant macrophages are rescued with 
mCherry_PGRP-SA, the phenotypes upon infections are almost restored to 
the GFP-Moesin phenotypes (Videos 21-24 and Fig. 6). Then, that the 
presence of PGRP-SA can compensate to some extent the absence of one 
copy of PGRP-LC.  
As an overall, the data so far allow to infer that PGRP-SA and PGRP-
LC participate in the processes of phagocytosis-clearance and that the 
presence of WTA impair this clearance. Thus, both receptors can act as 
opsonins, participate in the clearance and may help to retain the bacteria 
and their non-totally digested products enclosed in a subcellular space 
until the apoptotic body is formed and phagocytosed. Through this 
mechanism, PGRP-SA and PGRP-LC limit the infection by helping to 
prevent the spreading of the bacteria that would occur if the cell did not 
induce its apoptotic pathway or rather would succumb by a necroptotic 
death. Finally, as it was not observed impaired uptake of the bacteria by 
any of the mutant macrophages tested, but it was observed earlier/later 
phagocytosis-induction apoptosis associated with impairment of the 
clearance, then this natural mechanism of apoptotic death is triggered not 
by the uptake/engulfment, but rather upon the formation of the 
phagolysosome and possibly the balance between the rate of uptake and 
the rate of clearance. 
 
PGRP-SA is a lytic enzyme that aids in bacterial clearance 
upon phagocytosis. 
PGRP-SA is a secreted protein that circulates in the haemolymph of 
the Fly. As such, it came as a surprise to find that the protein localised 
mostly in the macrophages, either at the cytoplasm or at the cell surface, 
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rather than almost exclusively in the extracellular medium (Videos 12-16 
and 21-24). Since the phenotype upon infection of the mutant 
macrophages was restored with the addition of mCherry_PGRP-SA and the 
fluorescent signal of the mCherry co-localised with the DAPI signal of the 
bacteria, what was observed was the localisation of the fusion protein and 
not of a cleaved form separating the mCherry from the PGRP-SA protein. 
Hence, how come a secreted protein seems to be mostly found inside the 
cell? Since it was not observable differences in the uptake of the bacteria, 
but it seemed that they accumulated in the cytoplasm whilst not being 
cleared, then when inside the cell, PGRP-SA is participating in clearance. 
Moreover, as it was observed that the binding of mCherry_PGRP-SA to the 
bacteria seemed to be higher when the bacteria were inside the cell which 
suggests that PGRP-SA binds better when inside rather than outside the 
cell.  Consequently, if indeed PGRP-SA participates in bacterial clearance, 
it should be present with the bacteria inside the phagolysosomes. Thus, the 
protein ought to bind and possess hydrolytic activity at a low pH. 
 Accordingly, when live cells of either parental strains from S. 
aureus and B. subtilis were incubated with mCherry_PGRP-SA at pH 3, the 
protein showed optimal ability to bind to these cell walls (Fig. 6), in 
contrast to what had been observed when the assays were performed in 
the haemolymph physiological pH (Fig. 2, Chapter II). As the pH rises, the 
binding decreases, thus there is an inverse proportionality between the pH 
and the binding ability of PGRP-SA (Fig. 7). In addition, at pH 3 
mCherry_PGRP-SA showed to be able to cleave the PGN from different 
bacterial types (Fig. 8). The reason for an optimal binding of the protein of 
the bacterial cell surface, might be related to a partial breakdown of the 
WTA polymers upon acidic conditions [42], coupled with the denaturation 
of the cell wall proteins. The optimal activity of the protein at low pH for 
both binding and lytic activity favours the hypothesis of it being involved 
in bacterial clearance and present inside the phagolysosomes. Perhaps, the 
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reason for PGRP-SA having such strong activity at low pH is so that the 
destruction happens in a confined compartment in order that the 
fragments of destroyed bacteria are not spread and circulate in the 
haemolymph as it could provoke toxicity, inflammation and/or an 
anaphylactic shock. 
 
WTA impair phagocytosis and clearance because 
degradation of the PGN is vital for bacterial destruction. 
 Both S. aureus Δ tagO and B. subtilis Δ tagO mutants showed 
decreased virulence towards the macrophages than the correspondent 
parental strains. Since the only difference between these mutants and the 
wild-type strains is a more exposed PGN at their cell wall due to the lack of 
WTA, it implies that WTA are impairing phagocytosis and clearance.  
The results also suggest that for efficient killing, the degradation of 
PGN is paramount for bacterial destruction inside the phagolysosomes. As 
a consequence, one may assume that WTA impair the effect of the 
hydrolytic PGN enzymes present inside the phagosome, perhaps in a 
similar fashion as they prevent PGRP recognition. Thus, WTA are 
impairing the binding of PGRP-SA and PGRP-LC as receptors and their 
activity in the clearance upon phagocytosis. 
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Conclusions 
 
In this Chapter I present novel data regarding phagocytosis and 
bacterial clearance by the macrophages of Drosophila melanogaster.  
I show evidence that possibly the macrophages present two 
different canonical ways of phagocytosis-clearance processes: 1) 
phagocytosis-exocytosis and 2) phagocytosis-apoptosis. The occurrence of 
one process or the other seems to be highly dependent on the type of 
bacteria – virulent/non-virulent, easily killed or not – and also on the 
bacterial load. Apoptosis is triggered by the cell to promote clearance as a 
response towards: 1) high levels of pathogenicity that harm the 
macrophages and 2) high numbers of bacteria to be phagocytosed which 
is in turn dependent on how efficient the process of PGN degradation is 
inside the phagolysosomes. The formed apoptotic bodies will then be 
phagocytosed and this process of phagocytosis-induced apoptosis may 
happen several times until the bacteria are completely cleared. It is 
possible that the apoptotic macrophages use bacterial components as 
ligands to promote/improve their phagocytosis. The non-phagocytosed 
bacteria are again recognised by PGRP-SA and PGRP-LC, which will play 
their roles as receptors that trigger the late-induced AMPs by the TOLL and 
IMD pathways. The secreted systemic AMPs target the bacteria that were 
not contained by the cellular responses.  
I present data that suggests that both PGRP-SA and PGRP-LC 
engage in cellular responses and both participate in the clearance of the 
bacteria. Moreover, also at the level of clearance, the WTA impair the 
activity of these PGRPs.  
Lastly, I showed that PGRP-SA possesses lytic activity. Since it 
showed promiscuity towards the binding and cleavage of different types 
of PGN, it is probable that the protein cleaves at the glycan chains. This 
proposed activity is different from the L,D-carboxypeptidase activity 
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proposed by Chang et al. 2004 [43] and from the serine proteases activity 
proposed by Reiser at al. 2004 [44]. Furthermore, since the glycans are the 
most conserved moiety of the PGN, it is intuitive to think that a protein 
involved in pathogen degradation (as well as recognition) would target the 
most conserved region of the molecule. To compensate for the existence of 
lysozymes in the host, it is possible that PGRP-SA may possess a 
glucosaminidase activity. 
I propose a model whereby PGRP-SA and PGRP-LC detect bacteria 
through recognition of their PGN and act as opsonins promoting 
phagocytosis. Upon phagocytosis, these PGRPs are also involved in 
bacterial clearance. PGRP-SA is likely to localise at the phagolysosome 
where it exerts a strong lytic activity towards the PGN at very low pH.  
In order to ascertain the interpretations that I presented, further 
work needs to be done which will continue to make the most of the 
microscopy techniques. The use of microscopy, in particularly time-lapse 
microscopy, is still the first method of choice to study cell death, since it 
allows to follow the morphological changes and the kinetics of the 
processes. Nevertheless, it is important to correlate these observable 
morphological changes with the kinetic of the different biochemical 
parameters that distinguish apoptosis from necroptosis. A simple and 
common method consists in the detection of propidium iodide and 
phosphatidylserine. The propidium iodide is a fluorescent membrane-
impermeable dye (it stains the nuclei). The phosphatidylserine is actively 
localized on the inner leaflet of the plasma membrane in healthy cells. 
Thus, they allow to determine loss of cell membrane integrity. In most 
cases, phosphatidylserine positivity precedes the propidium iodide 
positivity in apoptotic cells, whilst the two events coincide in necrotic cells 
[34]. Subsequently, to further characterise the apoptotic process, it is 
possible to perform caspase activity assays. Regarding the co-localisation 
of PGRP-SA in the phagolysosome, experiments of tracking of 
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lysosomes/phagolysosomes, should show the presence of mCherry_PGRP-
SA and the bacteria inside these acidic compartments. Finally, to properly 
characterise a lytic activity of PGRP-SA, not only should other controls be 
included, such as the mCherry protein alone, but it should also be 
identified the cleavage site at the PGN molecule. 
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Materials and Methods 
 
Bacterial Strains and culture, Flies and Protein purification. 
The bacterial parental and mutant strains of S. aureus and B. 
subtilis and the fly strains semmelweis and semmelweis/PGRP-LCΔE12 used 
were the same and were grown as described in Chapter III. For the 
zymogram assays it was used M. luteus DMS20030 [45], M. nematophilum 
CBX102 (provided by M. J. Gravato-Nobre, Hodgkin Lab), S. aureus NCTC 
8325-4 and NCTC 8325-4 Δ oat Δ tagO [28]. GFP-Moesin flies [31] were 
used as a wild-type background for the ex vivo assays of the macrophages. 
The proteins rPGRP-SA and mCherry_PGRP-SA were purified as 
described previously. LytA was also purified from BL21 cells, using a DEAE 
cellulose resin and Lysozyme was purchased from Sigma-Aldrich 
(Germany).  
 Haemolytic assays were performed as described in Chapter II.  
 
Time-lapses microscopy experiments. 
Macrophage preparation. 
When the role of PGRP-SA was accessed, only male larvae from a 
cross of semmelweis or semmelweis/PGRP-LCΔE12 female virgins with GFP-
Moesin were collected for the experiments.  Three third instar larvae were 
washed in 1 mL of ddH2O followed by 50% (v/v) bleaching and vortex. The 
larvae were quickly washed three times with autoclaved MilliQ H2O and 
left swimming whilst the slides were prepared. Into previously washed 
metal slides (100% (v/v) Ethanol) with a 1.0 mm coverslip it was put 
Schneider medium supplemented with 5% (v/v) Fetal Calf Serum. The 
larvae were bled into the medium and the macrophages were let settle for 
1h at RT in a humid chamber. 
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Preparation of the bacteria. 
200 µL of an O/N culture were harvested at RT and washed with of 
Schneider. The cells were resuspended in 200 µL of Schneider with 0.5 µL 
of a DAPI solution (at 1 mg/mL in MilliQ H2O) and incubated for 5 min at 
RT, without shaking. The cells were washed with 200 µL of Schneider and 
resuspended in 100 µL of Schneider. Finally, they were dilute 1/10 in 
Schneider in a 200 µL final volume. 
 
Imaging of the macrophages with the bacteria. 
To the macrophages slide, 200 µL of the bacterial suspension was 
added and a YSI 5775 Standard Membrane (YSI Incorporated, Japan) was 
glued on top. For rescue of the PGRP-SA phenotype, it was added 180 μL of 
mCherry_PGRP-SA at 0.3 µg/µL in Schneider (fresh solution) and 20 μL of 
non-diluted cells. Acquisition was done at 25ºC in a humid chamber for 
18h every 3min in a GE Healthcare DeltaVision Elite integrated imaging 
system, using an Olympus MPLAPON-Oil immersion objective (100X 
1.40A). The Photometrics Evolve-512 EMCCD camera for high-sensitivity 
imaging was used to allow lower intensities of excitation light. For 
denoising, it was used Denoise Prism with default parameters except: no. 
of iterations 3, adaptability 10 and patch radius 3. Analysis of the data was 
performed using softWoRx® (AppliedPrecision®, USA), which permitted 
the conversion of the time-lapse images into a “.mov” file at 5 frames/sec. 
 
Live bacteria co-precipitation assays. 
The binding assays of mCherry_PGRP-SA with live cells were 
conducted as before, expect that it was used a 25 mM Glycine pH 3. Images 
were acquired with a Zeiss Axio ObserverZ1 microscope equipped with a 
Photometrics CoolSNAP HQ2 camera (Roper Scientific using Metamorph 
software, Meta Imaging series 7.5) and analysed using the ImageJ software. 
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Zymography assay.  
The zymogram presented in Figure 9 was performed as described 
in Vaz and Filipe, 2015 [46], except that the renaturing buffer was replaced 
by 250 mM Tris; 20 mM Glycine pH 3 and 5 µg of mCherry_PGRP-SA and 
LytA were loaded on the gels.  The protocol of  Figure 10 was performed 
with some differences, since it was the original protocol for Zymography, 
from which it was optimized into what is now the protocol described by 
Vaz and Filipe, 2015 [46]. 
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CHAPTER V 
Bacteria present mechanisms to evade cellular and 
humoral responses mediated through 
peptidoglycan recognition by PGRP-SA and PGRP-LC 
 
 In this thesis I present novel data regarding the interaction of the 
Host and the Bacteria, particularly in the Fruit Fly. I believe that these 
results will help to further understand the intricate and complex 
interactions that happen when the Host meets the pathogen. 
 I started by unravelling how PGRP-SA can detect a bacteria 
through recognition of its peptidoglycan (PGN). The recognition relies on 
the access to PGN that is surface exposed at the septum during cell division. 
The binding of PGRP-SA is dependent on the probability of meeting a 
bacteria that is in a certain stage of cell division that temporarily presents 
newly synthesised PGN at the septum which has not yet been incorporated 
into the polymer mesh. Thus, the coordination of the synthesis of new PGN, 
degradation of old chains and the joining of the new material with the old, 
is crucial for the bacteria not only to survive but also to escape from PGRP-
SA recognition. It is likely that other PGN receptors may target the same 
region. I identified that Sle1 has a vital role for cell splitting and re-shaping 
of the septum by giving physical space through cleavage of old PGN that 
permit the incorporation of the new material. I propose a model in which 
efficient evasion of PGN detection during cell division is determined by the 
activity of the autolysins in coordination with the incorporation of new 
PGN. In addition, I showed that less virulent bacteria, induce lower levels 
of antimicrobial peptides (AMPs). Therefore, I inferred that it was because 
of a lower bacterial load in circulation which in turn is due to a better 
cellular early response. As these responses proved to be highly dependent 
on PGRP-SA recognition, I hypothesised that PGRP-SA could be involved in 
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cellular responses of clearance. However, what was evident from the data 
gathered at that moment, was that recognition of PGN is key for a potent 
and efficient immune response. Since the virulence by haemolysins, which 
target the haemocytes, was not affected in the non-virulent atl mutant, 
recognition of PGN, up to certain levels, is sufficient for survival of the Host. 
Subsequently, for as long as the PGN is not accessible by PGRP-SA (and 
probably other PGRPs), the bacteria can efficiently employ its virulence 
factors. Thus, protection of PGN from Host receptors is paramount for 
bacteria to establish an infection. Accordingly, the subsequent findings 
corroborated these interpretations and conclusions. 
 I next addressed how the Host discriminates (or not) different PGN 
types. I showed that PGRP-SA and PGRP-LC can recognise both Lys- and 
DAP- type PGN and act as bacterial receptors of both phagocytosis and late 
induced AMPs responses. Upon recognition of PGN by PGRP-SA and PGRP-
LC, there is the triggering of phagocytosis. It is likely that bacteria that 
survive the phagocytosis-clearance processes, are again recognised by 
both PGRPs which trigger the TOLL and IMD cascades. This results in the 
expression of the AMPs, whose primary function is to kill the remaining 
bacteria and protect the Host from reincidence of infection.  
Regarding the phagocytic processes, these proteins appear to not 
only act as receptors but also to be involved in the clearance of the bacteria. 
The results suggest that upon phagocytosis, the bacteria-PGRPs complex 
are internalised into the phagosome and seems to continue to the stage of 
the phagolysosome. At this structure, with a low and optimal pH for PGRP-
SA binding and lytic activity, the protein helps in the cleavage of the PGN. 
The biological reason for this lytic activity to be best at low pH may have 
to do with the fact that it helps to eliminate the bacteria in a controlled 
manner. When inside a vesicle, the products released from PGRP-SA 
cleavage are contained in an enclosed environment. If PGRP-SA would 
possess a high activity at the haemolymph`s pH, it could be detrimental for 
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the Host as it would perhaps accumulate bacterial debris and provoke 
toxicity and acute inflammation.  As PGRP-SA is promiscuous for different 
PGN types and since the glycans are the most conserved region of the 
macromolecule, PGRP-SA probably cleaves the glycan backbone.  
Moreover, the data points towards two phagocytosis-clearance 
pathways employed by macrophages: 1) phagocytosis-exocytosis and 2) 
phagocytosis-apoptosis. The phagocytosis-exocytosis is the canonical 
route and it occurs only when the bacteria is not pathogenic and when it is 
a bacteria that can be easily destroyed in the phagolysosomes. Under 
certain cases, it is likely that the phagocytosis-exocytosis might end up in 
the phagocytosis-apoptosis route. For instance, under stress conditions 
that the macrophages may feel compromise in the clearance processes, or 
if it is the case that even a very susceptible bacteria may be present in very 
high numbers. The phagocytosis-apoptosis seems to be triggered under 
two different situations. One is in response to the pathogenicity of the 
bacteria. It is a protective mechanism to avoid a death caused by the 
bacterial factors which would result in an uncontrolled death and 
therefore, the inability to control the infection. Through apoptosis, the 
macrophages aim to contain the already internalized bacteria and drive 
them into a new process of phagocytosis. The other situation occurs when 
non-pathogenic bacteria are present in high number. In this scenario, the 
macrophages are saturated with bacteria at their surface ready to be 
phagocytosed whilst accumulating the phagosomes/phagolysosomes to 
clear the bacteria. As the rate of clearance does not level up with the 
amount of bacteria to be internalised, the macrophages trigger apoptosis.  
As a result of apoptosis, the bacteria are contained inside the 
apoptotic bodies. These bodies may present at their surface bacterial 
components originated from the initial bacterial degradation. These would 
serve as ligands for the phagocytic receptors, thus promoting the 
phagocytosis and hence the clearance process by other macrophages. It is 
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likely that this process of phagocytosis-apoptosis repeats itself, until 
complete clearance of the bacteria.   
In addition, efficient early and late immune responses are 
dependent on the access of PGRP-SA and PGRP-LC to the PGN. Bacteria that 
have a more exposed PGN are easier to be detected thus, in terms of the 
time course of infection, as the responses can be triggered more quickly, 
the resolution of the infection is quicker for the Host. Also, a more exposed 
PGN renders the bacteria more susceptible both to the destruction by the 
Host lytic enzymes, via the phagocytosis-clearance route and to the activity 
of the late induced AMPs.   
I propose a model whereby from the side of the bacteria, the WTA 
and the OM are conserved immune evasion mechanisms that are 
transversal to bacteria. They compose a protective barrier that shields the 
PGN from the outer environment.  It is the access of the PGRPs through the 
cell wall that dictates the recognition of the PGN. From the side of the Host, 
I propose a model whereby it possesses two major receptors, PGRP-SA and 
PGRP-LC. They are promiscuous to different types of PGN composition and 
they participate in both cellular-early and humoral-late responses.  
I believe that the work presented in this thesis helps to re-shape 
the current model of bacterial detection in the Fly and perhaps, at some 
level, it may be possible to extrapolate for other Hosts. I hope that it opens 
up new questions that will bring answers regarding how we perceive 
bacteria, how do they hide and subvert our protective responses and what 
can we do to achieve a balance when this interaction is detrimental to us, 
Humans, as Hosts.  
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